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1 Introduction 
1.1 Spindle orientation in eukaryotes 
Correct assembly and orientation of the mitotic spindle is crucial for proper segregation of 
chromosomes and for determination of cell fate. Errors in chromosome segregation can give 
rise to aberrant numbers of chromosomes (aneuploidy), which is often correlated with 
development of cancer. The orientation of the mitotic spindle can furthermore influence 
distribution of cellular contents to daughter cells and in multicellular organisms positioning of 
the daughter cell in the tissue. In higher eukaryotes, orientation of the mitotic spindle also 
dictates the exact position of the cleavage furrow, hence its correct orientation is required to 
determine whether the cell divides asymmetrically or symmetrically (Figure 1) 
(Rappaport 1997; Betschinger and Knoblich 2004; Glotzer 2004; Neumuller and 
Knoblich 2009).  
 
Figure 1 Cartoon representation of asymmetric and symmetric cell divisions. Cell polarity is established 
through different cell polarity determinants (brown dots, red and blue lines indicate different poles). Arrows 
indicate cell polarity axes. For asymmetric divisions, the mitotic spindle (green lines and dots) is aligned along the 
cell polarity axis, ensuring asymmetric distribution of cell fate determinants (brown dots). For symmetric cell 
divisions the mitotic spindle is oriented perpendicular to the polarity axis, leading to a symmetric distribution of 
molecules. Illustration taken from http://www.ifom-ieo-campus.it/research/images/mapelli/figI.jpg 
 
Asymmetric cell division is a very common and highly conserved mechanism to generate two 
daughter cells with different cell fates (Figure 1). This type of cell division is governed by 
intrinsic and extrinsic signals that influence cell polarity. Alteration of cell polarity may also 
change the position of the cleavage furrow. This results in an asymmetric distribution of cell 
content and can additionally affect the size of daughter cells. Three different mechanisms are 
known to affect cell polarity: 1. asymmetric localisation of cell polarity regulators, which is 
usually accomplished by reorganisation of the actomyosin network, 2. cell fate determinants 
localising exclusively to given regions of a polarised cell or 3. regulated orientation of the 
mitotic spindle in respect to the environment and the cell axis (Palmer, Sullivan et al. 1992; 
Rhyu and Knoblich 1995). Well studied examples are the one-cell embryo of C. elegans, 
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neurogenesis in Drosophila, the budding yeast S. cerevisiae and stem cells in mammalians 
(Betschinger and Knoblich 2004; Siller and Doe 2009). All examples will be explained in 
more detail in the following chapters. Asymmetric cell division also occurs in prokaryotes 
such as the bacterium Caulobacter crescentus (Jenal 2000). 
Symmetric cell division, on the other hand, gives rise to daughter cells with identical cell fates 
(Figure 1). These divisions occur in all proliferating and growing tissues of multicellular 
organisms, e.g. during development or in injured tissues. In contrast to asymmetric divisions, 
the spindle is oriented by passive mechanisms at the center of the cell in this process 
(McCarthy and Goldstein 2006). 
Mitotic spindles consist of two spindle poles (centrosomes) and three different types of 
microtubules. All microtubules are nucleated from their minus end by the gamma-tubulin 
complex at the spindle poles (Moritz, Braunfeld et al. 2000; Wiese and Zheng 2000). Astral 
microtubules probe the cytoplasm and cell cortex with their plus-ends and are required for 
orientation of the spindle along the polarity axis. Inward extending kinetochore microtubules 
attach to chromosomes to align and segregate them together with interpolar microtubules 
(Mitchison and Salmon 2001). All microtubules undergo a constant process of growth and 
shrinkage at their plus-ends through rapid tubulin addition and substraction, so called 
“dynamic instability” (Mitchison and Kirschner 1984). Dynamic instability allows astral 
microtubules to probe the cytoplasm for cortical anchor sites and to exert forces on the 
spindle (Inoue and Salmon 1995). Although microtubules attach with their plus-ends to 
cortical sites or kinetochores, dynamic instability is not inhibited and forces are exerted on 
the mitotic spindle resulting in displacement of the spindle. In addition, forces on the mitotic 
spindle can be generated by minus-end directed motor proteins, translocating along cortically 
attached microtubules.  
Spindle orientation is one example of important processes that depend on the interaction 
between actin filaments and microtubules. Actin-based motors interact with proteins (+TIPs) 
located at free plus-ends of astral microtubules. Translocation of these motors along actin 
filaments then generates force resulting in displacement of microtubules and the mitotic 
spindle. This crosstalk between actin-based motors and +TIPs is a well conserved feature in 
eukaryotes (Lansbergen and Akhmanova 2006). 
Spindle orientation is best understood in the budding yeast S. cerevisiae, which will be 
outlined in more detail, with examples from higher eukaryotes, in the following chapters. 
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1.1.1 Spindle orientation in Saccharomyces cerevisiae 
Budding yeast divides asymmetrically, with daughter cells smaller at the time of division than 
mother cells. Given that the yeast bud can divide for several generations, Yamashita and 
colleagues even proposed that it is a primitive stem cell equivalent (Yamashita and 
Fuller 2008). Budding yeast undergoes a closed mitosis, without breakdown of the nuclear 
envelope. Therefore spindle orientation correlates to orientation of the nucleus. Many of the 
relevant proteins involved in spindle orientation in budding yeast are evolutionarily 
conserved, making this organism a powerful tool for investigation of the underlying molecular 
details (Siller and Doe 2009).  
The axis of cell polarity is established during G1-phase of the cell cycle by localisation of 
Cdc 42p to the cell cortex at the incipient bud site (Figure 2A). In haploids the bud site is 
adjacent to the previous one, whereas in diploids buds are formed from either end 
(Bretscher 2003). Cdc 42p is a member of the Rho/Rac like family of Ras-GTPases. It is 
involved in cell polarisation, control of reorganisation of the actin cytoskeleton, septin 
recruitment to the future bud site and septin ring assembly. Reorganisation of the actin 
cytoskeleton at bud emergence results in assembly of two types of F-actin: actin filament 
bundles (cables) that extend from the incipient bud site into the cell and actin patches at the 
cortex forming a necklace-type ring around the incipient bud site (Adams and Pringle 1984; 
Kilmartin and Adams 1984). Both types of F-actin are constantly reorganised during the cell 
cycle (Bretscher 2003). Septin proteins are subsequently accumulating around the incipient 
bud site, marking the bud neck (Pruyne and Bretscher 2000).  
After establishment of polarity, the mitotic spindle has to be aligned correctly along the so 
called mother-bud axis to ensure proper chromosome segregation. Spindle orientation in 
budding yeast is controlled by two partially redundant pathways: the early pathway (Bim1p-
Kar9p-Myo2p pathway), aligns the mitotic spindle along the mother-bud axis before 
anaphase (Miller and Rose 1998; Yin, Pruyne et al. 2000; Liakopoulos, Kusch et al. 2003), 
whereas the late pathway (dynein-dynactin pathway) elongates the spindle through the bud 
neck during anaphase (Lee, Tirnauer et al. 2000; Grava, Schaerer et al. 2006) (Figure 2B). 
Each pathway can rescue defects in the other one. However, a knock-out of components in 
both pathways impairs nuclear segregation and results in lethality (Carminati and Stearns 
1997; Miller and Rose 1998).  
Astral microtubules and microtubules required for the formation of the mitotic spindle 
emanate from spindle pole bodies (SPBs), the yeast equivalent of centrosomes. SPBs are 
cylindrical multilaminate organelles embedded in the nuclear envelope (Byers, Shriver 
et al. 1978; O'Toole, Winey et al. 1999). Duplication of the SPB occurs during G1-phase of 
the cell cycle (Figure 2A). The new and the old SPB are subsequently separated to form the 
mitotic spindle (Jaspersen and Winey 2004). The old SPB is destined for the daughter cell 
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and consequently oriented towards the bud neck, whereas the new SPB stays in the mother 
cell (Pereira, Tanaka et al. 2001). SPB asymmetry is established by three different steps: 
1. In S-phase Clb5p associated kinase inhibits microtubule nucleation from the new SPB until 
a bipolar spindle is formed (Segal, Clarke et al. 2000). 2. Localisation of the protein Kar9p 
from the early spindle orientation pathway is restricted to the old SPB (Liakopoulos, Kusch 
et al. 2003; Maekawa, Usui et al. 2003). 3. Dynein involved in the spindle elongation pathway 
localises to the old SPB during metaphase (Grava, Schaerer et al. 2006). 
 
 
 
Figure 2 Mitotic spindle orientation in S. cerevisiae (A) Cell cycle in budding yeast. Image was taken from 
D.W. Haley, Yeast Resource Center, University of Washington. Microtubules are labelled in green and DNA in 
red. (B) Cartoon representation of the two pathways involved in spindle orientation and elongation in budding 
yeast.  
 
The early and the late pathway of spindle orientation 
The early pathway of spindle orientation promotes capture of astral microtubules emanating 
from the old SPB at the bud cortex before anaphase. These microtubules are then guided 
into the nascent bud via association of microtubule plus-ends with actin cables at the bud 
neck and bud tip resulting in an orientation of the mitotic spindle along the mother-bud axis 
(Moore and Cooper 2010; Merlini and Piatti 2011). This process involves the EB1-family 
member Bim1p, the adapter Kar9p (related to adenomatous polyposis coli (APC)) and the 
type-V myosin Myo2p (Figure 2B). Myo2p generates the force required for spindle orientation 
via translocation along actin filaments. The research presented here investigates the role of 
the proteins Bim1p and Kar9p in this pathway. These proteins will be introduced in more 
detail in following chapters (see 1.2.1 and 1.3.1).  
After the mitotic spindle is aligned along the mother-bud axis, astral microtubules are 
captured at the bud neck and bud tip by the actin- and formin-binding protein Bud6p 
(Segal, Bloom et al. 2000). Bud6p localises to those regions in a septin-dependent manner 
(Luedeke, Frei et al. 2005). While attached to the cortex, these microtubules undergo 
shortening, resulting in final orientation of the mitotic spindle (Adames and Cooper 2000; 
Kusch, Meyer et al. 2002; Huisman, Bales et al. 2004). 
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During anaphase, the nuclear envelope is elongated and the old SPB translocated through 
the bud neck by the late pathway. This pathway requires the minus-end directed dynein-
dynactin complex, a large multi-subunit complex conserved in all eukayotes 
(Eshel, Urrestarazu et al. 1993; Carminati and Stearns 1997). The dynein-dynactin complex 
is transported to microtubule plus-ends at the bud neck and bud tip by several associated 
proteins, where it is cortically anchored and activated. The activated dynein-dynactin 
complex then generates force with its minus-end directed motor activity, resulting in 
microtubule sliding along the cell cortex, thereby pulling the old SPB toward the bud cortex 
(Adames and Cooper 2000).   
Budding yeast has evolved at least two control mechanisms to ensure proper orientation of 
the mitotic spindle (Caydasi, Ibrahim et al. 2010). First of all, the redundancy of both 
pathways involved in spindle orientation ensures that upon failure of one pathway the other 
pathway can still rescue correct orientation of the mitotic spindle. Besides this redundancy, 
yeasts have developed the so called spindle position checkpoint (SPOC), which prevents 
cells exiting from mitosis with misaligned spindles. The SPOC delays exit from mitosis by 
inhibiting the mitotic exit network (MEN). Further details are beyond the scope of this 
introduction, but several reviews can guide the interested reader (Schuyler and Pellman 
2001; Piatti, Venturetti et al. 2006; Fraschini, Venturetti et al. 2008; Caydasi, Ibrahim et al. 
2010; Merlini and Piatti 2011). 
 
1.1.2 Spindle orientation in the Caenorhabditis elegans zygote 
The C. elegans zygote is one of the best understood model systems for generating 
asymmetric cell sizes. The zygote divides into a larger anterior AB cell and a smaller 
posterior P1 cell (Cowan and Hyman 2004; Neumuller and Knoblich 2009). This first mitotic 
division relies on reorganisation of the cortical actin cytoskeleton (Moore and Cooper 2010). 
After fertilisation, the cortex of the zygote is covered with a meshwork of actin filaments 
(Figure 3A). Symmetry is broken by a cue associated with the position of the sperm 
pronucleus (paternal nucleus) within the egg (Pearson and Bloom 2004; Munro and 
Bowerman 2009). Subsequently, the actomyosin network retracts away from the sperm cue 
to the anterior half of the cell cortex, thereby subdividing the cortex into an anterior and a 
posterior domain (Figure 3A) (Cowan and Hyman 2004; Munro and Bowerman 2009; 
Moore and Cooper 2010). Polarisation of the cell is further established by enrichment of 
evolutionary conserved polarity determinants (Par proteins) within the anterior and posterior 
domain. A complex formed by Par-3, Par-6 and the atypical protein kinase C (aPKC-3) 
retracts together with the actomyosin network towards the anterior domain, whereas Par-2 
and Par-1 become enriched at the posterior domain upon depletion of the other proteins 
(Figure 3A) (Gonczy 2008). The asymmetric distribution of the Par proteins results in a 
 INTRODUCTION  
6 
differential localisation of cell fate determinants. Asymmetry of Par proteins furthermore 
guides the orientation of the spindle along the anterior-posterior axis by controlling 
microtubule-cortex interactions (Kusch, Liakopoulos et al. 2003). Subsequent displacement 
of the spindle towards the posterior pole ensures correct segregation of cell fate 
determinants and occurrence of unequally sized daughter cells (Figure 3A). Pulling forces to 
orient and position the spindle are exerted by attachment of astral microtubule plus-ends to 
cortically anchored dynein-dynactin complexes (Siller and Doe 2009). Posteriorly directed 
forces are higher than anteriorly directed forces, resulting in spindle displacement toward the 
posterior pole (Gusnowski and Srayko 2011). In contrast to budding yeast, force for spindle 
orientation is generated by dynein motor activity, whereas force for spindle positioning is 
generated by microtubule depolymerisation at the plus-ends and the dynein-dynactin 
complex simply acting as a cortical anchor (Siller and Doe 2009).  
 
1.1.3 Spindle orientation in the Drosophila melanogaster neuroectoderm 
Spindle orientation during asymmetric cell division  
Drosophila neuroblasts are a well-established model system for studying the molecular 
mechanisms of tissue-renewing and asymmetric stem cell division. Asymmetric cell division 
is one of the primary mechanisms of neural stem cells (neuroblasts) to generate neuronal 
diversity (Kim and Hirth 2009). The mono-layered neuroectoderm of Drosophila embryos 
contains pre-neuroblasts that delaminate from the monolayer to undergo asymmetric 
divisions along the apical-basal axis (Figure3B) (Bienz 2001). Each asymmetric division 
gives rise to a larger apical neuroblast that retains its stem cell characteristics and a smaller 
basal ganglion mother cell (GMC) (Gonczy 2008; Kim and Hirth 2009). The smaller ganglion 
mother cell inherits cell-fate determinants that enable the cell to undergo a terminal division 
to produce two post-mitotic neurons/glial cells (Kim and Hirth 2009). Apical-basal polarity is 
established before the pre-neuroblast delaminates from the polarised epithelium. The 
delaminating neuroblast inherits the highly conserved Par-complex proteins Bazooka 
(Baz/Par-3), Par-6 and aPKC, (see chapter 1.1.2) from the neuroectoderm (Kim and 
Hirth 2009; Siller and Doe 2009). The Par-complex then binds through Baz to several 
adapter proteins that interact with the heterotrimeric G protein subunit, Gαi (Egger, Chell 
et al. 2008). Gαi itself binds to the microtubule-associated adapter Mud, which either directly 
anchors microtubules at the cortex or possibly recruits the dynein-dynactin complex to the 
apical cortex. Analogue to S. cerevisiae and C. elegans, pulling forces are exerted to align 
the spindle along the apical-basal axis (Siller and Doe 2009).  
Similar to S. cerevisiae, a second, eventually redundant spindle orientation pathway involving 
the kinesin Khc73 exists in Drosophila neuroblasts (Kim and Hirth 2009; Siller and 
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Doe 2009). The latter is primarily active during metaphase, whereas the Par/Mud-pathway is 
active prior to metaphase (Yu, Kuo et al. 2006). 
 
 
Figure 3 Asymmetric cell divisions in higher eukaryotes. (A) Molecular mechanism involved in cell-polarity 
determination in the C. elegans zygote. A: Initial asymmetry is established by reorganisation of the actin-
cytoskeleton. grey: paternal nucleus, blue/orange: F-actin/Myosin II. B: Differential localisation of Par-proteins in 
concert with the reorganisation of the actin-cytoskeleton further establishes cell polarity. green: Par-3, Par-6, 
PKC-3, red: Par-1, Par-2. Picture taken from (Toyoshima and Nishida 2007). (B) Asymmetric cell divisions in 
Drosophila neuroblasts. The mitotic spindle is oriented along the apical-basal axis. Apical-basal polarity is 
established by differential localisation of cell-fate determinants (light and dark grey). Neuroblasts divide into self-
renewing neuroblasts and ganglion mother cells (GMC), which can undergo differentiation. Picture taken from 
(Munro and Bowerman 2009).  
 
Spindle orientation during symmetric cell divisions 
Epithelial cells in the neuroectoderm can also undergo symmetric cell divisions along the 
planar axis (Bienz 2001). The cue for symmetric cell divisions is provided by adherens 
junctions, which mediate adhesion between epithelial cells (Bienz 2001). This cue depends 
on a homologue of the tumour suppressor adenomatous polyposis coli (APC) namely 
E-APC (dAPC2) and the microtubule-end binding protein 1 (dEB1) (Lu, Roegiers et al. 2001). 
APC has been proposed to be a functional homologue of Kar9p in budding yeast whereas 
dEB1 is a homologue of Bim1p, suggesting a similar role in spindle orientation. E-APC 
associates with adherens junctions and is required for planar spindle orientation together 
with dEB1 (Bienz 2001). Since E-APC is missing its C-terminal domain mediating 
EB1-binding and does not bind dEB1 (Lu, Roegiers et al. 2001), it remains elusive how both 
proteins contribute to spindle orientation. One possible link is the other Drosophila 
APC-homologue (dAPC) that contains the EB1-binding region, but it is not known if dAPC is 
involved in this process (Bienz 2001). APC is furthermore important for the alignment of the 
spindle in male germline stem cells (mGSCs) in Drosophila, possibly by linking adherens 
junctions with microtubules (Toyoshima and Nishida 2007). 
 INTRODUCTION  
8 
1.1.4 Spindle orientation in mammalians 
Similar to Drosophila neuroblasts, mammalian stem cells undergo asymmetric or symmetric 
divisions, depending on the orientation of the mitotic spindle along the planar or apical-basal 
axis (Pease and Tirnauer 2011). Establishment of cell-polarity depends on the formation of 
cell-cell junctions and cell-extracellular matrix (ECM) interactions (Pease and Tirnauer 2011). 
Spindle orientation is also dependent on the evolutionary conserved Par-proteins and the 
dynein-dynactin complex, as already described for C. elegans and Drosophila (see chapter 
1.1.2 and 1.1.3). Cortical attachment sites for astral microtubules are provided by adherens 
junctions (Siller and Doe 2009; Pease and Tirnauer 2011). In HEK293 cells and HeLa cells, 
positioning of the mitotic spindle in the geometrical center of the cell requires APC and/or 
EB1 (Toyoshima and Nishida 2007). A knock-down of APC in HEK293 cells by RNAi results 
in spindle misorientation due to destabilisation of astral microtubules. APC has been shown 
to stabilise microtubules through its binding to microtubules and EB1 (Pease and 
Tirnauer 2011). Additionally, APC plays a role in cell polarisation, suggesting that mutations 
of APC could cause spindle misorientation by altering cortical cues. (Etienne-Manneville, 
Manneville et al. 2005). This effect may be mediated by interaction of APC with components 
of the actin cytoskeleton or with the adherens-junctions associated protein β-catenin 
(Nathke 2005). 
Taken together, these results show the importance of APC in controlling spindle orientation 
through effects on astral microtubule stabilisation and cell cortex polarisation in mammalian 
cells (Pease and Tirnauer 2011). Whether its role is similar to Kar9p remains unknown. 
Another interesting question is whether the Par/dynein pathway and the APC/EB1 pathway in 
Drosophila and mammalians function independently in spindle orientation or exhibit a similar 
redundancy as the Kar9p/Bim1p and dynein-dynactin dependent pathways in S. cerevisiae.  
 
1.2 EB1-like family of proteins 
Members of this highly conserved family are so called +-TIP proteins, which associate with 
and selectively track the growing plus-ends of microtubules (Lansbergen and Akhmanova 
2006; Wolyniak, Blake-Hodek et al. 2006; Morrison 2007; Akhmanova and Steinmetz 2011). 
All members of the EB1-like family are characterised by an N-terminal CH- (calponin-
homology) domain, a flexible linker region (middle domain), and a C-terminal 
dimerisation/cargo-binding domain, the so called EB1-like motif (Figure 4A,C) (Bu and 
Su 2003). The structures of the CH-domain and the EB1-like motif have been solved 
individually. (Honnappa, John et al. 2005; Slep, Rogers et al. 2005; Slep and Vale 2007; 
Honnappa, Gouveia et al. 2009) (Figure 4B).  
The highly conserved CH-domain mediates binding to microtubules (Hayashi and Ikura 2003; 
Slep and Vale 2007) and is responsible for the autonomous microtubule plus-tip tracking 
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activity (Bieling, Laan et al. 2007). The C-terminal domain of EB1 comprises a coiled-coil 
mediating the dimerisation of these proteins (Honnappa, John et al. 2005; Slep, Rogers 
et al. 2005; De Groot, Jelesarov et al. 2010) and binding to cargo (Honnappa, Gouveia 
et al. 2009). Heterodimerisation of the CH-domain is furthermore a prerequisite in vivo for 
microtubule binding and plus-end localisation (Slep and Vale 2007; Zimniak, Stengl 
et al. 2009; De Groot, Jelesarov et al. 2010). 
Common features of EB1-like proteins are the promotion of microtubule polymerisation and 
the association of microtubules with kinetochores, the cell cortex or the actin cytoskeleton 
(Akhmanova and Hoogenraad 2005; Akhmanova and Steinmetz 2008). Drosophila EB1 and 
budding yeast Bim1p increase catastrophe frequencies of microtubules whereas fission 
yeast Mal3p and vertebrate EB1 decrease catastrophe frequencies (Lansbergen and 
Akhmanova 2006). In vivo experiments indicate that Bim1p and EB1 localise exclusively to 
the plus-ends of microtubules (Tirnauer, O'Toole et al. 1999; Mimori-Kiyosue, Shiina 
et al. 2000), whereas Mal3p has additional functions. Electron microscopy (EM) together with 
metal-shadowing revealed that Mal3p interacts with the microtubule lattice seam. Further 
results strongly suggest that Mal3p is stabilising microtubules by “clamping” the lattice seam 
(Sandblad, Busch et al. 2006). If this is also true for Bim1p or EB1 remains to be shown.   
 
1.2.1 Bim1p 
BIM1 (binding to microtubules) has been first identified in a yeast-two hybrid screen using the 
entire coding sequence of TUB1 (encoding α-tubulin) as bait (Schwartz, Richards 
et al. 1997). Deletion mutants of BIM1 are viable, but have a strong bilateral karyogamy 
defect. Additionally, deletion of BIM1 results in hypersensitivity to the microtubule 
destabilising drug Benomyl, aberrant spindle behaviour, nuclear positioning defects and 
growth defects at extremely high (≥ 37°C) or low (≤ 14°C) temperatures (Schwartz, Richards 
et al. 1997). Synthetic lethality is observed with mutations of tub1, spindle assembly 
checkpoint genes and genes encoding kinetochore components (Mayer, Pot et al. 2004). 
Overexpression of BIM1 results in lethality and cell-cycle arrest in wild-type cells (Schwartz, 
Richards et al. 1997). Localisation experiments with Bim1p show that it colocalises with 
intranuclear and extranuclear microtubules in wild-type cells, presumably by binding sites on 
α-tubulin (Schwartz, Richards et al. 1997). Tirnauer and colleagues have shown that Bim1p 
localises to dots at the distal ends of microtubules and regulates microtubule dynamics in a 
cell-cycle dependent manner (Tirnauer, O'Toole et al. 1999). The authors furthermore 
showed that a deletion of BIM1 affects the length and dynamics of microtubules during G1 
phase, indicating a role of Bim1p in promoting dynamic instability of microtubules (Tirnauer, 
O'Toole et al. 1999).  
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Sequence alignments confirm that Bim1p belongs to the highly conserved family of EB1-like 
proteins. Bim1p is well conserved, with 33-36 % identity and 56-61% similarity of the protein 
sequence to its human, mouse, Drosophila and S. pombe homologues (Schwartz, Richards 
et al. 1997) (Figure 30).  
For Bim1p structural information is only available for the N-terminal CH-domain (Slep and 
Vale 2007), whereas for the C-terminal EB1-like motif of Bim1p only the homologous crystal 
structure from human EB1 has been published so far (Honnappa, John et al. 2005; Slep, 
Rogers et al. 2005) (Figure 4A-C). Since both proteins share about 35% sequence identity, 
structure predictions are of limited reliability (Rost 1999).  
Structural analyses of the tubulin-binding CH-domains together with biochemical analyses 
have revealed common properties of those domains (Slep and Vale 2007). Superimposition 
of the crystal structures of Bim1p with human EB1 shows a high structural conservation 
within this class of proteins, suggesting that this might be also true for the EB1-like motif 
(Slep and Vale 2007). Additional experiments demonstrated that the homodimerised 
CH-domain together with the middle domain of Bim1p potently promotes microtubule binding 
and polymerisation, which agrees with the results of Tirnauer and colleagues showing that 
Bim1p affects microtubule dynamics (Tirnauer, O'Toole et al. 1999; Slep and Vale 2007; 
Zimniak, Stengl et al. 2009) (Figure 4C). 
 
Role of Bim1p in the early spindle orientation pathway 
Together with Kar9p, Bim1p is essential for the early spindle orientation pathway in budding 
yeast. An interaction between both proteins was first observed in a yeast-two hybrid screen 
using full-length Kar9p as bait (Korinek, Copeland et al. 2000; Miller, Cheng et al. 2000). 
A double knock-out of BIM1 and KAR9 is viable, indicating that only the early spindle 
elongation pathway is affected. In contrast, double knock-outs of BIM1 or KAR9 with genes 
of the late pathway are lethal (Miller, Cheng et al. 2000).  
Co-immunoprecipitation experiments with either protein confirmed their interaction in vivo 
(Korinek, Copeland et al. 2000; Lee, Tirnauer et al. 2000; Miller, Cheng et al. 2000). A direct 
interaction between Bim1p and Kar9p was also observed in vitro using in vitro synthesised 
radiolabelled Kar9p and Bim1p expressed in E. coli (Korinek, Copeland et al. 2000). 
Furthermore, co-immunoprecipitation experiments with Bim1p and Kar9p co-expressed in 
vitro in rabbit reticulocyte lysate confirmed strong interaction between both proteins 
(Lee, Tirnauer et al. 2000). Moreover, Bim1p and Kar9p co-fractionated in velocity 
sedimentation and size-exclusion experiments (Lee, Tirnauer et al. 2000). The size of the 
complex was estimated to be 250 kDa based on the Stokes radii and Svedberg values, 
suggesting that several molecules of each protein are present in the complex or that 
additional factors contribute to the complex (Lee, Tirnauer et al. 2000).  
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Upon deletion of BIM1, localisation of Kar9p to the bud tip or the SPB was not altered, 
whereas localisation of Kar9p along cytoplasmic microtubules was affected (Miller, Cheng 
et al. 2000). These data suggest that Bim1p plays a direct role in the interaction of 
cytoplasmic microtubules with the cortical dot of Kar9p. In vitro experiments showed that 
Bim1p efficiently promotes recruitment of Kar9p onto microtubules, whereas Kar9p alone 
does not bind microtubules efficiently (Lee, Tirnauer et al. 2000).  
A minimal binding region in Bim1p for Kar9p has been mapped by yeast-two hybrid 
experiments. This region encompasses 89 residues (187-254) and comprises the EB1-like 
motif (Miller, Cheng et al. 2000). The high conservation of this region strongly suggests that 
the mode of cargo-binding is similar in all EB1-family members. However, further delineation 
of this region with specific mutations is required to determine the residues involved in binding 
to Kar9p.  
In addition to its role in spindle orientation, Bim1p localises to the nucleus and is important 
for the structural stability of the anaphase spindle (Gardner, Haase et al. 2008). 
Bim1p supports a stable interpolar microtubule (ipMT) overlap in the spindle midzone by 
promoting polymerization of ipMTs during anaphase, which is required for proper spindle 
elongation (Khmelinskii and Schiebel 2008). Bim1p is furthermore required for efficient sister 
chromatid cohesion (Mayer, Pot et al. 2004). Taken together, these results indicate that 
Bim1p plays several roles at different locations. However, most of the molecular details and 
the regulation of Bim1p activity remain undetermined.  
One possible regulation mechanism of Bim1p activity might be through phosphorylation by 
Aurora B/Ipl1p. Bim1p associates directly with the Ipl1p kinase and becomes phosphorylated 
at six serine residues in the flexible middle domain (Zimniak, Stengl et al. 2009). 
Phosphorylation of Bim1p occurs in mid to late anaphase and reduces binding of Bim1p to 
microtubules. Also human EB1 interacts with Aurora-B kinase (Sun, Gao et al. 2008), 
suggesting conservation of this posttranslational modification. 
 
1.2.2 human EB1 
The sequence of human EB1 is to 35 % identical with its yeast ortholog Bim1p (Schwartz, 
Richards et al. 1997). EB1 was initially identified as a protein that interacts with the 
C-terminal part of the adenomatous polyposis coli (APC) tumour suppressor protein 
(Su, Burrell et al. 1995). The C-terminal domain of EB1 is important for interaction with APC, 
the dynactin component p150glued and spectraplakins (Bu and Su 2003; Slep, Rogers 
et al. 2005). EB1 targets APC to microtubules and a stable interaction between EB1 and 
APC is required for microtubule capturing and stabilisation (Nakamura, Zhou et al. 2001; 
Wen, Eng et al. 2004). In humans, the C-terminal EB1-like motif is sufficient to bind to a 
peptide of the APC protein (Honnappa, John et al. 2005; Slep, Rogers et al. 2005). Likewise 
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in yeast the EB1-like domain of Bim1p is sufficient to bind to Kar9p (Miller, Cheng 
et al. 2000). The APC-EB1 interaction is likely to be critical for cancer progression of many 
malignant human colon tumours. The majority of APC mutations in those tumours lack the 
EB1-binding site, suggesting that the abrogation of the APC-EB1 interaction may contribute 
to cancer progression (Powell, Zilz et al. 1992; Su, Burrell et al. 1995; Tirnauer and 
Bierer 2000). 
 
Crystal structures of human EB1 
Crystal structures of the CH domain from yeast and human (Hayashi and Ikura 2003; 
Slep and Vale 2007) and of the EB1-like motif from human EB1 (Honnappa, John et al. 2005; 
Slep, Rogers et al. 2005) have been determined (Figure 4B). The structure of the CH-domain 
is very similar to the one in Bim1p and all features of this domain have been already 
described in chapter 1.2.1.  
The crystal structure of the C-terminal EB1-like motif reveals a dimeric structure formed by a 
coiled-coil that folds back to form a four-helix bundle (Slep, Rogers et al. 2005). Each 
monomer consists of a long smoothly curved helix, which is followed by a hairpin-like loop 
and a short second helix at the C-terminus (Honnappa, John et al. 2005) (Figure 4B). The 
four-helix bundle contains many highly conserved residues forming a hydrophobic core 
(Honnappa, John et al. 2005; Slep, Rogers et al. 2005). The large hydrophobic surface 
buried in this bundle is also expected to contribute to the stability of the EB1-dimer 
(Honnappa, John et al. 2005). Of particular significance is a highly conserved “FYF”-motif 
flanked by several acidic residues (Slep, Rogers et al. 2005). This region is a putative cargo-
binding site. 
To identify residues in EB1 that bind cargo, surface plasmon resonance experiments using a 
fragment of the mammalian spectraplakin MACF (Slep, Rogers et al. 2005) and ITC 
experiments using an APC-derived C-terminal peptide (Honnappa, John et al. 2005) were 
performed. MACF and APC both bind to EB1 with a similar binding motif, suggesting that 
their binding modes are similar (Slep, Rogers et al. 2005). Mutational analysis of the highly 
conserved region in EB1 revealed a cluster of residues along the long helix with particular 
importance of the highly conserved “FYF”-motif (Slep, Rogers et al. 2005). These results 
have been confirmed by co-crystallisation of the EB1-like motif with MACF and by NMR 
analysis of the EB1-like motif with a peptide of APC (Honnappa, Gouveia et al. 2009).  
The high degree of conservation of the binding regions in either EB1 or APC/MACF argues 
for a similar mode of cargo binding. The functional homologue of APC in yeast (Kar9p) does 
not have a repeat motif as APC or MACF, but shares limited sequence homology to the EB1-
binding-mediating domain in APC (Bienz 2001). It will be therefore interesting to compare the 
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molecular basis of the APC-EB1 and the Kar9p-Bim1p interaction to determine if similar or 
unique features govern these interactions (Slep, Rogers et al. 2005).  
  
 
Figure 4 EB1-like family of proteins (A) Domain composition of EB1-like proteins. All proteins have an 
N-terminal CH-domain followed by an unstructured linker domain and a C-terminal dimerisation/cargo-binding 
domain (EB1-motif). (B) Crystal structure of the C-terminal domain of human EB1. Image was taken from 
(Slep, Rogers et al. 2005). PDB-ID: 1YIB. (C) Structural organisation of EB1-like proteins. Crystal structures of the 
N-terminal CH-domain and the C-terminal EB1-like motif are depicted as surface representations. Dashed lines 
indicate flexible linker regions. The binding site for APC is indicated in blue and green. Picture taken from 
(Slep, Rogers et al. 2005) 
 
 
1.3 Role of other proteins involved in spindle orientation 
1.3.1 Kar9p 
The KAR9 gene was originally identified as a bilateral karyogamy mutant (Kurihara, Beh 
et al. 1994). There have been many functional studies reported in yeast (Miller and 
Rose 1998) but there is not much information available about the protein itself. The protein 
has an overall size of 644 amino acids and a molecular weight of 74 kDa. It consists of an 
N-terminal acidic domain, a coiled-coil region in the middle and a proline-rich and basic 
domain at the C-terminus (Figure 6A). Within different yeast species this protein is highly 
conserved and there is the previously mentioned functional homolog APC in higher 
eukaryotes. Kar9p and APC have sequence homologies at their C-termini, which mediates 
the binding to Bim1p in yeast and respectively to EB1 in higher eukaryotes (Bienz 2001). 
Kar9p initially localises together with Bim1p to the spindle pole body (SPB) independently of 
astral microtubules (Liakopoulos, Kusch et al. 2003; Maekawa and Schiebel 2004). 
Interestingly the homolgues EB1 and APC also localise to centrosomes, the equivalent of 
SPBs (Louie, Bahmanyar et al. 2004). In contrast to Bim1p, Kar9p localises exclusively to the 
mother SPB destined for the daughter cell. (Liakopoulos, Kusch et al. 2003; Maekawa, Usui 
et al. 2003; Maekawa and Schiebel 2004; Miller, D'Silva et al. 2006). This step is critical for 
proper spindle orientation and tightly regulated, ensuring deployment of Kar9p to astral 
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microtubules adjacent to the bud (Liakopoulos, Kusch et al. 2003; Maekawa, Usui et al. 
2003; Maekawa and Schiebel 2004; Miller, D'Silva et al. 2006). Kar9p localises to the SPB in 
G1 phase of the cell-cycle and moves to the plus-end during S phase and metaphase 
(Maekawa, Usui et al. 2003). This translocation is enhanced by the kinesin related Kip2p and 
requires the plus-end tracking proteins Bik1p (CLIP-170), Stu2p (XMAP215) and Bim1p 
(Moore and Cooper 2010). Interestingly, the Kar9p-homolog APC also moves to the end of 
microtubules in a kinesin-dependent manner (Bloom 2000; Mimori-Kiyosue, Shiina 
et al. 2000). Located at the plus-ends of dynamically growing microtubules, Kar9p can 
encounter cortical Myo2p. Through interaction with the globular tail (cargo binding) domain of 
Myo2p, the Kar9p-decorated microtubules are then guided along actin filaments into the bud 
(Beach, Thibodeaux et al. 2000; Yin, Pruyne et al. 2000; Hwang, Kusch et al. 2003). A fusion 
protein of Myo2p and Bim1p is sufficient to orient the spindle in the cell, supporting the role of 
Kar9p as adapter protein (Hwang, Kusch et al. 2003). The Myo2p-Kar9p dependent transport 
of microtubules along actin filaments furthermore enhances the efficiency of microtubule 
capture at the cortex. As previously mentioned (chapter 1.1.1), microtubules are captured at 
the cortex by the formin-binding protein Bud6p. This protein is also required to maintain 
Kar9p at the bud cortex (Beach, Thibodeaux et al. 2000; Huisman, Bales et al. 2004).  
 
Posttranslational modifications of Kar9p 
Kar9p is subjected to three different types of posttranslational modifications: phosphorylation, 
sumoylation, and ubiquitination. Phosphorylation of Kar9p is required for asymmetric 
localisation of Kar9p to the mother SPB (Liakopoulos, Kusch et al. 2003; Maekawa, Usui 
et al. 2003; Maekawa and Schiebel 2004; Miller, D'Silva et al. 2006; Moore and Miller 2007). 
Asymmetric localisation of Kar9p is regulated by the yeast Cdk1 Cdc28p in a Clb5p/Clb4p 
(B-type cyclins) dependent manner (Liakopoulos, Kusch et al. 2003; Maekawa, Usui 
et al. 2003; Maekawa and Schiebel 2004; Moore and Miller 2007). Two Cdc28p-dependent 
phosphorylation sites have been identified in Kar9p, at serines 197 and 496 
(Liakopoulos, Kusch et al. 2003; Maekawa, Usui et al. 2003; Maekawa and Schiebel 2004; 
Miller, D'Silva et al. 2006; Moore and Miller 2007). Serine 496 lies within the homologous 
region to APC. Since APC is also phosphorylated (Trzepacz, Lowy et al. 1997), modification 
of this residue is thought to represent a conserved mechanism for regulated association with 
microtubules and microtubule organising centres (Liakopoulos, Kusch et al. 2003; Honnappa, 
John et al. 2005; Moore and Miller 2007). Mutations that disrupt Cdc28p or Clb5p/Clb4p 
activity as well as mutations of the phosphorylation sites in Kar9p result in localisation of 
Kar9p to both SPBs (Liakopoulos, Kusch et al. 2003; Maekawa and Schiebel 2004; 
Moore and Miller 2007; Moore and Cooper 2010). This possibly results in an orientation of 
microtubules from both SPBs towards the bud (Liakopoulos, Kusch et al. 2003; 
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Moore, D'Silva et al. 2006; Moore and Cooper 2010). Phosphorylation of serine 197 is critical 
for the essential function of Kar9p revealed by the absence of dynein, whereas 
phosphorylation of serine 496 is not (Moore and Miller 2007). Phosphomimetic mutations of 
Kar9p rescue asymmetric localisation of Kar9p to the mother SPB when Cdc28p or Clb5p 
are mutated. Phosphorylation of serine 496 is of particular importance for its localisation to 
the mother SPB, whereas phosphorylation of serine 197 attenuates the interaction of Kar9p 
with Stu2p (Moore and Miller 2007). Taken together these results indicate that 
phosphorylation by Cdc28p allows Kar9p to recognise an intrinsic asymmetry between the 
SPBs (Moore and Miller 2007; Moore and Cooper 2010). However, molecular details remain 
unclear. 
Two recent studies identified four lysine residues in Kar9p that are sumoylated 
(Leisner, Kammerer et al. 2008) and one leucine residue that alters sumoylation of Kar9p 
(Meednu, Hoops et al. 2008). In both studies, mutations of those residues impair localisation 
of Kar9p to one SPB, but the overall findings differ from each other in both studies.  
Meednu and colleagues identified L304 which upon mutation to proline disrupts the 
interaction with proteins in the sumoylation pathway in yeast-two hybrid screens. The 
interaction to other Kar9p binding proteins such as Bim1p, Stu2p, Bik1p and Myo2p was not 
disrupted (Meednu, Hoops et al. 2008). L304 is in close vicinity to a SUMO consensus site 
(Ψ K x D/E, K301), suggesting a regulatory role of L304 in sumoylation of K301 (Hay 2005; 
Meednu, Hoops et al. 2008). They furthermore show that Kar9p is sumoylated in vitro on at 
least two residues by proteins of the sumoylation machinery (Meednu, Hoops et al. 2008). 
Sumoylation of proteins can also be influenced by phosphorylation. Consistently a 
phosphomimetic mutant (A196E S197E) does not interact with the sumoylation machinery 
anymore in yeast-two hybrid screens (Meednu, Hoops et al. 2008). Although these results 
suggest a regulatory role of phosphorylation for sumoylation of Kar9p, the molecular details 
and the in vivo relevance remain unclear.  
In the other study, Leisner and colleagues identified four lysine residues in Kar9p that are 
sumoylated (K301, K333, K381, and K529) in vivo (Leisner, Kammerer et al. 2008). A yeast 
strain expressing a Kar9p version that has mutated all four sumoylation sites fails to 
accumulate Kar9p asymmetrically on the mother-directed spindle pole body and emanating 
astral microtubules (Leisner, Kammerer et al. 2008). They could furthermore show that 
sumoylation and phosphorylation regulate Kar9p asymmetry independently 
(Leisner, Kammerer et al. 2008). Since sumoylation is hardly detectable in G1 phase but well-
established during metaphase, this modification was proposed to have a positive effect on 
the function of Kar9p during mitosis (Leisner, Kammerer et al. 2008). Meednu and 
colleagues furthermore detected in a yeast-two hybrid screen that sumoylation might control 
multimerisation of Kar9p (Meednu, Hoops et al. 2008). But it might also control the 
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accessibility of Kar9p to other regulators, or the interaction with microtubule or SPB 
associated proteins such as Bim1p, Bik1p, Stu2p. Further in vitro binding assays will be 
required to study the role of sumoylation of Kar9p (Leisner, Kammerer et al. 2008).  
In constrast to sumoylation, the ubiquitination of Kar9p requires phosphorylation of Kar9p by 
Cdc28p (Kammerer, Stevermann et al. 2010). Upon ubiquitination Kar9p is degraded by the 
proteasome. Both processes depend on an intact cleavage apparatus (septins and formins) 
and the transport of Kar9p to the bud neck by Myo2p. Mutations that prevent Kar9p 
ubiquitination enhance the interaction of astral microtubules with the cortex at the cleavage 
plane (Hotz and Barral 2010). Ubiquitination of Kar9p is especially important after the 
metaphase-anaphase transition to maintain the correct orientation of the mitotic spindle. 
Kammerer and colleagues proposed that ubiquitination affects the binding of Kar9p to Myo2p 
and reduces the interaction between astral microtubules and the bud neck (Kammerer, 
Stevermann et al. 2010).   
 
1.3.2 Adenomatous polyposis coli (APC) 
APC is the functional homolog of yeast Kar9p in higher eukaryotes. It is much larger in size 
than Kar9p and involved in many different processes (Bienz 2001; Nathke 2004) 
(Figure 5A,B). In humans, mutations in APC or loss of APC are responsible for development 
of familial adenomatous polyposis (FAP) and resulting colorectal cancer (Half, Bercovich 
et al. 2009). Loss of the C-terminal part of APC that mediates binding to EB1 is also 
correlated with tumorigenesis (Powell, Zilz et al. 1992; Su, Burrell et al. 1995; Tirnauer and 
Bierer 2000). APC is a multifunctional protein that is involved in degradation of β-catenin and 
plays a role in cell migration, cell adhesion and mitosis by regulating cytoskeletal proteins 
(Figure 5A). It can bind to actin and microtubules itself but also interacts with EB1 for its 
tethering to microtubules (Nathke 2004). APC has a size of 312 kDa and consists of multiple 
domains mediating its different functions (Aoki and Taketo 2007). During mitosis, APC 
localises to kinetochores, spindles and centrosomes, suggesting a role in kinetochore 
function and chromosome segregation through direct or indirect interaction with microtubules 
(Aoki and Taketo 2007; Cheng and Mao 2011).  
Although the sequence similarity between Kar9p and APC is very limited (Figure 5B) 
(Bienz 2001), both proteins have common binding partners and functions (Nathke 2004). 
Both bind to EB1/Bim1p and the mode of this interaction seems to be similar. However, the 
molecular details are still unknown. Furthermore, Kar9p and APC both localise to 
centrosomes/SPBs and microtubule tips and might be both involved in sustaining asymmetric 
cell divisions (Liakopoulos, Kusch et al. 2003; Yamashita, Jones et al. 2003; Nathke 2004).  
In Drosophila one form of APC might play a role in cortical attachment. Loss of such specific 
cortical attachment sites might result in defective spindle anchoring (Nathke 2004). Similar to 
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this function of APC, Kar9p also mediates the anchoring of microtubules at the bud neck and 
cortex (Huisman, Bales et al. 2004).  
 
 
Figure 5 Functions of adenomatous polyposis coli (APC) (A) Representation of the different functions of APC. 
APC binds directly or indirectly to F-actin and microtubules but also plays an important role in β-catenin signalling. 
Image taken from (Huisman, Bales et al. 2004). (B) Sequence alignment of human and Drosophila APC with the 
functional yeast homologue Kar9p. The region mediating the binding to EB1 in APC and the EB1 homologue 
Bim1p in yeast are conserved, suggesting a common binding mechanism. Picture taken from (Nathke 2004). 
 
 
1.4 Objectives 
Mitotic spindle orientation is a well conserved mechanism that is important for proper 
chromosome segregation and determination of cell fate. In humans, impaired spindle 
orientation is often correlated with development of cancer. Identifying the molecular 
mechanisms regulating mitotic spindle orientation will likely contribute to our understanding 
of these disorders. Most proteins involved in spindle orientation are conserved from yeast to 
human, making yeast an adequate, but also comparably easier model system to investigate 
the underlying molecular details.  
This research presented here aims to understand the assembly of the mitotic spindle 
orientation complex in Saccharomyces cerevisiae, formed by Bim1p, Kar9p and Myo2p. 
Although yeast-two hybrid screens helped to identify domains that mediate interactions with 
their respective binding partners, the underlying molecular details remain sketchy (Miller, 
Cheng et al. 2000).  
In this study a multidisciplinary approach using biochemical and structural experiments as 
well as functional studies in living cells was employed. Such a multidisciplinary approach 
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established a more detailed understanding of the Bim1p-Kar9p interaction. It furthermore 
helped to relate structural information with functionality by cross-validating mechanistic 
insights from different experimental approaches.  
The first part of the work focused on determination of the three-dimensional structure of 
Kar9p and posttranslational modifications of Kar9p required for interaction with Bim1p. In the 
second part, the interaction between Bim1p and Kar9p and its regulation by posttranslational 
modifications was studied in more detail to elucidate the molecular principles underlying 
spindle orientation in yeast.   
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2 Results 
2.1 Expression, purification and crystallisation of Kar9p  
2.1.1 Expression and Purification of full-length Kar9p (FL) 
Full-length Kar9p (FL) is comprised of 644 amino acids and has a molecular weight of 
74.2 kDa. Secondary structure and domain predictions (Miller, Cheng et al. 2000) suggest 
that the protein consists of three domains. Recent studies have shown that the protein is 
posttranslationally modified by phosphorylation (Maekawa and Schiebel 2004; Moore, D'Silva 
et al. 2006; Moore and Miller 2007) and sumoylation (Leisner, Kammerer et al. 2008; 
Meednu, Hoops et al. 2008) (Figure 6A). I cloned the full-length KAR9 gene from yeast 
genomic DNA into different E.coli and insect cell expression vectors (see chapter 4.11.1 and 
4.11.4). Protein expression was accomplished as a GST- or His-tagged version in E.coli 
(BL21 and Rosetta) as well as in insect cells and in yeast.  
Purification of the protein was performed as described in chapter (4.11.5 and 4.11.6). 
Kar9p (FL) with a GST-tag was found to degrade rapidly, whereas the His-tagged protein did 
not degrade after addition of 10 mM arginine and 10 mM glutamic acid to the buffer during 
the first purification step. Ultimate purity achieved was ≥ 95%, as shown in Figure 6B. 
Expression in yeast cells under the endogenous KAR9 promoter did not yield satisfactory 
amounts of protein, a likely cause being low expression levels in yeast (656 molecules/cell). 
Purification of Kar9p (FL) from both insect and E.coli cells achieved similar and higher yields. 
With the protein from insect cells not as well behaving as the one extracted from E.coli, for all 
crystallisation experiments purified Kar9p (FL) from E. coli was used. Crystallisation 
experiments were always done in the presence of the His-Tag as the usual removal of the 
His-tag with TEV-protease also degraded the protein. Kar9p (FL) expressed in minimal 
medium containing Selenomethionine could also be purified as soluble protein.  
Dynamic-light scattering analysis showed that Kar9p (FL) has a hydrodynamic radius of 
~ 7.5 nm and that it aggregates at concentrations ≥ 4 mg/ml. This aggregation could be 
reversed by diluting the protein solution to concentrations below 4 mg/ml. Small-angle X-ray 
scattering analysis (SAXS) (see chapter 4.10.5) revealed that Kar9p has a radius of gyration 
of 5.15 nm and a molecular weight of 180 kDa, which corresponds to a trimer or tetramer. 
Initial bead models were calculated from the SAXS data using the Gasborp and Gasbori 
software (Svergun, Petoukhov et al. 2001). Despite the apparent good quality of input data, 
resulting bead models were variable and not sufficient for further structural characterisation 
of this protein.  
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Figure 6 Domain organisation and purification of Kar9p (FL) (A) Kar9p (FL) consists of three domains: an 
acidic domain at the N-terminus, followed by a coiled-coil region in the middle domain and a basic (proline-rich) 
domain at the C-terminus. The protein is posttranslationally modified at four lysine residues (sumoylation: K301, 
K333, K381, K529) and two serine residues (phosphorylation: S197, S497). (B) Example of a purification of Kar9p 
(FL) from E.coli after size-exclusion chromatography. The protein is stable and can be purified to high purity 
(≥95%).  
 
2.1.2 Crystallisation of Kar9p (FL) 
Recombinant Kar9p (FL) was concentrated in size-exclusion chromatography (SEC) buffer to 
concentrations up to 6 mg/ml. Initial crystallisation screens were performed with different 
concentrations of protein solution (1-6 mg/ml) at RT and 4°C. Crystals of Kar9p (FL) 
appeared after 1-2 days in three conditions ([A] 0.1 M Hepes pH 7.5 + 25 % (w/v) PEG 2000 
MME; [B] 0.2 M trisodium citrate + 20 % (w/v) PEG 3350; [C] 0.2 M tripotassium citrate + 
20 % (w/v) PEG 3350) (Figure 7A). After refinement, crystals of Kar9p (FL) were grown at 
21°C by hanging-drop vapor-diffusion using a 1:1 mixture of protein (1-6 mg/ml) and 
crystallisation solution containing 0.1M Hepes pH 8.0, 21 % PEG 2000 MME, 125 mM serine 
or 0.1 M potassium citrate, 20 % PEG 3350, 125 mM serine. Needle-like crystals with 
cracked ends appeared within 1-2 days and had a size of 20 - 50 µm x 100 – 400 µm (Figure 
7B). The cracked ends were present in all crystals and are likely to be caused by fast crystal 
growth. Formation of ice crystals while freezing the crystals was prevented by adding a 
number of cryo-protectants (glycerol, ethylene glycol, PEG 400) in different concentrations 
and for a variety of incubation periods. Diffraction data of crystals were collected at various 
beam lines at the ESRF in Grenoble and crystals showed diffraction up to 7 Å resolution. The 
diffraction patterns displayed mostly well-defined spots (Figure 7E) and datasets could be 
processed with XDS or Mosflm. Processing of the datasets showed that the crystals belong 
to space group P3 with unit-cell parameters of 200x200x250 Å and approximately 
16 molecules per asymmetric unit.  
One crystal grown in 0.1M Hepes pH 7.5, 29 % PEG 2000 MME, 125 mM serine with 
20 % glycerol as cryo-protectant showed diffraction up to 3 Å resolution. The dataset, 
however, was incomplete, as only 180° were recorded and some angles showed smeared 
spots that could not be used for processing of the dataset. The presence of several ice-rings 
in the diffraction pattern caused additional problems, and prevented processing of resolutions 
better than 3.4 Å (Figure 7F). Processing of the dataset with XDS showed that this crystal 
consists of the space group P2 and has a smaller unit cell with a size of 46x76x120 Å. This 
form of crystal however, could not be reproduced again (see below).  
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To prevent the appearance of cracked ends and to improve the X-ray diffraction properties of 
the crystals, different growth conditions were tested to slow down the speed of crystal 
formation. In a first attempt at this, the reservoir solution was covered with oil as a barrier to 
slow down vapour diffusion between the reservoir solution and the drop (Chayen 1997). For 
this purpose, silicone oil and paraffin oil were used in different ratios (50:50, 65:35) and 
different volumes (200 µl - 500 µl) to cover the reservoir solution. Paraffin oil alone allows 
only for very little vapour diffusion, whereas silicone oil alone allows for vapour diffusion 
almost comparable to crystallisation without oil. Thus, using different mixtures and volumes 
of these oils, the rate of vapour diffusion was controlled. Despite several trials, also at 4°C, 
this attempt did not slow down crystal growth. None of the crystals thus generated displayed 
better X-ray diffraction properties.  
Organic solvents are frequently used in crystallisation to alter the sample-sample as well as 
the sample-solvent interactions. They can stabilise the protein but also act as precipitants, as 
they can cause denaturation of the protein by displacing water molecules on the protein 
surface (Anand, Pal et al. 2002). Addition of 4-6 % isopropanol or MPD to the crystallisation 
solution was tried, but did not improve the properties of the crystals.  
Glycerol is another component that has been successfully used in the crystallisation of 
proteins with flexible domains. It has been shown to stabilise unstructured parts of proteins 
(Sousa 1995). It is also thought to interfere with nucleation. Therefore addition of glycerol to 
the crystallisation solution may result in fewer but bigger crystals. Accordingly, low 
concentrations of glycerol (2-10%) were added to the purified Kar9p (FL) and the 
crystallisation solution, but did not help to improve the quality of the crystals.  
Crystals grown at 4°C in the conditions described above appeared after 3-4 days and were 
again needle shaped, but thicker than the crystals grown at 21°C and without cracked ends 
(Figure 7C). Despite the slower growth and the better morphology, however, these crystals 
only showed X-ray diffraction up to 10 Å.  
Elsewhere, it has been shown that the addition of proteases to proteins (in situ proteolysis) 
that have already formed crystals can improve the X-ray diffraction properties of the crystals 
(Dong, Xu et al. 2007; Wernimont and Edwards 2009). Addition of trace amounts of 
proteases to the crystallisation trials mostly results in the digestion of flexible parts of the 
protein. Usually 20-40 residues of the N- or C-termini as well as affinity tags (His-tag etc.) are 
removed. Addition of proteases can also result in the removal of internal flexible loops or 
even of entire domains. Flexible regions may interfere with the crystal packing and therefore 
hinder the formation of a well-ordered crystal lattice with good X-ray diffraction properties.  
Trypsin and Endoproteinase Glu-C were consequently added to the protein solution in 
different ratios (w/w, 1:1000, 1:500, 1:200) prior to setting up crystal screens. Trypsin cleaves 
at the C-terminal part of basic residues, whereas Glu-C cleaves at the C-terminal part of 
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glutamic acid residues and with a much slower rate at aspartic acid residues. Although 
Kar9p (FL) can be digested with these proteases into smaller fragments, this did not improve 
the quality of the crystals.  
A technique termed “seeding” can be used to control the growth rates of crystals or to 
change the crystal morphology (Bergfors 2003). It allows crystals to grow in a metastable 
zone where the protein and the reagent concentration are not sufficient for spontaneous 
nucleation, but allow seed crystals to grow bigger. Two different techniques have been tried, 
namely streak seeding and Seed beads. Both methods were utilized with tools from Hampton 
Research (Seed beads and Seeding Tool, Aliso Viejo, USA). For the Seed beads method 
one crystal was transferred from a plate into an Eppendorf tube containing the crystallisation 
solution and one Seed bead, and broken up into small crystal fragments by vigorous 
vortexing. Serial dilutions of this solution were prepared (10-1 – 10-5, in crystallisation 
solution) and added to fresh crystallisation setups. Streak seeding uses an animal whisker to 
break loose small crystal fragments from existing crystals and transfer those seeds into a 
new drop. It can also be used to stir old drops with precipitate since this can equally induce 
nucleation and crystal growth. Seeds were prepared as described with the Seed beads and 
transferred to crystallisation setups with a cat whisker. Despite several trials, none of both 
methods improved the diffraction quality of the Kar9p (FL)-crystals.  
Another attempt to improve the crystals was made by methylating Kar9p in vitro. It has been 
shown that methylation of lysine residues can help to improve the formation of a crystal 
lattice by changing the surface properties of the protein and by immobilizing these flexible 
side chains (Kim, Quartey et al. 2008). 	  
A protocol how lysine residues of purified Kar9p were methylated is described in chapter 
4.12.3. The methylated protein was concentrated to 6 mg/ml and initial crystallisation screens 
were set up with protein concentrations of 2, 4 and, 6 mg/ml. Crystals appeared after 2-3 
days in various conditions in the initial screens. The shapes of the crystals were either thin 
needles or thin plates, which were often intergrown (Figure 7D). The needles lacked the 
cracked ends found in crystals of unmethylated Kar9p (FL). Refinement initiated crystal 
growth in 0.1 M ammonium acetate, 0.1 M Bis-Tris pH 6.5 and 16 % PEG 3350. 
Subsequently, different additives (amino acids, sugars) were tested in a ratio of 1:20 (v/v), 
resulting in the formation of both crystal forms, depending on the additive. Cryo-protection 
was achieved with different concentrations of ethylene glycol or sucrose. None of the crystals 
tested at the synchrotron diffracted X-rays. 
Kar9p was also expressed and purified as Selenomethionine labelled protein. Crystals 
appeared in the same conditions as the unlabelled protein but either showed no or only weak 
X-ray diffraction (≥ 10 Å). Soaking of the native crystals with different heavy atom solutions 
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was also tried, (see chapter 4.12.6), but did not improve the diffraction properties of the 
crystals.  
In addition to all the attempts described, crystals of Kar9p (FL) were tested at room 
temperature using the MiTeGen MicroRT system (MiTeGen, LLC, Ithaca USA). 
Measurements at room temperature were used to determine whether the cause of poor X-ray 
diffraction properties is due to poorly ordered crystals, crystal damage caused by cryo-
protectant soaks, or crystal damage caused by the flash cooling in liquid nitrogen. Crystals 
were mounted on a MicroMount, which was subsequently covered with a polymer capillary 
tubing filled with some mother liquid at the tip to prevent the crystal drying out. When tested 
at the synchrotron, all crystals showed the same X-ray diffraction properties as the ones 
frozen in liquid nitrogen. Hence the poor diffraction properties were not due to suboptimal 
cryo-protection or issues with the freezing of the crystals, but rather due to crystal packing.  
 
 
Figure 7 Crystallisation of Kar9p (FL) (A) Crystals of Kar9p (FL) in the initial crystallisation screens and 
(B) crystals of Kar9p (FL) in the refinement screens. The crystals were needle shaped and had always cracked 
ends. (C) Crystals of Kar9p (FL) at 4°C lacked cracked ends (D) Crystals of methylated Kar9p (FL) were either 
needle shaped or plate-like, which were often intergrown (E) Diffraction pattern of a crystal of Kar9p (FL). Crystals 
diffracted up to 7 Å with many well-defined spots. (F) Diffraction pattern of one crystal of Kar9p (FL) showing 
diffraction up to 3 Å. Some angles of the data set contained many well-defined spots (as in (E)), whereas some 
diffraction patterns at certain angles contained many smeared spots (F). All frames of the dataset contained ice-
rings, which made processing of the dataset above 3.4 Å impossible. 
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2.1.3 Expression and Purification of Kar9p-variants 
As purification and crystallisation of Kar9p (FL) did not yield good enough results to solve the 
crystalline structure of Kar9p, several strategies were pursued to identify shorter fragments of 
Kar9p, to be used for crystallisation and interaction studies with Bim1p. Differences of only a 
few residues at the C- or N-termini of proteins can have dramatic effects on the solubility of 
the protein and protein crystallisation. Expressing many variants of the protein can therefore 
increase success rates.  
First, limited proteolysis of Kar9p (FL) with different site-specific proteases was performed as 
described in chapter 4.10.6. Four of the resulting protease-resistant protein fragments were 
subjected to Edman-sequencing. Due to sample heterogeneity no sequence could be 
unambiguously assigned to Kar9p (FL) and thus not be used to design new constructs. 
Therefore, shorter fragments of Kar9p were designed based on secondary structure 
predictions (Jpred, (Cole, Barber et al. 2008)) and on a three-dimensional structure 
prediction calculated by the HHPred Server (Soding, Biegert et al. 2005). The structure 
prediction from HHPred Server suggests that the N-terminal half of the protein consists 
mostly of α-helices, whereas the C-terminal part of the protein is supposedly completely 
devoid of structure (Figure 8A). Secondary structure predictions propose mostly α-helices in 
the N-terminus, but also some α-helices together with large unstructured parts in the 
C-terminal half of the protein. Several new fragments of KAR9 were cloned in vectors with 
either a GST- or a His-tag and tested for protein expression and purification in E.coli. 
Because the C-terminal part of Kar9p interacted with Bim1p in yeast-two hybrid screens 
(Miller, Cheng et al. 2000; Moore and Miller 2007), this portion of the protein was also 
considered in expression tests. An overview of the fragments tested and their behavior 
during purification and crystallisation is shown in Table 1. 
It was then first observed that variants of Kar9p lacking only some amino acids at the 
N-terminus or the C-terminus had the same expression and purification characteristics as 
full-length Kar9p.  
Deletion of the structured N-terminal part leads to rapidly degrading proteins that were hard 
to express and purify, both in the presence of a GST- or a His-Tag. Because the putative 
coiled-coil region of Kar9p is missing in these fragments, a GST-tag was tested. GST-tags 
can dimerise and stabilise the proteins. However, in light of the unsatisfactory outcome of 
these expression and purification tests, the purification of the fragments was not pursued 
further.  
Deletion of the unstructured N-terminal part on the other hand resulted in highly expressible 
proteins. Depending on the length of the deletion, however, some proteins degraded during 
purification. Only one fragment consisting of the amino acids 1-398 remained sufficiently 
soluble and could be purified either with a GST- or a His-tag. All other fragments could only 
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be expressed and purified in the presence of a His-tag. A purification of Kar9p (1-398) with 
either tag is shown in Figure 8B.  
 
Construct Tag Expression Purification Initial crystals Refined crystals 
Kar9p (FL) His + + + 7Å (one with 3Å) 
Kar9p (FL) GST +/- - - - 
Kar9p (5-644) His + + - - 
Kar9p (7-644) His + + - - 
Kar9p (10-644) His + + + 7Å (as crystals from Kar9p (FL) 
Kar9p (12-644) His + + + 7Å(as crystals from Kar9p (FL) 
Kar9p (1-640) His + + Not tested  
Kar9p (5-640) His + + Not tested  
Kar9p (7-640) His + + Not tested  
Kar9p (10-640) His + + Not tested  
Kar9p (12-640) His + + Not tested  
Kar9p (1-637) His + + Not tested  
Kar9p (5-637) His + + Not tested  
Kar9p (7-637) His + + Not tested  
Kar9p (10-637) His + + Not tested  
Kar9p (12-637) His + + Not tested  
Kar9p (1-635) His + + Not tested  
Kar9p (5-635) His + + Not tested  
Kar9p (7-635) His + + Not tested  
Kar9p (10-635) His + + Not tested  
Kar9p (12-635) His + + Not tested  
Kar9p (1-608) His + + Not tested  
Kar9p (12-608) His + + Not tested  
Kar9p (1-478) His ++ ++ No crystals  
Kar9p (1-517) His ++ ++ No crystals  
Kar9p (245-644) His +/- - Not tested  
Kar9p (245-644) GST +/- - Not tested  
Kar9p (250-644) His +/- - Not tested  
Kar9p (250-644) GST +/- - Not tested  
Kar9p (298-644) His +/- - Not tested  
Kar9p (298-644) GST +/- - Not tested  
Kar9p (307-644) His +/- - Not tested  
Kar9p (307-644) GST +/- - Not tested  
Kar9p (1-451) His ++ +/- Not tested  
Kar9p (1-451) GST +/- - Not tested  
Kar9p (1-429) His ++ +/- Not tested  
Kar9p (1-429) GST +/- - Not tested  
Kar9p (1-408) His ++ ++ Crystalline 
precipitate 
 
Kar9p (1-404) His ++ ++ Crystalline 
precipitate 
 
Kar9p (1-401) His ++ ++ Crystalline 
precipitate 
 
Kar9p (10-401) His ++ ++ Not tested  
Kar9p (12-401) His ++ ++ Not tested  
Kar9p (1-398) His ++ ++ + 7Å, additional spots at 4-5Å 
Kar9p (1-398)  GST ++ ++ + Not tested 
Kar9p (10-398) His ++ ++ Not tested  
Kar9p (12-398) His ++ ++ Not tested  
Kar9p (1-395) His ++ ++ Crystalline 
precipitate 
 
Kar9p (10-395) His ++ ++ Not tested  
Kar9p (12-395) His ++ ++ Not tested  
Kar9p (1-373) GST +/- - Not tested  
Kar9p (1-355) GST +/- - Not tested  
Kar9p (1-338) GST +/- - Not tested  
Kar9p (1-307) His + + Not tested  
Kar9p (1-307) GST +/- - Not tested  
ACR023W1 (1-769) His +/- - Not tested  
ACR023W1 (1-769) GST +/- - Not tested  
CAGL0A01155g   
(1-609) 
His +/- - Not tested  
CAGL0A01155g   
(1-609) 
GST +/- - Not tested  
Table 1 Overview of Kar9p variants tested for expression, purification and crystallisation ++: high level of 
expression/high amount of purified protein; +: good level of expression/amount of protein enough for purification; 
+/-: very low protein expression/protein rapidly degrading 
 RESULTS  
26 
 
Figure 8 Structure prediction of Kar9p (FL) and purification of Kar9p (1-398) (A) Structure prediction of 
Kar9p (FL) from HHPred-Server. The N-terminal part of the protein is predicted to be structured, whereas the C-
terminal part may be unstructured. (B) and (C) Purification of Kar9p (1-398) with a His-tag (B) or a GST-tag (C). 
Both proteins are shown after cleavage of the GST-tag with the PreScission protease and size-exclusion 
chromatography.  
 
A fragment consisting of amino acids 1-517 was also successfully purified and subsequently 
used for limited proteolysis with Endoproteinase Glu-C (see chapter 4.10.6). Two shorter 
fragments could be identified by Edman-sequencing, one starting at the N-terminal His-tag 
and the other one starting at amino acid 8 of Kar9p. Molecular weight determination by mass 
spectrometry, however, did not give interpretable results. The molecular weight of these 
fragments was instead estimated from SDS-PAGE. It suggests that both fragments comprise 
the structured N-terminal part predicted by HHPred server (residues ~1 - 400). From this 
experiment, it can be concluded that the N-terminal part of Kar9p is likely to fold into a 
globular domain. In contrast, the C-terminal domain can be digested by proteases and thus 
might be flexible and partially unfolded. These interpretations are consistent with structure 
predictions.  
 
2.1.4 Crystallisation of Kar9p-variants 
As the crystallisation of Kar9p (FL) did not yield high quality diffracting crystals, different 
shorter Kar9p variants were crystallised as described for Kar9p (FL). Most of these Kar9p 
variants did not form crystals in the initial screens (Table 1). Only Kar9p-fragments lacking a 
few amino acids at the very N-terminus (1-12) or lacking large parts of the C-terminus (1-398; 
1-401) formed crystals in the initial screens. Crystals lacking parts of the N-terminus grew in 
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similar conditions as Kar9p (FL) and did not show any improvement in X-ray diffraction. 
Those crystals also had the same shape as crystals of Kar9p (FL).  
Crystals grown from Kar9p (1-398) were needle shaped but did not have cracked ends like 
crystals from Kar9p (FL). These crystals were grown at concentrations of 0.5-1 mg/ml with a 
crystallisation solution containing 50 mM MES pH 6.0; 5 % PEG400, 0.5 M ammonium 
sulfate and either 0.1 M urea, 2.5 mM Glutathione or 1 % MPD as additive. Crystals 
appeared after 2-3 days. Crystals of this fragment showed diffraction up to 7 Å resolution 
with some additional smeared spots around 4-5 Å resolution (Figure 9A-C). Processing of the 
datasets with XDS or Mosflm was not possible, since some spots of the diffraction patterns 
were too smeared and could therefore not be correctly integrated by the programs. Different 
cryo-protectants (MPD; ethylene glycol, PEG 400, glycerol, sucrose, glucose) and incubation 
times with cryo-protectants as well as longer exposure times to the X-rays at the synchrotron 
did not improve the diffraction properties of these crystals. Additionally, X-ray diffraction 
properties of the crystals were tested at room temperature using the MiTeGen MicroRT 
system (MiTeGen, LLC, Ithaca USA), but were worse. To improve the properties of the 
crystals, several slightly larger or smaller fragments were purified and screened for 
crystallisation, but only crystalline precipitation was obtained in the initial screens. 
Considering that the morphology and X-ray diffraction properties of the crystals of 
Kar9p (1-398) did not change or improve in comparison to crystals of Kar9p (FL), fragments 
identified by limited proteolysis (Kar9p (10-398) and (7-398)) have not been tested for 
crystallisation.  
 
 
Figure 9 Crystallisation of Kar9p (1-398) (A) Crystals in the initial screens. (B) Crystals after refinement. 
(C) Diffraction pattern of the crystals at the synchrotron. Crystals diffract up to 7 Å with some additional spots 
around 4-5 Å (weak smeared spots on the left and right side in the middle). 
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2.1.5 Expression and purification of Kar9p-homologs from other yeast species 
To increase the likelihood of successful crystallisation of Kar9p, databases were searched to 
identify homologous proteins from other yeast species. Homologues of Kar9p from Ashbya 
gossypii (ACR023W1) and Candida glabrata (CAGL0A1155g) were identified as possible 
candidates. The proteins have a sequence identity of 34%/35% and a sequence similarity of 
52%/56% compared to Kar9p. ACR023W1 is comprised of 769 amino acids and thus 125 
amino acids longer than Kar9p (FL) whereas CAGL0A1155g is comprised only of 609 amino 
acids and therefore 35 residues shorter than Kar9p (FL) (Figure10). Both genes were cloned 
as full-length constructs and expressed in E.coli as His- or GST-tagged fusion proteins. 
However, both proteins degraded during purification regardless of the tag used, this 
approach was not pursued further.  
 
 
Figure 10 Sequence alignment of Kar9p (FL) and homologous proteins from other yeast species Colour 
code: dark blue: identical residues, light blue: medium conservation, white: no conservation 
 
2.1.6 Co-crystallisation of Kar9p and Bim1p 
Another commonly used procedure to improve X-ray diffraction properties of crystals is to 
crystallise proteins in the presence of an interaction partner. An interaction partner can 
stabilise the other protein, for instance when the protein binds to unstructured regions or 
when the interaction partner induces folding of unstructured parts. Since Bim1p has been 
suggested to bind to the unstructured part in the C-terminus of Kar9p, it was chosen as 
candidate for co-crystallisation (see also 2.1.3). Two different variants of Bim1p were chosen 
for co-crystallisation trials: Bim1p (FL) and the C-terminal dimerisation domain of 
Bim1p (182-282, C-term), which has been suggested to bind to Kar9p (Miller, Cheng 
et al. 2000). Proteins were purified separately and mixed in different molar ratios prior to 
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crystallisation trials (see chapter 4.12.4). Crystals appeared under several crystallisation 
conditions only with Bim1p (C-term) and Kar9p (FL). Dependent on the conditions the 
crystals were either needle-shaped like crystals from Kar9p (FL) or plate-like. Both crystal 
forms could be reproduced in refinement screens. Cryo-protection was achieved with 
different concentrations of glycerol or ethylene glycol and the crystals were tested for 
diffraction at various beamlines at the ESRF in Grenoble. Needle-shaped crystals only 
weakly diffracted X-rays up to 8 Å, whereas the plate-like crystals showed diffraction up to 
2.5 Å, albeit with some anisotropy. Processing of the datasets recorded from the plate-like 
crystals showed that they belong to space group P222 with a unit cell size of 27x43x99 Å. 
This unit cell size is too small to fit in both proteins, therefore molecular replacement with the 
known human EB1 structures (PDB IDs 1wu9, 1YIB, 1YIG) was performed and a solution 
was obtained with the MOLREP software (Vagin and Teplyakov 2010). As the refinement 
statistics of this solution were not sufficient and could not be further refined, the structure of 
Bim1p (C-term) could not be solved by this approach. With both proteins not co-crystallising, 
no additional attempts to co-crystallise Bim1p and Kar9p were performed. Subsequent 
experiments showed that the proteins when purified from E.coli do not interact with each 
other and thus offered an explanation for the failed crystallisation trials. Therefore, with no 
success in producing diffraction-quality crystals despite serious efforts, the aim of the 
research was revised to focus more prominently on the interaction between Kar9p and 
Bim1p.  
 
2.2 Role of posttranslational modifications of Kar9p  
Parallel to the co-crystallisation experiments with Bim1p (C-term) and Kar9p (FL) I tested the 
potential of a direct interaction between Bim1p and Kar9p purified from E.coli without 
posttranslational modifications. Pull-down experiments with either GST-tagged 
Bim1p (C-term) or Bim1p (FL) and His-tagged Kar9p (FL) were carried out. No direct 
interaction between these proteins could be observed. Moreover, no interaction was 
observed when both proteins were loaded together onto a size-exclusion chromatography 
column. Both proteins eluted at their respective elution volume.  
This poses the question whether posttranslational modifications of Kar9p are required for the 
interaction with Bim1p. Earlier studies have shown that Kar9p is posttranslationally modified 
by sumoylation and phosphorylation (Liakopoulos, Kusch et al. 2003; Maekawa, Usui et al. 
2003; Maekawa and Schiebel 2004; Moore, D'Silva et al. 2006; Moore and Miller 2007; 
Leisner, Kammerer et al. 2008; Meednu, Hoops et al. 2008). Since the unmodified proteins 
from bacteria do not interact, these modifications might be required for the interaction of 
Bim1p and Kar9p. To test this hypothesis, pull-down experiments with recombinant 
Bim1p (FL) or Bim1p (C-term) and extracts from Myc-Kar9p expressing yeast cells were 
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performed. With both proteins Kar9p could be clearly detected in subsequent western blots 
with an α-myc antibody (Figure 19). This indicates that posttranslational modifications of 
Kar9p or a yet unknown additional binding partner are required for the interaction of Kar9p 
and Bim1p. For further analysis of the role of posttranslational modifications, several yeast 
strains harbouring mutant versions of Kar9p were generated and tested in pull-down 
experiments.   
 
2.2.1 Phosphorylation of Kar9p is not required for the interaction with Bim1p 
Kar9p is phosphorylated at two serines (197 and 496) by the Clb4p/Cdc28p kinase (Figure 
11A) (see chapter 1.3.1). To test whether these posttranslational modifications play a role in 
formation of complexes with Bim1p, yeast strains that harbour single point mutations in either 
Kar9p phosphorylation site, preventing their modification were generated. Another yeast 
strain harbouring the corresponding double mutant was generated. In pull-down experiments 
with recombinant Bim1p all of the Myc-Kar9p (S197A)/(S496A) or (S197A+S496A) 
expressing strains showed a wild type like binding to Bim1p (Figure 11B). It can therefore be 
concluded that the formation of complexes between Bim1p and Kar9p is not regulated by 
Clb4p/Cdc28p-dependent phosphorylation at serine 197 or serine 496.  
 
 
Figure 11 Role of phosphorylation of Kar9p on complex formation with Bim1p (A) Domain composition of 
Kar9p (FL), showing the two modification sites S197 and S496. (B) Western blot of pull-down experiments with 
yeast strains harbouring point mutations in Kar9p. None of the mutants showed an effect on complex formation 
between Bim1p and Kar9p.  
 
2.2.2 In vivo effects of phosphorylation deficient Kar9p-variants 
Another not yet answered question was whether mutations of phosphorylation sites in Kar9p 
do have an effect in vivo, when the yeast strains are challenged by different temperatures or 
exposed to Benomyl.  The Myo2p-Kar9p-Bim1p dependent spindle orientation pathway is 
partially redundant with the dynein-dependent spindle elongation pathway (Miller and 
Rose 1998). Therefore, the effect of mutations on spindle orientation in either pathway is 
better observed when cells are challenged. Benomyl is a microtubule-destabilising antimitotic 
fungicide, which is often used to analyse mutants causing defects in mitosis (Quinlan, 
Pogson et al. 1980; Stearns, Hoyt et al. 1990). When the cells were exposed to different 
temperatures and Benomyl concentrations (see chapter 4.14.3), weak effects were observed 
with the double mutant. This mutation showed better growth on Benomyl-plates and at 37°C 
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compared to the wild-type (Figure 12). With Kar9p overexpressed under the GAL1-promoter, 
expression of the wild-type protein already leads to increased sensitivity towards Benomyl 
and reduced growth at 37°C. The reduced sensitivity therefore likely means that the protein 
is less active. Yeast strains harbouring the single point mutation S197A are also less 
sensitive to Benomyl than wild-type yeast strains. An overview of the effects is given in 
Table 2. 
 
 
Figure 12 In vivo effects of phosphorylation deficient Kar9p mutations Growth test at different temperatures 
and Benomyl concentrations.  
 
 Effect in pull-down Benomyl supersensitivity Temperature sensitivity 
Kar9p (WT) normal binding Highly sensitive at 2.5 µg and 5 µg 
Slightly sensitive at 30°C 
and 37°C 
Kar9p (S197A) normal binding Highly sensitive at 2.5 µg and 5 µg as WT 
Kar9p (S496A) normal binding Highly sensitive at 2.5 µg and 5 µg 
more sensitive at 30°C 
and 37°C as compared to 
WT 
Kar9p (S197A + S496A) normal binding less sensitive at 2.5 µg and 5 µg as compared to WT 
less sensitive at 30°C and 
37°C as compared to WT 
 
Table 2 Overview of the effects of mutations of the phosphorylation sites in Kar9p 
 
2.2.3 Co-immunoprecipitations of Kar9p from yeast extracts 
Co-immunoprecipitation (co-IP) experiments with myc-tagged Kar9p were performed as 
described in 4.14.2. These experiments were to identify possible new interaction partners of 
Kar9p. In addition, to these co-IPs with wild-type Kar9p, co-IPs with all three yeast strains 
harbouring mutations in the phosphorylation sites of Kar9p were carried out. Since these 
mutations did not have an effect on the binding to Bim1p it was of interest to establish a 
potential effect on other proteins co-immunoprecipitating with Kar9p. After co-IP, the samples 
were analysed by SDS-PAGE, followed by silver staining and analysis of desired bands by 
mass-spectrometry.  
The overall complex composition was similar in all four strains tested (WT, S197A, S496A, 
S197A+S496A). All known complex components could be identified by mass-spectrometry 
(Bim1p, Myo2p), but also other associated proteins were co-immunoprecipitated. The 
amount of peptide sequences in relation to protein sequences is much higher for Myo2p than 
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for Bim1p. The abundance of Bim1p was very low, suggesting that the association of Kar9p 
with Myo2p is comparably stronger than with Bim1p under the given conditions.  
Actin and Tpm1/2p were identified in all co-IPs. Both proteins are likely to be 
co-immunoprecipitated via their interaction with Myo2p. The tropomyosins Tpm1p and 
Tpm2p bind to and stabilise actin cables and filaments. Therefore, it is likely, that these 
proteins were immunoprecipitated via their association with actin.  
Another protein present in all co-IPs is Nap1p. This protein interacts with mitotic cyclin Clb2p. 
It is furthermore required for the regulation of microtubule dynamics during mitosis and 
controls bud morphogenesis. Another role of the protein is the transport of H2A and H2B 
histones to the nucleus. Why this protein is present in all co-IPs remains unknown and 
further experiments are required to elucidate whether the interaction with Kar9p is direct or 
indirect. Clb2p is known to interact with Cdc28p, which might suggest an association with 
Kar9p via Cdc28p. Chapter 7.2 gives a detailed overview of the proteins identified by mass-
spectrometry. 
 
2.2.4 Sumoylation of Kar9p is required for the interaction with Bim1p 
Kar9p is sumoylated at amino acids K301, K333, K381, and K529 (Leisner et al., 2008) 
(see chapter 1.3.1). To test the effect of sumoylation of Kar9p on the interaction with Bim1p, 
different yeast strains harbouring point mutations in the sumoylation sites of Kar9p were 
generated (Figure 11A). As for the phosphorylation mutants, these proteins had to be 
expressed under the GAL1-promoter to allow for their detection in western blots. Pull-down 
experiments were performed as described in chapter 4.10.7 and myc-tagged Kar9p was 
detected by western blot.  
Mutation of individual sumoylation sites into residues that are not sumoylated had different 
effects on the binding to Bim1p. Whereas strong defects were observed with Kar9p (K333E) 
and Kar9p (K381R), the Bim1p interaction was only slightly impaired with Kar9p (K333R) and 
almost no effect was observed with Kar9p (K301R) and Kar9p (K529R). Mutation of multiple 
sumoylation sites resulted in an additive decrease in binding. The double (2R: K301R + 
K381R) and triple (3R: 2R + K529) mutants showed only mild defects, while an almost 
complete loss of binding to Bim1p (FL) was observed when all four sumoylation sites (4R: 3R 
+ K333R) are mutated (Figure 13) 
It was therefore concluded that all sumoylation sites seem to have an effect on binding to 
Bim1p (FL), with an important role for K381. An overview of the effects of the different 
mutations in pull-down experiments and in vivo is given in Table 3. 
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Figure 13 Effect of sumoylation of Kar9p on the interaction with Bim1p. Pull-down experiments with different 
yeast strains harbouring mutations in the sumoylation sites of Kar9p. Mutations of all for residues (4R) and of 
K381 led to an almost complete loss of binding, whereas the other mutations showed only mild effects.  
 
2.2.5 In vivo effects of sumoylation deficient Kar9p-variants 
To study the effect of mutating individual or several Kar9p-sumoylation sites in vivo, growth 
defects were analysed by temperature- and Benomyl-sensitivity test as already described for 
the phosphorylation mutants (see chapter 2.2.2). 
Since the overexpression of Kar9p (WT) already leads to growth defects at 37°C and with 
low concentrations of Benomyl, it was assumed that mutant proteins showing a weaker 
phenotype are less active. As a matter of fact, the mutation Kar9p (K333E), which showed 
the strongest effect in the pull-down experiments was less sensitive to Benomyl, whereas the 
mutations Kar9p (K301R) and Kar9p (K529R), which showed almost no effects in the pull-
down experiments displayed the same strong phenotype in response to Benomyl as the wild-
type. The same was true for the double, triple and quadruple mutations of Kar9p. Whilst the 
double mutant showed only mild defects in the pull-down experiments upon Benomyl 
treatment, it showed the same growth phenotype as the wild-type protein. On the other hand 
the triple and quadruple mutants showed minor growth defects, which is fully consistent with 
the in vitro results (Figure 13 and Figure 14).  
It was consequently assumed that a more complex mechanism exists in vivo. The 
inconsistent pull-down and in vivo results point to this. However, the overall outcome of the 
experiments suggests that sumoylation plays an important role in Bim1p binding and that the 
effect is additive. These findings also explain why recombinant Kar9p from E.coli does not 
interact with Bim1p.  
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 Effect in pull-down Benomyl-supersensitivity Temperature sensitivity 
Kar9p (WT) normal binding highly sensitive at 2.5 µg and 5 µg slightly sensitive at 30°C and 37°C 
Kar9p (K301R) slightly reduced binding highly sensitive at 2.5 µg and 5 µg slightly sensitive at 30°C and 37°C 
Kar9p (K333R) slightly reduced binding less sensitive at 2.5 µg and 5 µg than compared to WT 
slightly sensitive at 30°C 
and 37°C 
Kar9p (K333E) strongly reduced binding no sensitivity at 2.5 µg and less sensitivity at 5 µg 
slightly sensitive at 30°C 
and 37°C 
Kar9p (K381R) strongly reduced binding highly sensitive at 2.5 µg and 5 µg slightly sensitive at 30°C and 37°C 
Kar9p (K529R) slightly reduced binding highly sensitive at 2.5 µg and 5 µg slightly sensitive at 30°C and 37°C 
Kar9p (2R) reduced binding more sensitive at 2.5 µg and 5 µg than compared to WT 
slightly sensitive at 30°C 
and 37°C 
Kar9p (3R) reduced binding less sensitive at 2.5 µg and 5 µg than compared to WT 
slightly sensitive at 30°C 
and 37°C 
Kar9p (4R) strongly reduced binding less sensitive at 2.5 µg and 5 µg than compared to WT 
slightly sensitive at 30°C 
and 37°C 
Table 3 Overview of the effects of mutations of sumoylation sites in Kar9p 
 
 
Figure 14 In vivo effects of sumoylation deficient Kar9p-variants (A) Temperature and Benomyl sensitivity of 
single mutations of Kar9p. (B) Temperature and Benomyl sensitivity of double, triple and quadruple mutations of 
Kar9p. 2R: K301R + K381R; 3R: 2R + K529R; 4R: 3R + K333R 
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2.3 Structural analyses of Bim1p  
Bim1p belongs to the family of EB1-like proteins. Members of this family are highly 
conserved in all eukaryotes and share an overall sequence identity of ~ 35%. A sequence 
alignment in Figure 30 shows the high conservation of this class of proteins. The protein 
consists of two domains: an N-terminal CH-domain, which mediates the binding to 
microtubules; and a C-terminal EB1-like domain, which mediates the binding to different 
cargoes (Figure 15A). The crystal structure of the CH-domain has been solved (Slep and 
Vale 2007), whereas structural information of the EB1-like domain is only available on the 
human homolog (Honnappa, John et al. 2005; Slep, Rogers et al. 2005). No structural 
information is available for this cargo-binding domain of Bim1p. Furthermore, Bim1p contains 
a sequence insertion of 24 residues (Figure 20, red box) (amino acids 240 to 263), for which 
structure predictions fail. Since this domain also mediates the binding to Kar9p a crystal 
structure would be of high interest.  
 
2.3.1 Expression and Purification of Bim1p (FL) 
Full-length Bim1p (FL) is comprised of 344 amino acids and has a molecular weight of 
38.4 kDa. I have cloned the full-length gene from yeast genomic DNA into different E.coli 
expression vectors (see chapter 4.9.1). Protein expression was achieved as a GST- or MBP-
tagged version in E.coli (BL21) and purification was performed as described in chapter 
4.11.7 and 4.11.8. The GST-tagged protein was used after cleavage and removal of the 
GST-tag with the PreScission protease for crystallisation trials and SAXS experiments, 
whereas the MBP-tagged protein was used for pull-down experiments. The result of a 
purification of Bim1p (FL) with a GST–tag is shown in Figure 15B.  
 
2.3.2 Expression and Purification of Bim1p (C-term) 
In crystallisation trials with Bim1p (FL) only amorphous precipitate was observed. To find a 
soluble fragment of the C-terminal cargo-binding domain that binds to Kar9p, several 
fragments were cloned and expressed in E.coli as GST-tagged proteins (see chapter 4.11.1). 
The shortest fragment comprising amino acids 182-282 (see Figure 15A) could be expressed 
and purified (see chapter 4.11.7) in high amounts. This fragment was used for co-
crystallisation trials with Kar9p, as well as for crystallisation trials alone and SAXS-
experiments. The MBP-tagged protein was purified as described in chapter 4.11.8 and used 
for pull-down experiments.  
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2.3.3 Crystallisation of Bim1p (C-term) 
In order to establish whether Bim1p (C-term) adopts a similar fold as human EB1 
crystallisation trials were performed. The procedures for crystallising the native protein are 
described in chapter 4.12.5. Since attempts to solve the Bim1p (C-term) structure by 
molecular replacement with the already known structure of human EB1 (PDB-ID: 1WU9, 
1YIB, 1YIG) consistently failed (see chapter 2.1.6), another strategy had to be used to solve 
the phase problem. Bim1p (C-term) has only one methionine in its amino acid sequence, 
which is insufficient for phasing by single- (SAD) or multi-wavelength anomalous dispersion 
(MAD) using selenomethionine labelled protein. Selenomethionine labeling is a standard 
method in protein crystallography to determine phases. It has been estimated that for solving 
a protein structure using MAD, one selenomethionine residue is required for ~75-100 
residues (Hendrickson 1997). Since Bim1p (C-term) has a total length of 113 residues, 
additional methionine residues are needed to obtain a higher phasing power and figure of 
merit (FOM). Therefore additional methionines were introduced by site-directed mutagenesis 
(see chapter 4.9.1). Four residues (L199M, Y206M, L224M, F264M) were chosen for 
mutagenesis based on the indirect structural information derived from sequence homology to 
human EB1 and its solved structure as well as on secondary structure predictions for 
Bim1p (C-term). The protein was expressed in minimal medium containing selenomethionine 
(see chapter 4.11.2) and purified like the unlabelled protein. Crystallisation trials yielded only 
very tiny (20-30 µm x 5-10 µm) needle shaped crystals, which did not show X-ray diffraction 
at the synchrotron. Therefore, for solving the phase problem, different heavy atom 
derivatives were used for soaking of the native crystals. As a preliminary experiment, the 
purified protein was incubated with several heavy atoms in different concentrations 
(see chapter 4.12.6) and analysed on a native PAGE (Figure 15C). Three heavy atom 
derivatives showed clearly a band shift of the protein on the native PAGE and have been 
used for heavy atom derivatisation of Bim1p (C-term) (K2Pt(NO2)4, (PtCl2(H2NCH2CH2NH2), 
Pt(NH3)2(NO2)2).  
 
2.3.4 Structure determination and refinement of Bim1p (C-term) 
Plate-like crystals (Figure 15D) were tested at various beamlines at the ESRF in Grenoble. 
Datasets from the native crystals (Figure 15E) were recorded at beamline ID 29 at a 
wavelength of 1.254 Å. Although crystals showed X-ray diffraction up to 2.1 Å, processing of 
the data revealed high-quality diffraction only for the resolution range of 20-2.45 Å. Data was 
integrated and scaled with XDS and SCALA (Evans ; Kabsch ; Evans 2006). Crystals belong 
to the spacegroup P21 with cell dimensions of a=28.00 Å, b=42.5 Å, c=100.5 Å, α = γ =90°, 
β =90.3°. From the unit cell a Matthews’s coefficient of 2.99 Å3/dalton of protein was 
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calculated (Matthews 1968) with one molecule (dimer) per asymmetric unit and a solvent 
content of 58.89 %.  
Single anomalous dispersion (SAD) experiments for the platin-derivatised crystals were 
recorded at beamline ID 29 (ESRF, Grenoble, France) at a wavelength of 1.071 Å. Crystals 
showed diffraction up to 2.1 Å and significant anomalous signal up to 3.5 Å. Data were 
integrated and scaled as for the native datasets and the unit cell has a dimension of 
a=28.00 Å, b=44.25 Å, c=101.25 Å, α = γ =90°, β =94.7°. Using ShelxD (Sheldrick 2008), two 
platin positions could be located within the asymmetric unit. Phases were calculated with 
SHARP (Bricogne, Vonrhein et al. 2003) using SAD. The model was built manually with 
COOT (Emsley and Cowtan 2004) and the platin-derivatised dataset. Molecular replacement 
with PHASER (McCoy 2007) has been used to solve the structure of the native dataset with 
the model of the platin-derivatised dataset as template. Refinement was performed with 
BUSTER (Blanc, Roversi et al. 2004) using Non-Crystallographic Symmetry. The final model 
on Bim1p (C-term) contains 91 out of 113 amino acids. Final R-factors are Rwork = 0.209 and 
Rfree = 0.24, and the Ramachandran plot shows 97.01 % of the residues in allowed regions. 
The main crystallographic statistics are listed in Table 4. 
 
Data collection   Refinement (native)  
Data set Native Pt Peak   
X-ray source  ID 29  
(ESRF) 
ID 29  
(ESRF) 
  
Space group P21 P21   
Wavelength (Å) 1.254 1.071   
Data range (Å) 20-2.45 50-2.1 
Observations 
 (unique) 
31883 
(8834) 
90864 
(30751) 
Rwork  
(Rfree) 
0.209 
(0.240) 
I/σI 
(last shell) 
13.12 
(2.07) 
8.16 
(1.71) 
RMS bond length (Å)  
RMS bond angles (deg) 
0.0098 
1.18° 
Completeness (%) 
(last shell) 
98.8 
(98.3) 
99.0 
(63.8) 
Ramachandran plot (%)   
(allowed) 
(additionally allowed) 
outliers 
 
97.0 
1.8 
1.2 
Rsym  
(last shell) 
7.8 
(71.7) 
14.2 
(98.5) 
  
Cell symmetry Native: P21 cell constants (Å):  
a=28.00, b=42.5, c=100.5, α=γ=90°, β=90.3° 
Cell symmetry Pt: P21 - cell constants (Å):  
a=28.00, b=44.25, c=101.25, α=γ=90°, β=94.7° 
Resolution range of last shell: 2.59-2.45 Å 
Rsym is the un-weighted R-value on I between symmetry mates. 
Rwork = ∑hkl II Fobs(hkl)I -IFcalc (hkl) II / ∑hkl I Fobs (hkl)I for reflections in the working data set.  
Rfree = cross validation R-factor for 5% of reflections against which the model was not refined.  
Table 4 Crystallographic statistics for Bim1p (C-term) 
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Figure 15 Purification and Crystallisation of Bim1p (FL) and Bim1p (C-term) (A) Domain composition of 
Bim1p (FL) and Bim1p (C-term). The residues modified by phosphorylation are indicated in the linker region. 
(B) Purification of Bim1p (FL) after cleavage of the GST-tag and size-exclusion chromatography. (C) Native SDS-
PAGE after incubation of purified Bim1p (C-term) with different heavy atom derivatives. Arrows indicate the heavy 
atom derivatives that showed a band shift on the gel and which have been used for soaking of the crystals. 
(D) Crystal of Bim1p (C-term). (E) Diffraction pattern of the native crystals. (F) Diffraction pattern after soaking of 
the crystals with K2Pt(CN)4. 
 
2.3.5 Crystal structure of Bim1p (C-term) 
The structure of Bim1p (C-term) includes residues 1-68 and 82-105. For 14 residues in the 
flexible loop region and 8 residues at the very C-terminus no electron density was observed. 
The missing residues 69-81 are located in a Bim1p-specific sequence insertion of 
24 residues (amino acid 240 to 263 in Bim1p (FL) and amino acid 58 to 81 in 
Bim1p (C-term)) which contains many glycine residues and which is therefore likely to be 
highly flexible.  
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The overall structural arrangement is similar to human EB1 and shows that Bim1p (C-term) is 
a dimer. The C-terminal domain of Bim1p is formed through a coiled-coil followed by a four-
helix bundle. Each monomer consists of a long helix (α1, residues 1-63) which is followed by 
a 24-residue loop leading to a short second helix (α2, residues 84-102), which is antiparallel 
to α1 (Figure 16A). The Bim1p-specific sequence insertion, for which no electron density was 
visible, is located between the two helices of each monomer.  
Although both momoners look similar, their superimposition shows that their respective 
structures are not identical. One monomer has a kink in the lower third of the long helix, 
which induces asymmetry (Figure 29A). Residues 43-46 contain a highly conserved 
FYF motif that might influence the difference in their structure. These residues are also likely 
involved in the binding to Kar9p and in forming intramolecular contacts. Since the structural 
asymmetry is found in all molecules of the unit cell, the crystal-packing does not seem to 
influence the structural difference between the two monomers, (Figure 29B). Despite this 
difference, the residual mean square deviation (RMSD) from an overlay of both monomers is 
rather small (1.60 Å).  
An analysis of the crystallographic contacts with the PDBe PISA server 
(www.ebi.ac.uk/pdbe/prot_int/pistart.html) (Krissinel and Henrick 2007) shows that the 
hydrophobic dimerisation interface involves a large buried surface of 1987 Å2, suggesting 
stable dimerisation in solution. All data obtained from the PDBe PISA server is shown in 
Table 5.  
Assessment of the electrostatic surface potential of Bim1p (C-term) revealed that this domain 
contains has a rather uncharged overall surface with few pronounced regions of positive or 
negative charge (Figure 16B).  
 
 
Figure 16 Crystal structure of Bim1p (C-term) (A) Crystal structure of Bim1p (C-term). The domain is formed 
by two monomers. Each monomer consists of a long α-helix followed by a short α-helix. The coiled-coil is formed 
by the long helices, whereas the short helices fold back thereby forming a four-helix bundle. Monomers are shown 
in blue and green. N- and C-termini are labelled with “N” and “C”. (B) Surface charge of Bim1p (C-term). No 
clusters of positively or negatively charged residues are visible. (C) Surface conservation of Bim1p (C-term) 
based on sequence alignment of different EB1-family members. A highly conserved region lies at the four-helix 
bundle in the upper part of the structure.   
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To visualise, which areas in Bim1p (C-term) are highly conserved, the sequence alignment 
from Figure 30 was plotted onto the surface of the Bim1p structure. A region at the interface 
of the four-helix bundle shows a high degree of conservation (Figure 16C), but does not 
overlap with regions of pronounced positive or negative surface charges. The region at the 
four-helix bundle contains two highly conserved hydrophobic patches, one in the long helix 
(FYF-motif) and the other at the end of the short helix. It has been shown for EB1 that these 
two regions mediate the binding to cargo (Honnappa, John et al. 2005; Slep, Rogers et al. 
2005; Honnappa, Gouveia et al. 2009). This similarity supports the assumption that Kar9p 
potentially also binds in this region. 
The submission of the Bim1p (C-term) crystal structure to the RSCB protein data bank (PDB) 
is in preparation. 
 
2.3.6 Structural comparison of the cargo-binding domains of Bim1p and human EB1 
An overlay of the crystal structures of the cargo-binding domains from Bim1p (C-term) and 
human EB1 shows a similar overall fold, with an RMSD of only 1.2 Å (Figure 17). The most 
obvious difference in both structures is that the large helix of Bim1p is about one-third longer 
than in human EB1 (total length ~ 93 Å versus ~ 63 Å). The sequence of the protein fragment 
of Bim1p that was crystallised is also about one-third longer than the corresponding fragment 
of human EB1 (100 residues versus 66 residues). Another minor difference between the two 
structures is the kink in one of the long helices of Bim1p (C-term). This difference is a 
possible explanation as to why molecular replacement approaches with human EB1 failed.  
 
 
 
 
Figure 17 Overlay of the crystal structures of the cargo-
binding domains from Bim1p (C-term) and human EB1. 
Both domains shown and overall similar fold with an RMSD of 
only 1.2 Å. The long alpha helix of Bim1p is substantially 
longer than the alpha helix in EB1. 
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2.3.7 Analysis of Bim1p (C-term) and (FL) by small-angle-X-ray scattering (SAXS) 
Small-angle-X-ray Scattering (SAXS) is often used as a complementary technique to X-ray 
crystallography to observe and verify the conformation and oligomeric state of a protein in 
solution. It can also be used to calculate surface envelopes of molecules that fail to 
crystallise and to fit known structural models into the envelopes.  
To confirm whether the dimer of Bim1p (C-term) observed in the crystal lattice is also present 
under nearly physiological conditions, SAXS experiments were performed as described in 
chapter 4.10.5. The molecular mass determined from the scattering intensity extrapolated to 
zero angle confirms that Bim1p (C-term) is a dimer in solution (Figure 18A). To obtain 
information on the shape and size of Bim1p (C-term), the radius of gyration (Rg) was 
determined from the scattering curves. For Bim1p (C-term) an average Rg of 2.96 nm was 
calculated, which is quite large for a molecule with this molecular weight, but can be 
explained by the extended shape (long helices). Furthermore, the CRYSOL software was 
used to calculate a theoretical scattering curve from the crystal structure and to compare 
it with the experimental scattering curve of the protein in solution. An overlay of both 
scattering curves of Bim1p (C-term) shows an almost perfect match, confirming that the 
dimer observed in the crystal structure is likely physiologic (Figure 18B). Bead models of 
Bim1p (C-term) were calculated with the DAMMIN software and show approximately the 
same dimensions as the molecule in the crystal structure (length of 98.4 Å versus 101.2 Å). 
The model obtained from the SAXS data seems to have additional density around the four-
helix bundle. This difference can be explained by the existence of the flexible loop region, for 
which no electron density was visible in the crystal structure.  
Another question was whether the full-length protein is dimeric in solution too and whether 
envelopes of Bim1p (FL) can be obtained. The envelopes would then be used to obtain 
insights into the overall shape of the protein and to fit the known structures of the CH-domain 
(Slep and Vale 2007) and the C-terminal domain. Analysis of Bim1p (FL) by SAXS confirmed 
that full-length Bim1p is also a dimer in solution (Figure 18A) and has a radius of gyration of 
5.88nm. The scattering curves obtained were however not of sufficient quality to calculate 
envelopes for fitting of the known structures. Together with the SAXS analysis of 
Bim1p (C-term) these results confirm that the C-terminus mediates dimerisation of Bim1p.  
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Figure 18 Small-angle-X-ray scattering (SAXS) analysis of Bim1p (A) Table showing the experimental setup, 
the measured radius of gyration and molecular weight. Conc = protein concentration, Rg= radius of gyration, 
MWtheor = molecular weight calculated from the amino acid sequence, MWexp = molecular weight obtained by 
SAXS-analysis. (B) CRYSOL analysis of Bim1p (C-term) shows an almost perfect match of the theoretical 
(blue line) and the measured scattering curve (red dots).  
 
2.4 In vitro and in vivo analysis of the Bim1p-Kar9p interaction 
As already described above (chapter 2.2), the interaction of Bim1p and Kar9p requires 
sumoylation of Kar9p. Therefore all experiments described in the following section were 
accomplished with MBP-tagged Bim1p expressed in and purified from E.coli and lysate from 
yeast cells expressing myc-tagged Kar9p.  
In order to find out whether Bim1p (C-term) binds to Kar9p, pull-down experiments were 
performed at different salt concentrations (Figure 19). Bim1p (C-term) can pull-down Kar9p in 
all reactions as detected by western blot, but the binding to Kar9p is always weaker than 
compared to Bim1p (FL). The binding of both Bim1p variants to Kar9p gets also weaker with 
increasing salt concentrations and is almost invisible for Bim1p (C-term) at 500 mM NaCl. 
This difference in binding suggests that an additional so far undetected region outside the 
C-terminal domain of Bim1p might contribute to Kar9p binding. 
 
 
 
 
 
 
 
Figure 19 Pull-down experiments with 
Bim1p (C-term) or Bim1p (FL) and 
myc-Kar9p from yeast extracts. 
Bim1p (FL) always binds stronger to 
Kar9p than the C-terminal EB1 motif 
alone.  
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2.4.1 The Bim1p-specific loop is not required for the binding to Kar9p 
The C-terminal domain of Bim1p contains a yeast specific insertion of 24 amino acids, 
connecting the long and the short helix. Since no electron density could be observed in the 
crystal structure, it would be interesting to find out whether this region is important for Kar9p 
binding. For EB1 it has been shown that this loop is not involved in cargo binding (Honnappa, 
John et al. 2005; Slep, Rogers et al. 2005). However, since Bim1p contains a much larger 
insertion it might indeed contribute to the binding. To test the importance of the loop region 
for Kar9p binding, mutants of Bim1p (FL) and Bim1p (C-term) with loop deletions of either 12 
or 14 amino acids were generated and tested in pull-down experiments. Since recombinant 
Bim1p (Δ12) or Bim1p (Δ14) did not show defects in Kar9p binding (Figure 20A), it can be 
concluded that the yeast-specific loop in Bim1p is unlikely to be required for Kar9p binding. 
 
2.4.2 Mutational analysis of the Bim1p-Kar9p interaction 
Based on the information obtained from the crystal structure of Bim1p (C-term) and 
interaction studies of human EB1 with different cargoes (Honnappa, John et al. 2005; Slep, 
Rogers et al. 2005; Honnappa, Gouveia et al. 2009) as well as sequence conservation and 
surface exposure in Bim1p a total of 20 point mutations were introduced in Bim1p (FL). 
These mutants were then tested in pull-down experiments for binding to myc-tagged Kar9p 
from yeast extracts. A detailed overview of the mutated residues and their location in the 
C-terminal domain of Bim1p is given in Figure 20B,C. 
Of the total of 20 mutations, 5 mutations resulted in rapidly degrading proteins, whereas 15 
of these mutants were soluble proteins. Most of the mutations resulting in degrading proteins 
are located in the hydrophobic region of the short alpha helix. The hydrophobic side chains of 
these residues are oriented towards the hydrophobic residues of the long alpha helix. 
Replacement of these residues with alanine might induce structural changes of this helix or a 
better accessibility of those hydrophobic residues to the solvent and could therefore lead to 
protein unfolding and aggregation. All 15 well-behaving mutated protein versions were tested 
in pull-down experiments with extracts from myc-tagged Kar9p expressing cells. Reduced 
binding to Kar9p was observed with mutations R217A, F219A, Y220A, F221A, and H232A in 
Bim1p (FL) and mutation E228A even abolished Kar9p binding (Figure 20D). An unexpected 
two-fold enhanced binding to Kar9p could be observed with the mutation E214A. Mutations 
E218A and N222A also showed a milder increase in Kar9p binding. None of the other 
mutations (I215A, K223A, R225A, D226A, I227A, I229A) showed a significant effect on 
binding to Kar9p. To establish whether these mutations have the same effect in 
Bim1p (C-term), nine of these point mutations were introduced in Bim1p (C-term) and tested 
in pull-down experiments. The results were consistent with Bim1p (FL) except for mutation 
I227A, where a slightly increased binding was observed and mutation R225A, where a 
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slightly reduced binding (Figure 20D) was observed. Since mutation I227A is buried in the 
hydrophobic core of Bim1p, this effect can be explained by likely structural changes of the 
protein (Figure 20C).  
 
 
Figure 20 Mutational analysis of the interaction between Bim1p and Kar9p (A) The extended loop region in 
the C-terminal domain of Bim1p is not required for binding of Kar9p. Deletions of either 12 or 14 residues of this 
loop in Bim1p do not have an effect on Kar9p-binding in pull-down experiments. (B) Location of the residues 
mutated in Bim1p on a surface model of its crystal structure. Red: mutated residues. (C) Detailed view of 
mutations in Bim1p that affect the binding to Kar9p. Red = severely reduced binding, orange = mild binding 
defects, green = increased binding. I227A is buried, but showed increased binding to Kar9p upon mutation in 
Bim1p (C-term). (D) Western blots of pull-down experiments with different mutations in Bim1p (FL), 
Bim1p (C-term) and human EB1. (E) Quantification of western blots from pull-down experiments with mutations in 
Bim1p (C-term), confirming the results observed in (D).  
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Western blots from pull-down experiments with mutations in Bim1p (C-term) were also 
subjected to quantification of the myc-Kar9p signals with a digital imaging system 
(see chapter 4.10.3). Quantification of the myc-Kar9p signals confirmed what had already 
been observed in the western blots. In particular, the two-fold increase in binding of mutation 
E214A or the almost abolished binding of mutation E228A was consistent between 
Bim1p (FL) and Bim1p (C-term) (Figure 20E).  
Since human EB1 shows high similarity to Bim1p (C-term) in terms of structural 
arrangements and sequence conservation, the C-terminal cargo-binding domain of human 
EB1 was also tested in pull-down experiments with myc-tagged Kar9p. Since no interaction 
with Kar9p was observed for human EB1, I concluded that both proteins are likely to bind 
their cargo in a somewhat different manner.  
 
2.4.3 In vivo effects of the Bim1p-mutations 
To test the in vivo effects of Bim1p mutations six mutations which showed Kar9p-binding 
defects in the pull-down assay were chosen for expression in yeast. Several yeast strains 
were generated harbouring mutant versions of Bim1p (FL) fused to an HA-tag under the 
control of the native BIM1 promoter in an otherwise ∆BIM1 background. As for the mutations 
in Kar9p the yeast cells were incubated with different concentrations of the microtubule-
depolymerising drug Benomyl. It had already been shown that bim1-null mutants are more 
sensitive to Benomyl than wild-type cells. Therefore, if a particular mutation has an effect, the 
cells should be highly sensitive (Schwartz, Richards et al. 1997; Parsons, Brost et al. 2004; 
Ye, Peyser et al. 2005). Additionally, wild type and mutant Bim1p-expressing yeast strains 
were incubated at 23°C, 30°C, and 37°C to assess temperature-induced defects in spindle 
orientation (Schwartz, Richards et al. 1997). Both assays were performed as colony growth 
tests on agar plates.  
No growth defect was observed in the temperature-sensitivity assays for any of the tested 
mutations (Figure 21). Despite the impaired binding to Kar9p in vitro, the interaction in vivo 
seems to be more robust. Indeed, the dynein-dynactin pathway can partially rescue defects 
in the Myo2p-Kar9p-Bim1p pathway in vivo. However, when probing sensitivity to Benomyl, a 
yeast strain expressing the mutant Bim1p (F219A) did yield growth defects (Figure 21). 
Bim1p with this mutation had almost completely lost its ability to interact with Kar9p in pull-
down experiments (Figure 20D). It suggests that a reduced binding to Kar9p also results in 
growth defects with Benomyl. Surprisingly, Bim1p with the mutation I229A, which showed 
normal binding to Kar9p in the pull-down experiments (Figure 20D), was less sensitive to 
Benomyl when compared to wild-type Bim1p (Figure 21). No other mutation resulted in a 
growth defect in this assay.  
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In comparison to the in vitro assays, the experimental readout of the in vivo experiments is 
less straightforward. It either suggests that in vivo the complex assembly is more robust or 
that other mechanisms contribute to the rescue of the defects. Indeed, these findings are 
consistent with the assumption of a second, partially redundant Kar9p binding site in Bim1p, 
as already suggested above (see chapter 2.4). 
 
 
Figure 21 In vivo effects of mutations in Bim1p Yeast strains harbouring mutations in the C-terminal cargo-
binding domain of Bim1p were exposed to different concentrations of Benomyl or different temperatures. Only two 
mutations show effects in the presence of Benomyl, no effect can be observed at different temperatures.  
 
2.4.4 Bim1p has a second binding region for Kar9p 
The observation that Bim1p (FL) binds better to Kar9p than to Bim1p (C-term) (Figure 19) 
suggests a contribution of regions outside the C-terminal cargo-binding domain. 
To determine the contribution of such additional regions to Kar9p binding, several fragments 
with deletions of the C-terminal cargo-binding domain (Bim1p (1-187)) or of even larger 
fragments of the C-terminus (Bim1p (1-154) and Bim1p (1-124)) were tested in pull-down 
assays with myc-tagged Kar9p from yeast extracts. Bim1p (1-124) consists only of the 
CH-domain, which mediates binding to microtubules and of which the crystal structure is 
known (Schwartz, Richards et al. 1997). Bim1p (1-154) contains the CH-domain and part of 
the unstructured middle domain, connecting the CH-domain and the EB1-like domain. 
Bim1p (1-187) contains the CH-domain and the middle domain up to the beginning of the 
EB1-like domain (Figure 22A). With these fragments, no binding to Kar9p was observed in 
pull-down experiments (Figure 22B). These results argue against the presence of a second 
Kar9p-binding region in Bim1p.  
Taking into account that the crystal structure of Bim1p (C-term) and the SAXS analyses 
revealed a dimerisation of Bim1p by the EB1-like motif (Figure 16 and Figure 18), a second 
binding region might also require dimerisation of Bim1p for binding to Kar9p. Therefore, 
deletion of the C-terminal domain of Bim1p would impair its function.  
To find out whether a potential second Kar9p-binding region requires dimerisation of Bim1p, 
the C-terminal cargo binding domain was replaced by the dimerisation-mediating coiled-coil 
region of GCN4. This heterologous coiled-coil region is comparable in size to the coiled-coil 
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of Bim1p. All three Bim1p-GCN4 hybrid fragments (Figure 22B) were tested in pull-down 
experiments with myc-tagged Kar9p. Indeed, Kar9p could be pulled-down with 
Bim1p (1-187 GCN4) in comparable amounts to Bim1p (C-term) (Figure 22B). The more 
residues of the middle domain were deleted, the less interaction with Kar9p could be 
observed (Bim1p (1-514 GCN4) and Bim1p (1-124 GCN4)) (Figure 22B). These results 
suggest that the region between the CH domain and the EB1-like motif also mediates binding 
to Kar9p and that this function requires dimerisation of Bim1p by the C-terminal dimerisation 
domain. The proportion of Kar9p bound to Bim1p (C-term) and Bim1p (1-187 GCN4) 
furthermore suggests that both regions equally contribute to the binding. The proportion of 
Kar9p bound by Bim1p (FL) seems to be more than the amount of both regions alone taken 
together.  
 
 
Figure 22 The middle domain of Bim1p binds to Kar9p (A) Cartoon representation of the different fragments 
used for pull-down experiments. A dimerisation domain of GCN4 replaced the C-terminal dimerisation domain. (B) 
Western blot from pull-down experiments with the different fragments of Bim1p. Fragments of Bim1p without a 
dimerisation domain cannot bind to Kar9p, whereas fragments dimerised by the unrelated GCN4-domain can bind 
to Kar9p. Together these results suggest the presence of a second binding region in Bim1p.  
 
2.4.5 In vivo effects of Bim1p lacking the EB1-like motif 
Since the binding by each individual Kar9p-binding domain of Bim1p is considerably weaker 
than compared to full-length Bim1p (Figure 22), it would be of great interest to find out 
whether this previously undetected Kar9p-binding region of Bim1p alone is sufficient to 
mediate spindle orientation in vivo. A yeast strain harbouring a plasmid expressing 
Bim1p (1-187 GCN4) in a bim1-deletion background was generated and tested for Benomyl 
and temperature sensitivity. If Bim1p (1-187 GCN4) would rescue the effects of a bim1 
deletion, this should lead to reduced sensitivity to high temperature or Benomyl. Growth tests 
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on plates containing Benomyl or at different temperatures showed that Bim1p (1-187 GCN4) 
only marginally rescues the deletion of bim1. The effects are very weak and the growth rates 
are more comparable to a bim1-deletion than to wild-type BIM1 (Figure 23). This observation 
further supports the assumption of a cooperative binding of both Kar9p-binding domains.  
 
 
Figure 23 In vivo analysis of Bim1p lacking the C-terminal EB1-like motif Growth tests of a yeast strain 
expressing Bim1p (1-187 GCN4) at different Benomyl concentrations and temperatures. The phenotype of a 
bim1-deletion can only marginally be rescued by the expression of Bim1p (1-187 GCN4). 
 
2.4.6 Aurora B/Ipl1p dependent phosphorylation of Bim1p impairs binding to Kar9p  
A recent publication has shown that the middle domain of Bim1p is phosphorylated at six 
serine residues (amino acid positions 139, 148, 149, 165, 166, and 176) by the Aurora B 
kinase Ipl1p (Zimniak, Stengl et al. 2009) (Figure 15A). This phosphorylation occurs 
specifically during anaphase and is required for proper spindle mid-zone disassembly 
(Zimniak, Stengl et al. 2009). Since these residues are located in the novel Kar9p-binding 
region identified in this study, phosphorylation of these residues could also play a role in 
Kar9p-binding.  
In order to test whether phosphorylation of Bim1p directly affects the interaction with Kar9p, 
pull-down experiments with four different phosphomimetic mutants in the middle domain of 
Bim1p were performed. Zimniak and colleagues have shown that mutations of these serines 
into glutamic acids efficiently mimic phosphorylation of Bim1p and reduce microtubule 
binding (Zimniak, Stengl et al. 2009). A strongly impaired binding to Kar9p was observed with 
the phosphomimetic double mutant Bim1p (FL; S165D S166D), whereas Kar9p binding with 
Bim1p (FL; S148D S149D) was comparable to wild-type Bim1p (FL). A less reduced 
interaction with Kar9p was observed with the other two mutations of Bim1p (FL; S139D) and 
Bim1p (FL; S176D). 
 
 
Figure 24 Phosphorylation of Bim1p by Aurora B / Ipl1p affects 
binding to Kar9p Western blots of pull-down experiments with 
phosphomimetic mutations in the middle-domain of Bim1p. Three 
of four mutant versions of Bim1p show a reduced binding to Kar9p.  
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These results further support the finding that the middle domain has an additional Kar9p 
binding site. It also suggests that Aurora B/Ipl1p-dependent phosphorylation of the Bim1p 
middle domain regulates its binding to Kar9p. This interpretation is consistent with the 
observation that Aurora B/Ipl1p kinase-dependent phosphorylation of Bim1p is required for 
normal progression of mitosis (Zimniak, Stengl et al. 2009). 
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3 Discussion 
3.1 Crystallisation of Kar9p 
The function of Kar9p is well understood in vivo, but the molecular details of how the protein 
is folded and how it interacts with other proteins are unknown (Bloom 2000; Hwang, Kusch 
et al. 2003). Given that Kar9p has limited sequence similarities to its homologue APC 
(Bienz 2001), a crystal structure of Kar9p would help to improve our understanding of Kar9p 
and maybe even APC function.  
In this study, crystals of Kar9p were obtained for the full-length protein as well as for several 
Kar9p variants (Table 1). Most of the crystals diffracted X-rays not better than 7 Å and only 
crystals of Kar9p (1-398) showed some additional spots up to 4-5 Å (Figure 9C). This 
indicates that the protein generally tends to crystallise and represents therefore a promising 
starting point. Since several cryo-protection approaches have been tried without great 
differences, the poor X-ray diffraction properties are rather likely to be due to suboptimal 
crystal packing (see chapter 2.1.2 and 2.1.4).  
Common causes of suboptimal crystal packing are flexible or unstructured parts of a protein. 
Structure predictions of Kar9p obtained from HHPred Server (Soding, Biegert et al. 2005) 
showed that the C-terminal part of Kar9p is completely unstructured, whereas the N-terminal 
part is structured (Figure 8A).  
When large parts of the C-terminus were deleted, the protein yield was much higher than for 
Kar9p (FL) and additional spots around 4-5 Å appeared in the diffraction pattern of crystals of 
Kar9p (1-398). On the other hand, deletions of the N-terminal part of Kar9p led to rapid 
degradation of the proteins (see chapter 2.1.3). Additionally, fragments of the N terminal part 
of Kar9p were not digested by limited proteolysis, whereas the C-terminal part was prone to 
proteolysis.  
Taken together, these results indicate that the N-terminal part of Kar9p is structured, 
whereas the C-terminal part is not, further supporting the preliminary structural model 
obtained by HHPred Server (Soding, Biegert et al. 2005). The unstructured part of Kar9p 
might therefore hinder crystallisation of Kar9p (FL). A crystal structure of the N-terminal part 
of Kar9p based on these findings appears possible, but would require additional optimisation 
of the fragments as well as the crystal-growth conditions and cryo-protection. However, since 
multiple attempts to improve such conditions failed to result in well-diffracting crystals, this 
might not be an easy task. 
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3.2 Role of posttranslational modifications of Kar9p 
Several studies have shown that Kar9p is posttranslationally modified in vivo by 
phosphorylation and sumoylation (Liakopoulos, Kusch et al. 2003; Maekawa, Usui et al. 
2003; Maekawa and Schiebel 2004; Moore, D'Silva et al. 2006; Moore and Miller 2007; 
Leisner, Kammerer et al. 2008; Meednu, Hoops et al. 2008). Both types of modifications 
independently promote asymmetric localisation of Kar9p to the mother SPB (Leisner, 
Kammerer et al. 2008). Combining mutations in phosphorylation- and sumoylation-sites 
abrogates the asymmetric distribution of Kar9p more extensively than each mutation alone 
(Leisner, Kammerer et al. 2008). It will be therefore important to identify the molecular 
mechanisms underlying those types of regulations to gain further insights into Kar9p 
regulation and function. Of particular importance is the role of posttranslational modifications 
on the association of Kar9p with other proteins such as Bim1p.  
 
3.2.1 Phosphorylation of Kar9p 
Phosphorylation of Kar9p occurs at serines 197 and 496 in a Clb4p/Cdc28p-dependent 
manner (Liakopoulos, Kusch et al. 2003; Maekawa, Usui et al. 2003; Maekawa and Schiebel 
2004; Moore, D'Silva et al. 2006; Moore and Miller 2007). Two models have been proposed 
how this phosphorylation event could mediate asymmetry in Kar9p association with the 
mother SPB. Liakopoulos and colleagues have suggested that phosphorylation of Kar9p by 
Clb4p/Cdc28p disrupts the interaction between Kar9p and Bim1p and thereby prevents its 
loading onto the corresponding spindle pole (Liakopoulos, Kusch et al. 2003). In an 
alternative model, Moore and Miller have suggested that Kar9p is phosphorylated at both 
spindle poles, but that a factor present only at one of the two poles would associate with 
Kar9p (Moore and Miller 2007). 
Using in-vitro pull-down experiments, the research presented here demonstrates that 
mutations preventing phosphorylation of Kar9p at serine 197 and/or 496 show no defects in 
Bim1p binding (Figure 11). This observation suggests that Clb4p/Cdc28p-dependent 
phosphorylation is not directly involved in modulating the Bim1p interaction. These results 
are also in agreement with previous in vivo experiments elsewhere, which have 
demonstrated that phosphorylation of Kar9p is not required for association with Bim1p 
(Moore and Miller 2007). To gain further insights on the function of phosphorylation in vivo, 
yeast strains harbouring mutations of Kar9p at both or either phosphorylation site were 
generated. When tested for growth on Benomyl or at different temperatures, the strain 
harbouring the double mutation was less sensitive than compared to the wild-type, 
suggesting that this protein is less active (Figure 12 and Table 2). Given that the association 
with Bim1p is not impaired by this mutation, other mechanisms or microtubule-associated 
proteins must influence the activity of Kar9p (S197A; S496A). Therefore, future work will be 
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required to show whether the previously proposed unknown, asymmetric factor (Moore and 
Miller 2007) indeed exists to modulate the function of Kar9p at only one pole or whether 
phosphorylation of Kar9p is required for association with other microtubule-associated 
proteins. 
To identify such a potential asymmetric factor, co-immunoprecipitation (co-IP) experiments 
with myc-tagged Kar9p were performed with all mutations of phosphorylation sites, followed 
by mass-spectrometric analysis of the co-immuoprecipitating protein bands 
(see chapter 2.2.3). The proteins co-immunoprecipitating with Kar9p were similar in all 
experiments and no obvious difference in the overall composition was observed 
(see chapter 7.2). This either indicates that such an asymmetric factor is not present or, 
when considering that the cells were asynchronous, the detection of such an asymmetric 
factor requires synchronisation of the cells. Since the localisation of Kar9p to the mother SPB 
occurs within a short time frame of the cell-cycle such an asymmetric factor might only 
associate with Kar9p in a well-defined time frame. Therefore, co-IPs from synchronised yeast 
cultures might be required to detect the presence of such an asymmetric factor.   
 
3.2.2 Sumoylation of Kar9p 
Sumoylation is a highly conserved process and a major regulator of protein function in a wide 
range of cellular events (Hay 2005; Wilkinson and Henley 2010). Covalent attachment of 
SUMO (Smt3p in budding yeast) to lysine residues of target proteins involves an enzymatic 
cascade analogous to the ubiquitination pathway (Wilkinson and Henley 2010). Modifications 
of target proteins by sumoylation exert regulatory effects on protein-protein interactions, 
protein localisation and protein stabilisation (Johnson 2004; Meednu, Hoops et al. 2008). 
Furthermore, sumoylation might alter protein function at a molecular level by masking or 
adding interaction surfaces and by inducing conformational changes that result in altered 
protein–protein interactions (Meulmeester and Melchior 2008).  
Sumoylation of Kar9p has been reported to begin in metaphase, which is the time point when 
the Myo2p-Kar9p-Bim1p complex is active (Leisner, Kammerer et al. 2008). Is sumoylation 
therefore a possible regulator of complex assembly? To answer this question, the role of the 
individual sumoylation sites identified in the previous study (Leisner, Kammerer et al. 2008) 
was investigated in pull-down experiments and in vivo studies. In pull-down experiments, 
mutations of Kar9p (K333R) had only mild defects in binding to Bim1p and almost no effect 
was observed with Kar9p (K301R) and Kar9p (K529R), whereas strong defects were 
observed with Kar9p (K333E) and Kar9p (K381R). Combinations of these mutations resulted 
in an additive decrease in binding (Figure 13). The observation that Kar9p sumoylation in the 
majority of the four reported modification sites is required for efficient Bim1p interaction is 
also suited to explain why no interaction of the proteins with recombinant proteins expressed 
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in bacteria was observed. When testing these mutations in vivo in the already described 
dominant negative-overexpression assay for Benomyl and temperature sensitivity, the results 
did not always correlate in every detail with the in vitro results (Figure 14 and Table 3). 
However, a clear correlation between the number of mutated sumoylation sites and 
decreased binding to Bim1p as well as to reduced sensitivity towards Benomyl and higher 
temperatures was observed. One can therefore assume that a more complex mechanism 
might exist in vivo. The overall outcome of the experiments suggests that sumoylation plays 
an important role in Bim1p binding and that the effect is additive. Of particular importance is 
residue K381 that upon mutation almost abolishes binding to Bim1p. Whether sumoylation of 
this residue alone contributes to association of Kar9p with Bim1p or if the other sumoylated 
residues play also play a role remains unclear and requires further experiments such as 
in vivo co-localisation of these mutant proteins with Bim1p and other Kar9p associated 
proteins.  
A more indirect confirmation of these results comes from an observation of Miller and 
colleagues (Miller, Cheng et al. 2000). After pull-down experiments from yeast with 
HA-tagged Kar9p, the authors always detected two bands of Kar9p in western-blots that 
differed by 4000-5000 Da in apparent molecular weight. On the other hand when they pulled-
down Bim1p, only the higher molecular weight band of Kar9p was observed (Miller, Cheng 
et al. 2000). This shift in molecular weight suggests that there might be a significant 
functional or regulatory difference between the two bands of Kar9p. In conjunction with the 
results from this study, the observations strongly suggest that sumoylation of Kar9p is 
required for the interaction with Bim1p. If sumoylation of Kar9p at K381 is sufficient for the 
regulated association with Bim1p or if the other residues are also important remains unclear. 
The results of Miller and colleagues rather suggest that a single sumo-modification of Kar9p 
may be sufficient.  
Taken together, the results of the present study suggest that assembly of the spindle-
orientation complex is induced by Kar9p sumoylation Because sumoylation of Kar9p is 
prominent also in anaphase (Leisner, Kammerer et al. 2008) desumoylation-independent 
mechanisms must be in place to mediate disassembly of the Myo2p-Kar9p-Bim1p complex 
at the onset of anaphase. 
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3.3 Crystal structure of Bim1p 
3.3.1 Comparison of the crystal structure of Bim1p with human EB1 
The functions of the C-terminal domains of EB1 and Bim1p are related (Miller, Cheng 
et al. 2000; Honnappa, John et al. 2005; Slep, Rogers et al. 2005). In EB1 the C-terminal 
domain represents a general landing platform for a number of different +TIPS such as APC 
or spectraplakins (Lansbergen and Akhmanova 2006). Bim1p on the other hand interacts 
with Kar9p, the CLIP-170 homologue Bik1p, Stu2p, Dam1p and other proteins (Miller, Cheng 
et al. 2000; Shang, Hazbun et al. 2003; Wolyniak, Blake-Hodek et al. 2006). However, 
whether these interactions happen in all cases via the C-terminal domain is not yet known. 
Given that this domain in both orthologs exhibit similar functions, they are also likely to form 
very similar structures.  
To gain further insights into the regulation of Kar9p binding to Bim1p, the crystal structure of 
Bim1p (C-term) was solved in this study. The overall structural arrangement of Bim1p is 
similar to human EB1 and shows that Bim1p (C-term) is also a dimer (Figure 16 and Figure 
17). The RMSD value for the C-terminal domains between hEB1 and Bim1p is only 1.2 Å, 
indicating significant similarity of both overall folds. One very obvious difference is the length 
of the long alpha-helix, which is in Bim1p about one third longer than in hEB1 (Figure 17). 
Sequence alignments with EB1-like proteins from different species revealed that Bim1p 
contains a sequence insertion of 24 residues (amino acid 240 to 263 in Bim1p (FL) and 
amino acid 58 to 81 in Bim1p (C term) (Figure 30). This sequence insertion was not visible in 
the electron density presumably because of its high content in glycine residues and the 
resulting flexibility. This Bim1p-specific sequence insertion connects the long and the short 
helix. Pull-down experiments with Kar9p and deletions of this extended loop region showed 
no difference in binding to Kar9p (Figure 20A). These results clearly indicate that the 
extended loop region is not required for association of Kar9p with Bim1p. Why budding yeast 
has evolved such an extended loop region is not clear. One possibility is that other proteins 
interact with Bim1p via this unstructured loop.  
Sequence alignments between several EB1 family members revealed highly conserved 
residues in their C-terminal EB1-like domains (Figure 30). A surface plot of this alignment 
onto the Bim1p (C-term) structure shows that the majority of the highly conserved residues 
lie at the four-helix bundle forming a hydrophobic core (Figure 16C). This hydrophobic core 
contains a highly conserved „FYF“-motif, which has been shown for human EB1 to mediate 
binding to APC (Honnappa, John et al. 2005; Slep, Rogers et al. 2005). It is widely accepted 
that residues, which mediate protein-protein contacts are conserved between different 
species (Ma, Elkayam et al. 2003). Therefore, this region is very likely to mediate association 
with Kar9p. Furthermore, this region contains several highly conserved acidic residues, 
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contributing a net negative charge (Figure 16B). This conserved solvent-exposed region with 
hydrophobic and charged character might serve as cargo-binding site in Bim1p.  
 
3.3.2 The C-terminal domain of Bim1p mediates dimerisation of the protein 
The crystal structure of Bim1p (C-term) revealed that this domain is formed by a dimer. 
Several recent studies have shown that dimerisation via this domain is required for proper 
function of EB1-like proteins (Slep and Vale 2007; Honnappa, Gouveia et al. 2009; 
Komarova, De Groot et al. 2009; Zimniak, Stengl et al. 2009; De Groot, Jelesarov 
et al. 2010). Dimer formation of EB1 enables the protein to track microtubule plus-ends 
(Slep and Vale 2007). In addition, dimerisation of the CH-domain of Bim1p potently promotes 
microtubule nucleation (Slep and Vale 2007; Zimniak, Stengl et al. 2009) and microtubule 
binding (Zimniak, Stengl et al. 2009). To gain insight into dimer formation and the overall 
composition of Bim1p (FL), I performed small-angle X ray scattering (SAXS) experiments. 
The molecular weights calculated from the measured data clearly show that Bim1p (C-term) 
and Bim1p (FL) are dimeric in solution (Figure 18A). Crysol analysis of the theoretical 
scattering curve calculated from the crystal structure and comparison with the measured data 
shows an almost perfect match (chi-value of 1.1) (Figure 18B). Together these results 
confirm that the dimer observed in the crystal structure is also present at near-physiological 
conditions in solution.  
 
 
Figure 25 Low resolution model of human EB1. Calculated SAXS envelope (blue mesh) of human EB1. The 
crystal structures of the CH-domain (EB1-CH, red, PDB-ID: 1PA7) and the C-terminal domain (blue, PDB-ID: 
1WU9) of EB1 were manually docked into the map (Zimniak, Stengl et al. 2009). Picture taken from (Buey, Mohan 
et al. 2011) 
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While SAXS experiments were performed for Bim1p, a study was published indicating 
similiar properties of human EB1 (Buey, Mohan et al. 2011). In this study a low-resolution 
structure of the full-length EB1 protein was obtained by SAXS. Their model of EB1 depicts an 
elongated and globally asymmetric molecule, which resembles the shape of a golf club 
(Figure 25) (Buey, Mohan et al. 2011). The known X-ray structures of the CH-domain 
(Slep and Vale 2007) and the EB1 dimerisation domain (Honnappa, John et al. 2005; Slep, 
Rogers et al. 2005) were docked manually into the molecular envelope (Buey, Mohan 
et al. 2011). Both domains are in close proximity, suggesting that the linker domain is 
partially folded and interacts with both the CH-domain and the C-terminal EB1-like domain to 
form a complex interaction surface (Buey, Mohan et al. 2011). The overall structural 
arrangement requires the C-terminal dimerisation domain, since no dimers were observed for 
the isolated CH-linker domain fragments (Sandblad, Busch et al. 2006; Buey, Mohan 
et al. 2011). Thus dimerisation by the C-terminal EB1-like domain is likely to be a general 
feature of this class of proteins.  
 
3.4 Kar9p and APC share common binding features to Bim1p and EB1 
To gain further insights into the Kar9p-Bim1p complex assembly, structure-guided mutations 
were introduced in the C-terminal domain of Bim1p and tested for Kar9p binding. Pull-down 
experiments revealed several residues that either decreased or increased binding to Kar9p 
upon mutation to alanine (Figure 20B-E). Surprisingly, two point mutations (E218A, E214A) 
result in an almost two-fold increase in binding to Kar9p (Figure 20C-E). When plotting the 
interaction-modulating mutations onto the surface of the structure of the C-terminal domain of 
Bim1p, a patch within the highly conserved hydrophobic core can be observed (Figure 20C 
and Figure 16C). Both mutations enhancing binding to Kar9p are close to each other, but 
also in vicinity to two mutations that strongly decrease binding to Kar9p (R217A, F221A). 
This observation suggests that the region might be of particular importance for Kar9p 
binding. Alteration of the acidic residues obviously alters the net charge of the protein leading 
to an increased binding.  
When testing several mutations in vivo, sensitivity towards Benomyl and higher temperature 
was observed only for mutation F219A (Figure 21). The considerably weak effect in vivo 
suggests that either in vivo the complex assembly is more robust or that other mechanisms 
contribute to the rescue of the defects. Other mechanisms could include a second binding 
region or the partially redundant dynein-dynactin pathway, which can rescue defects in 
Bim1p-dependent spindle orientation. Therefore a synthetic lethality assay with a knockout of 
dynein is in preparation to assay if the defects of the mutations become more pronounced in 
absence of redundancy.  
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The availability of a co-structure of EB1 with an APC peptide and MACF (Honnappa, 
Gouveia et al. 2009) made a direct comparison of the results obtained in this study with 
structural information of these homologues possible (Figure 26). The analysis revealed that 
Kar9p also binds within the same highly conserved region of Bim1p that has been shown for 
EB1 to bind its cargoes (Honnappa, John et al. 2005; Slep, Rogers et al. 2005; Honnappa, 
Gouveia et al. 2009). Several of the corresponding residues in both proteins are identical and 
others lie in close vicinity (Figure 26), suggesting that the overall mode of interaction is 
similar for both EB1-like domains.  
 
 
Figure 26 Comparison of the residues mediating binding to different cargoes in EB1 and Bim1p. The 
residues mediating binding of Kar9p to Bim1p are identical or lie in close vicinity to the residues in EB1 required 
for binding to APC and MACF, suggesting that the mode of cargo binding is similar.  
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However, when testing the binding of human EB1 C-terminus with yeast Kar9p an interaction 
was not observed (Figure 20D,E). This finding indicates that despite their similarities cargo 
binding is not identical. However, for fission yeast it has been shown that human EB1 can 
substitute the function of the endogenous homolog Mal3p (Beinhauer, Hagan et al. 1997; 
Browning, Hackney et al. 2003). Mal3p can furthermore mimic the interaction of EB1 with 
APC in vitro, although an APC homologue has not been identified yet in fission yeast 
(Nakamura, Zhou et al. 2001). Nakamura and colleagues further showed that Mal3p can 
promote microtubule polymerisation in vitro in the presence of the C-terminal EB1-binding 
domain of APC (Nakamura, Zhou et al. 2001).  
These results indicate that the EB1-family members are not only conserved based on protein 
sequence and structural considerations but also at a functional level. Why an interaction with 
the C-terminal domain of human EB1 and Kar9p failed remains unclear. It might be that the 
full-length proteins contain additional binding regions required for the association with their 
homologous proteins. The identification of a second Kar9p-binding region in Bim1p in the 
present study indeed suggests that cargo interaction is more complex than previously 
anticipated. It would be interesting to see whether this new Kar9p-binding region in Bim1p is 
also functional and required in human EB1 for the binding of APC, MACF or its other binding 
partners. 
Interaction studies between the C-terminal domain of human EB1 and APC used a small 
peptide of APC, with which an interaction could be observed (Honnappa, John et al. 2005; 
Slep, Rogers et al. 2005; Honnappa, Gouveia et al. 2009). The peptide of APC mediating 
binding to EB1 is completely unstructured in solution, but the region binding to EB1 becomes 
ordered upon complex formation with EB1 (Honnappa, Gouveia et al. 2009). Moore and 
colleagues (Moore and Miller 2007) have identified a minimal binding region in Kar9p that still 
binds to Bim1p in an yeast-two hybrid assay (residue 534-580) (Figure 27). This region is 
located in the highly unstructured basic and proline rich C-terminal domain of Kar9p. It is 
therefore likely that Kar9p adopts a similar fold as APC upon binding to Bim1p. Although this 
region lies outside the sequence, which shows sequence conservation to APC (Figure 5B), 
several other general features are present that have been observed to be required for 
binding to EB1. Slep and colleagues identified repeat binding motifs in APC and MACF as 
well as other general features required for cargo binding of EB1 (Slep, Rogers et al. 2005). 
These general features are the presence of several hydrophobic residues (mainly prolines) 
and a net positive charge (Slep, Rogers et al. 2005). Despite Kar9p does not have a repeat 
motif architecture similar to APC or MACF (Slep, Rogers et al. 2005), the common features 
required for binding to EB1 are present in the region mapped by the yeast-two hybrid assay. 
Another hint that the binding of Kar9p to Bim1p is similar to APC and EB1 is the identification 
of an EB1-binding motif in APC and MACF (Honnappa, Gouveia et al. 2009). This short 
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polypeptide motif (Serine-x-Isoleucine-Proline (SxIP)) is used by numerous + TIPs for their 
localisation to microtubule plus-ends in an EB1-dependent manner (Honnappa, Gouveia 
et al. 2009). The SxIP-motif establishes an interaction network between the serine, 
isoleucine and proline motif and the hydrophobic core of the C-terminal domain of EB1 
(Honnappa, Gouveia et al. 2009). Intriguingly, this motif is also found in the minimal region of 
Kar9p binding to Bim1p. This leads to a speculation that this motif might also mediate the 
binding to Bim1p as has been shown for APC and MACF (Honnappa, Gouveia et al. 2009). 
Additional experiments will be required to delineate the role of this Kar9p region in binding to 
Bim1p. First of all a direct interaction between a peptide of the minimal Bim1p binding region 
of Kar9p and Bim1p has to be demonstrated. If this will be possible is arguable, since 
sumoylation of full-length Kar9p is required for the interaction with Bim1p and all identified 
sumoylation sites (Leisner, Kammerer et al. 2008) are outside this minimal region. 
Nevertheless, K529 is in close vicinity, which might argue for a potential role of this residue in 
regulating binding to Bim1p.  
 
Figure 27 Sequence of Kar9p. Blue: minimal sequence of Kar9p that has been mapped by yeast-two hybrid to 
bind to Bim1p (Moore and Miller 2007. The SxIP-motif found in APC and MACF to be required for binding to EB1 
is also present in this region (red) (Honnappa, Gouveia et al. 2009).  
 
3.5 Role of the middle domain of Bim1p in protein binding  
My observation that full-length Bim1p binds to Kar9p considerably stronger than its 
C-terminal EB1-like motif suggested additional features in Bim1p to participate in this 
interaction. Indeed, a second Kar9p binding site in the middle domain of Bim1p was identified 
(Figure 22A,B). However, the middle domain of Bim1p was only capable of Kar9p binding 
when the protein was dimerised. Full binding to Kar9p was only observed when the whole 
middle domain was present, whereas binding decreased when parts of the middle domain 
were deleted (Figure 22B). This binding to Kar9p via the Bim1p-middle domain is 
comparable in strength to the interaction of the EB1-like domain alone with Kar9p. Thus, the 
C-terminal EB1-like motif not only functions as Kar9p binding site but also provides the 
dimerisation required for Kar9p binding by the middle domain.  
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However, Bim1p (1-187 GCN4) only marginally counters the growth defects of a bim1 
deletion in vivo. This observation further supports the assumption of a cooperative binding of 
both Kar9p binding domains. The simultaneous binding to two regions is furthermore likely to 
increase the strength and the specificity for a given interaction. It should also be noted that 
the GCN4 fragments not only lacked the EB1-like motif but also 57 residues C-terminal to the 
EB1-like motif. It has been shown that these two regions together mediate binding of the 
Aurora B/Ipl1p kinase (Zimniak, Stengl et al. 2009) and thus might also be required to rescue 
the Δbim1 phenotype independent of their role in Kar9p binding. 
Secondary structure predictions and sequence alignments indicate that the middle domain is 
rather unstructured. It is also only weakly conserved, compared to other regions of Bim1p. 
Since protein-interaction surfaces are often highly conserved (Ma, Elkayam et al. 2003), it is 
likely that the mode of interaction between the middle domain of Bim1p and Kar9p follows a 
rather unique and unusual mechanism. On the other hand considering that this middle 
domain is also required for efficient microtubule binding in EB1 and Bim1p, the function of 
this domain seems to be conserved despite its weak conservation (Slep and Vale 2007; 
Zimniak, Stengl et al. 2009). It would be therefore interesting to see if this middle domain is 
also involved in cargo binding in EB1.  
Phosphorylation of the middle domain was shown to be important for the regulation of 
microtubule binding of Bim1p (Zimniak, Stengl et al. 2009). This region is phosphorylated by 
the Aurora B/Ipl1p kinase in a well-defined time window starting in anaphase (Zimniak, 
Stengl et al. 2009). To gain insight into the regulation of Kar9p binding, phosphomimetic 
mutants of Bim1p were tested in pull-down experiments. Compared to wild-type Bim1p (FL), 
the double mutant Bim1p (FL; S165D S166D) showed strongly reduced binding, whereas 
mutations of S139 and S176 had only mild defects. Aurora B/Ipl1p kinase-dependent 
phosphorylation of Bim1p occurs at a time point when the spindle is finally oriented and when 
the Myo2p-Kar9p-Bim1p complex has to disassemble. 
For the vertebrate homolog EB1 of Bim1p it has recently been reported that its binding to 
Aurora B kinase protects it from inactivation (Sun, Gao et al. 2008). In this context, it would 
be interesting to see whether phosphorylated EB1 or Bim1p shows increased binding to 
AuroraB/Ipl1p kinase, thereby protecting it from inactivation. If true, this feedback loop could 
constitute a novel entry point for inhibitory approaches. 
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3.6 Model of the cell-cycle dependent regulation of Bim1p-Kar9p complex 
assembly and disassembly  
The findings of this study suggest a model that explains the cell-cycle dependent regulation 
of the assembly and disassembly of the Myo2p-Kar9p-Bim1p complex. Given its role in 
spindle orientation, this complex should not assemble before metaphase and should be 
inactivated again at the beginning of anaphase. Leisner and colleagues showed that 
sumoylation occurs during metaphase and that a Kar9p version with all four lysine residues 
mutated fails to localise exclusively to the mother SPB (Leisner, Kammerer et al. 2008). 
Other studies have furthermore shown that the Bim1p-Kar9p complex assembles before 
loading onto the microtubules via the spindle pole bodies (Cuschieri, Miller et al. 2006). The 
present findings therefore suggest that sumoylation induces the assembly of the Bim1p 
Kar9p complex prior loading onto the spindle poles.  
 
Figure 28 Model for the assembly and disassembly of the Bim1p-Kar9p complex. In premetaphase, Kar9p is 
not sumoylated and therefore cannot bind to Bim1p. Kar9p becomes sumoylated in metaphase to regulate the 
binding to Bim1p. For complex disassembly in late anaphase, Bim1p becomes phosphorylated, thereby reducing 
binding to Kar9p. Arrows color code: green= binding when modified, black= binding regions, blue= 
phosphorylation/sumoylation events, red= reduced binding upon modification/without modification. 
 
Because sumoylation of Kar9p is prominent also in anaphase (Leisner, Kammerer 
et al. 2008), desumoylation-independent mechanisms must be in place to mediate 
disassembly of the Myo2p-Kar9p-Bim1p complex at the onset of anaphase. Since 
phosphorylation of Kar9p had no effect on the complex assembly (Figure 11), additional 
regulatory events were investigated. Bim1p is phosphorylated in its middle domain in late 
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anaphase by the Aurora B/Ipl1p kinase. Mimicking phosphorylation at these residues results 
in decreased Kar9p binding. Therefore the findings of this study suggest a cell-cycle 
dependent inactivation of the Bim1p-Kar9p interaction by phosphorylation of Bim1p in its 
middle domain. This inactivation would pave the way for the subsequent spindle elongation 
by the dynein-dependent complex. It is also consistent with the observation that 
Aurora B/Ipl1p kinase-dependent phosphorylation of Bim1p is required for spindle elongation 
to occur with normal kinetics and for efficient disassembly of the spindle midzone (Zimniak, 
Stengl et al. 2009).  
In summary, the present study not only offers a mechanism for the cell cycle-dependent 
regulation of the Bim1p interaction to Kar9p. It also provides a testable hypothesis for the 
regulation of the human EB1 interaction with its binding partners by EB1 phosphorylation 
through Aurora B kinase in its middle domain. 
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4 Materials and Methods 
4.1 Consumables and chemicals 
All commonly used chemicals were purchased in the highest available purity from Roth 
(Karlsruhe, Germany), Merck (Darmstadt, Germany), or Sigma (Deisenhofen, Germany), 
unless stated otherwise. Enzymes and nucleotides for molecular biology and molecular 
weight markers for electrophoretic analyses were obtained from Fermentas (St. Leon-Rot, 
Germany), New England Biolabs (Frankfurt, Germany) or Agilent Technologies (Waldbronn, 
Germany). Components to prepare media for bacterial and yeast cultivation were purchased 
from Becton Dickinson (Heidelberg, Germany) and Sigma Aldrich (Deisenhofen, Germany). 
Media for insect cell culture were obtained from Thermo Scientific (Bonn, Germany) and 
Sigma Aldrich (Deisenhofen, Germany). Chromatographic equipment, columns, media and 
autoradiography films for western blots were purchased from GE Healthcare (Munich, 
Germany), except for Amylose resin material, which was purchased from New England 
Bioloabs. Transfer membranes for western blotting were obtained from Roth (Karlsruhe, 
Germany). Crystallisation screens, crystallisation grade reagents, and crystallisation tools 
were obtained from Hampton Research (Aliso Viejo, USA), Qiagen (Hilden, Germany), and 
Jena Bioscience (Jena, Germany). DNA oligonucleotides were ordered from Thermo Fisher 
(Ulm, Germany).  
 
4.2 Oligonucleotides 
4.2.1 Oligonucleotides for biochemical characterization 
1 5'AAA AAGCTAGCATGGATAATGATGGACCCAG3'  174 5’AAAGTCGACATGGATAATGATGGACCCAG3‘ 
3 5’AAAGGATCCATGAGTGCGGGTATCGGAGAATC3’  175 5’AAAGCGGAAGCTCAATAAGTTGGGGTTTTATC3‘ 
11 5'AAAGAGCTCTCAATAAGTTGGGGTTTTATCTAAACG3'  176 5’AAACTCGAGATATCTCTAAATTGAATTG3’ 
12 5’AAACTCGAGTTAAAAAGTTTCCTCGTCGATGATCAAG3’  177 5’AAATCTAGAGGCAGTGCTACTGAAATC3’ 
15 5'AAAGCGGCCGCCAGGGGCCCCTGGAACAGAACTTCC3'  178 5’AAATCTAGAATGGATAATGATGGACCC3’ 
16 5'AAAGCGGCCGCATGGATAATGGACCCAG3'  181 5’AAAGTCGACATAAGTTGGGGTTTTATC3’ 
17 5'AAATCTAGATCAATAAGTTGGGGTTTTATCTAAACG3'  184 5’AAAGCGGCCGCATACTAACCTAAAACTGTATAC3’ 
18 5'AAAGGATCCATGTCCCCTATACTAGGTTATTGG3'  185 5’AAAGAGCTCGCCAATGTATCCTAGCGAA3’ 
19 5' AAAGGATCCTTGGTAGCGATACAAGCGGA 3'  186 5’AAAGTCGACTCCGGTTCTGCTGCTAGTGG3’ 
20 5'AAAGGATCCACTTTAGAGATTGAAAGAGA3'  187 5’AAAGCGGCCGCTTAGCTAGTGGATCCGTTC3’ 
21 5'AAACTCGAGATTCATTTCAAATCCTTCTG3'  198 5’GTACTTTAGCGATTGAAAG3’ 
22 5'AAACTCGAGGTTACTACCTTCGTTACCAT3'  199 5’CTTTCAATCGCTAAAGTAC3’ 
23 5'AAA AAGTCGACATGGATAATGATGGACCCAG3'  200 5’CTTTAGAGGCTGAAAGAG3’ 
26 5'AAA AAGTCGACAAATGGATAATGATGGACCCAG3'  201 5’CTCTTTCAGCCTCTAAAG3’ 
27 5'AAAAAAGAGCTCTCATTTAATATTCATCTTCTGCAG3'  202 5’TAGAGATTGCAAGAGAATT3’ 
28 5'AAAAAAGAGCTCTCATTCATCGGTTTCGTCATAAGG3'  203 5’AATTCTCTTGCAATCTCTA3’ 
29 5'AAA AAAGAGCTCTCATTTATCCGCTGTAGGCTTGAT3'  204 5’GAGATTGAAGCAGAATTTTAC3’ 
30 5'AAAAAGCTAGCGGGGATGACTTCCAAGAGAAC3'  205 5’GTAAAATTCTGCTTCAATCTC3’ 
31 5'AAAAAGAGCTCTCACTTTGCTATCGGTGTGTTTTC3'  206 5’TTGAAAGAGCATTTTACTTC3’ 
32 5'AAAAAGAGCTCTCATCTTGGTGAAAGTAACTGTG3'  207 5’GAAGTAAAATGCTCTTTCAA3’ 
33 5'AAAAAGCTAGCACCATTGGGGATGACTTCCAAG3'  208 5’GAAAGAGAAGCTTACTTCAAC3’ 
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34 5'AAAAAGCTAGCAGATCTATGACCATTGGGGATG3'  209 5’GTTGAAGTAAGCTTCTCTTTC3’ 
35 5'AAAAAGCTAGCGGACCCAGATCTATGACCATTGG3'  210 5’GAGAATTTGCCTTCAACAA3’ 
36 5'AAAGAGCTCTCATTTATCTAAACGCCCTTCTC3'  211 5’TTGTTGAAGGCAAATTCTC3’ 
37 5'AAAGAGCTCTCAACGCCCTTCTCTTGGTGAAAG3'  212 5’GAATTTTACGCCAACAAACT3’ 
40 5'AAAGGTACCAAATGAGTGCGGGTATCGGAGA3'  213 5’AGTTTGTTGGCGTAAAATTC3’ 
41 5'AAACTCGAGTTAAAAAGTTTCCTCGTCGA3'  214 5’TTACTTCGCCAAACTACG3’ 
55 5'AAAAAGCTAGCATGATACAGGTACCTAACGCG3'  215 5’CGTAGTTTGGCGAAGTAA3’ 
56 5'AAAAACTCGAGTCATGATAAGTTAAGAAGATC3'  216 5’ACTTCAACGCACTACGCGAC3’ 
57 5'AAAAAGAATTCAAATGATACAGGTACCTAACGCG3'  217 5’GTCGCGTAGTGCGTTGAAGT3’ 
58 5'AAAAAGCTAGCATGAGCAACCATGAGTTGACG3'  218 5’TCAACAAAGCACGCGACAT3’ 
59 5'AAAAACTCGAGTCAAAAAGGACGTCTCCTGGAAG3'  219 5’ATGTCGCGTGCTTTGTTGA3’ 
60 5'AAAAAGTCGACAATGAGCAACCATGAGTTGACG3'  220 5’ACAAACTAGCCGACATAGA3’ 
61 5'AAAAAGCGGCCGCTCAAAAAGGACGTCTCCTGGAAG3'  221 5’TCTATGTCGGCTAGTTTGT3’ 
91 5'AGGTTCGCGGCCCCGATACGG3'  222 5’AACTACGCGCCATAGAAAT3’ 
92 5'CCGTATCGGGGCCGCGAACCT3'  223 5’ATTTCTATGGCGCGTAGTT3’ 
93 5'GATCCGGAGGCGCCAAACAAA3'  224 5’TACGCGACGCAGAAATCCT3’ 
94 5'TTTGTTTGGCGCCTCCGGATC3'  225 5’AGGATTTCTGCGTCGCGTA3’ 
95 5'AGGGAATTGAGAGTCGAACTA3'  226 5’GCGACATAGCAATCCTGGT3’ 
96 5'TAGTTCGACTCTCAATTCCCT3'  227 5’ACCAGGATTGCTATGTCGC3’ 
97 5'TTGCAGTCGAGATTACTGACA3'  228 5’ACATAGAAGCCCTGGTCCA3’ 
98 5'TGTCAGTAATCTCGACTGCAA3'  229 5’TGGACCAGGGCTTCTATGT3’ 
99 5'TTGCAGTCGGAATTACTGACA3'  230 5’ACATAGAAGCCCTGGTCCA3’ 
100 5'TGTCAGTAATTCCGACTGCAA3'  231 5’TGGACCAGGGCTTCTATGT3’ 
101 5'GTCGCATCGAGGACAAATGAA3'  237 5’AAAAAGCTTCGGGGCGTAATCACCTAAC3’ 
102 5'TTCATTTGTCCTCGATGCGAC3'  238 5’AAAGAATTCTGGCTACGCTTACTCCAGG3’ 
103 5'GAAAATGAAAGGTCACCAGAC3'  239 5’GAGGAAACTTTTTCTAGATAAGTTGAGAAC3’ 
104 5'GTCTGGTGACCTTTCATTTTC3'  240 5’GTTCTCAACTTATCTAGAAAAAGTTTCCTC3’ 
105 5'AAAAAGCTAGCAGGGAATTGAAAGTCGAACTAATC3'  241 5’AAATCTAGATCCGGTTCTGCTGCTAGATAC3’ 
106 5'AAAAAGCTAGCAAACGTTGGAATATACTCTTTATT3'  242 5’AAATCTAGATTAGCTAGAAGCGTAATCTGG3’ 
107 5'AAA AAGTCGACAAAATATCCCTCCAATTGAAAAAAG3'  250 5’TTTATATGCTGCTGCAGAAG3’ 
108 5'AAA AAGTCGACAAGAAAAAAGTTTGACTGATATCC3'  251 5’CTTCTGCAGCAGCATATAAA3’ 
109 5'AAAAAGTCGACAAAGGGAATTGAAAGTCGAACTAATC3'  252 5’GCTACTGCAGAAGGATTTGAA3’ 
110 5'AAAAAGTCGACAAAAACGTTGGAATATACTCTTTATT3'  253 5’TTCAAATCCTGCTGCAGTAGC3’ 
127 5' CATTTCCATTACCATGGCCACCTTCATTTATTAAATC 3'  254 5’GCAGAAGGAGCTGAAATGAAT3’ 
128 5' CTCCCCCATTTCCATTACCACCTTCATTTATTAAATC 3'  255 5’CATTCATTTCAGCTCCTTCTGC3’ 
129 5' GATTTAATAAATGAAGGTGGCCATGGTAATGGAAATGG 3'  263 5’TTTCTCGAGTTATTGTATCGCTACCAACTGACC3’ 
130 5' GATTTAATAAATGAAGGTGGTAATGGAAATGGGGGAG 3'  264 5’TTTCTCGAGTTAACTCCCAGTGCCTGTGCATGA3’ 
135 5'AAAGAGCTCTCATTTGTCGATTAGTTCGACTTT3'  265 5’TTTCTCGAGTTAACGATACTTGCGCCTTGCATC3’ 
136 5'AAAGAGCTCTCACTTTGTTGTCAGTAATTTCG3'  268 5’AAAAAGCTTAGAATGAAACAACTTGAAGAC3’ 
137 5'AAAGAGCTCTCATTTATTACTGTCACCTTCATT3'  269 5’AAACTCGAGTCAGCGTTCGCCAACTAATTTC3’ 
138 5'AAAGCGGCCGCTCATTTGTCGATTAGTTCGACTTT3'  305 5’AAATCTAGAGGAATCCGGAATCTTTACCCA3’ 
139 5'AAAGCGGCCGCTCACTTTGTTGTCAGTAATTTCG3'  306 5’AAATCTAGACTAGCACTGAGCAGCGTAATC3’ 
140 5'AAAGCGGCCGCTCATTTATCCGCTGTAGGCTTGAT3'  307 5’AAAGCTAGCAGAATGAAACAACTTGAAGAC3’ 
141 5'AAAGCGGCCGCTCATTTATTACTGTCACCTTCATT3'  308 5’AAATCTAGAGCGTTCGCCAACTAATTTCTT3’ 
146 5'AAAGCGGCCGCTCATGATTTTCTCTCCAATTGCCTCTC3'  309 5’AAATCTAGATGCCGCGCTAGCTTGTATCGCTACCAACTGACCTTGGG3’ 
149 5'AAAGAGCTCTCAAACACTATTCGGTCGCCCAAAGCC3'  314 5’CGTACAGTAGACAACCCTACC3’ 
155 5’AAAAGTCGACATGCATCATCATCATCATCACGATAATGATGGACCCAGATC3‘  315 5’GGTAGGGTTGTTACTGTACG3’ 
165 5’AAAGAGCTCTCATGTAGGCTTGATATTCAGCC3‘  316 5’GCAAGAGGTCAGATGACACAGGCACTGGG3’ 
166 5’AAAGAGCTCTCAGATTAGAATTTTATCCGCTG3‘  317 5’CCCAGTGCCTGTGTCATCTGACCTCTTTGC3’ 
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167 5’AAAGAGCTCTCAGGAGGATTTGATTAGAATTT3‘  318 5’GCAACAAGACATGATGACCTGGGAATAAAC3’ 
168 5’AAAGAGCTCTCATTTGTTTGAAGCGGAGGATT3‘  319 5’GTTATTCCCAGGTCATCATGTCTTGTTGC3’ 
171 5’GCTAGCATGCATCATCATCATCATCATCACTCATCAAGTGCGGGTATCGGAGAATC3‘  320 5’AGAAAAACCGATGTTACCCAA3’ 
172 5’AAAGGTACCTTAATTCATTTCAAATCCTTCTGC3‘  321 5’TTGGGTAACATCGGTTTTTCT3’ 
173 5’AAAGGTACCTTAAAAAGTTTCCTCGTCG3‘    
 
4.2.2 Oligonucleotides for homologous recombination in S. cerevisiae 
53 (S2 Kar9) 5'GAGGGAGGATATATAAAAATGTATAAGTATACAGTTTTAGGTTAGTATCAATCGATGAATTCGAGCTCG 3' 
54 (S3 Kar9) 5'CACAGTTACTTTCACCAAGAGAAGGGCGTTTAGATAAAACCCCAACTTATCGTACGCTGCAGGTCGAC 3' 
68 (S1 Kar9) 5'CACGAATCTTTGTCTGTAACAGCCTTAAAGATTTCAGTAGCACTGCCATGCGTACGCTGCAGGTCGAC 3' 
69 (S1 Bim1) 5'CAGACTCAAAAGCAAGGATAATATTCCACCAAATCAGGGACGAAGCAATG CGTACGCTGCAGGTCGAC  3' 
70 (S2 Bim1) 5'AAAAAATAATACATATTCGAAAACAATACTGCTTTTTAGTTCTCAACTTAATCGATGAATTCGAGCTCG 3' 
 
4.3 Plasmids  
4.3.1 Plasmids for protein expression in E. coli 
 Insert Vector Template Primer Enzyme Reference 
pDH001 Bim1 (FL) pGEX-6P-1 Genomic DNA 3+12 BamHI/XhoI This study 
pDH003 Kar9 (FL) pET28a-TEV Genomic DNA 1+11 NheI/SacI This study 
pDH004 pFastBac1-GST pFastBac1 pGEX6P-1 15+18 BamHI/NotI This study 
pDH005 
pFastBac1      
Bim1 (FL) 
pFastBac1 Genomic DNA 3+12 BamHI/XhoI This study 
pDH008 
pFastBac1      
Kar9 (FL) 
pFastBac1 Genomic DNA 16+17 NotI/XbaI This study 
pDH009 pDH004 Kar9(FL) pDH004 Genomic DNA 16+17 NotI/XbaI This study 
pDH010 
Bim1 (C-term) 
182-282 
pGEX-6P-1 Genomic DNA 19+21 BamHI/XhoI This study 
pDH011 
Bim (C-term)    
182-319 
pGEX-6P-1 Genomic DNA 19+22 BamHI/XhoI This study 
pDH012 
Bim1 (C-term)    
182-344 
pGEX-6P-1 Genomic DNA 19+12 BamHI/XhoI This study 
pDH013 
Bim1 (C-term)    
212-282 
pGEX-6P-1 Genomic DNA 20+21 BamHI/XhoI This study 
pDH014 
Bim1 (C-term)    
212-319 
pGEX-6P-1 Genomic DNA 20+22 BamHI/XhoI This study 
pDH015 
Bim1 (C-term)    
212-344 
pGEX-6P-1 Genomic DNA 20+12 BamHI/XhoI This study 
pDH016 Kar9 (FL) pGEX-6P-1 Genomic DNA 23+26 
 
NotI/SalI This study 
pDH017 Kar9 (1-478) 
 
pET28a-TEV Genomic DNA 1+27 
 
NheI/SacI This study 
pDH018 Kar9 (1-517) 
 
pET28a-TEV Genomic DNA 1+28 
 
NheI/SacI This study 
pDH019 Kar9 (1-398) 
 
pET28a-TEV Genomic DNA 1+29 
 
NheI/SacI This study 
pDH020 Kar9 (12-644) 
 
pET28a-TEV Genomic DNA 11+30 
 
NheI/SacI This study 
pDH021 Kar9 (1-608) 
 
pET28a-TEV Genomic DNA 1+31 
 
NheI/SacI This study 
pDH022 Kar9 (1-635) 
 
pET28a-TEV Genomic DNA 1+32 
 
NheI/SacI This study 
pDH023 Kar9 (12-608) 
 
pET28a-TEV Genomic DNA 30+31 
 
NheI/SacI This study 
pDH024 Kar9 (12-635) 
 
pET28a-TEV Genomic DNA 30+32 
 
NheI/SacI This study 
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 Insert Vector Template Primer Enzyme Reference 
pDH025 Kar9 (10-644) 
 
pET28a-TEV Genomic DNA 11+33 
 
NheI/SacI This study 
pDH026 Kar9 (7-644) 
 
pET28a-TEV Genomic DNA 11+34 
 
NheI/SacI This study 
pDH027 Kar9 (5-644) 
 
pET28a-TEV Genomic DNA 11+35 
 
NheI/SacI This study 
pDH028 Kar9 (1-640) 
 
pET28a-TEV Genomic DNA 1+36 
 
NheI/SacI This study 
pDH029 Kar9 (1-637) 
 
pET28a-TEV Genomic DNA 1+37 
 
NheI/SacI This study 
pDH030 Kar9 (10-640) pET28a-TEV Genomic DNA 33+36 
 
NheI/SacI This study 
pDH031 Kar9 (10-637) 
 
pET28a-TEV Genomic DNA 33+37 
 
NheI/SacI This study 
pDH032 Kar9 (7-640) 
 
pET28a-TEV Genomic DNA 34+36 
 
NheI/SacI This study 
pDH033 Kar9 (7-637) 
 
pET28a-TEV Genomic DNA 34+37 
 
NheI/SacI This study 
pDH034 Kar9 (5-640) 
 
pET28a-TEV Genomic DNA 35+36 
 
NheI/SacI This study 
pDH035 Kar9 (5-637) 
 
pET28a-TEV Genomic DNA 35+37 
 
NheI/SacI This study 
pDH036 Kar9 (10-635) 
 
pET28a-TEV Genomic DNA 33+32 
 
NheI/SacI This study 
pDH037 Kar9 (7-635) 
 
pET28a-TEV Genomic DNA 34+32 
 
NheI/SacI This study 
pDH038 Kar9 (5-635) 
 
pET28a-TEV Genomic DNA 35+32 
 
NheI/SacI This study 
pDH043 ACR023W 1-769 
 
pET28a-TEV Genomic DNA 55+56 
 
NheI/XhoI This study 
pDH044 ACR023W 1-769 
 
pGEX-6P-1 Genomic DNA 56+57 
 
EcoRI/XhoI This study 
pDH045 
CAGL0A01155g 
1-609 
 
pET28a-TEV Genomic DNA 58+59 
 
NheI/XhoI This study 
pDH046 
CAGL0A01155g 
1-609 
 
pGEX-6P-1 Genomic DNA 60+61 
 
SalI/NotI This study 
pDH051 
Bim1 (FL)  pETM40 with 
modified linker 
Genomic DNA 3+12 BamHI/Xho1 This study 
pDH052 
Bim1 (C-term) 
182-282 
pETM40 with 
modified linker 
Genomic DNA 19+21 BamHI/XhoI This study 
pDH061 Kar9 (245-644) pET28a-TEV Genomic DNA 103+11 NheI/SacI This study 
pDH062 Kar9 (250-644) pET28a-TEV Genomic DNA 104+11 NheI/SacI This study 
pDH063 Kar9 (298-644) pET28a-TEV Genomic DNA 105+11 NheI/SacI This study 
pDH064 Kar9 (307-644) pET28a-TEV Genomic DNA 106+11 NheI/SacI This study 
pDH065 Kar9 (245-644) pGEX-6P-1 Genomic DNA 107+24 NotI/SalI This study 
pDH066 Kar9 (250-644) pGEX-6P-1 Genomic DNA 108+24 NotI/SalI This study 
pDH067 Kar9 (298-644) pGEX-6P-1 Genomic DNA 109+24 NotI/SalI This study 
pDH068 Kar9 (307-644) pGEX-6P-1 Genomic DNA 110+24 NotI/SalI This study 
pDH069 Kar9 (1-307) pET28a-TEV Genomic DNA 1+135 NheI/SacI This study 
pDH070 Kar9 (1-338) pET28a-TEV Genomic DNA 1+136 NheI/SacI This study 
pDH071 Kar9 (1-451) pET28a-TEV Genomic DNA 1+137 NheI/SacI This study 
pDH072 Kar9 (1-307) pGEX-6P-1 Genomic DNA 26+138 NotI/SalI This study 
pDH073 
Bim1 (C-term) 
Δ241-253 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 127, 129 BamHI/XhoI This study 
pDH075 
Bim1 (FL) Δ241-
253 
pETM40 with 
modified linker 
Genomic DNA 3, 12 127, 129 BamHI/XhoI This study 
pDH076 
Bim1 (FL) Δ241-
253 
pETM40 with 
modified linker 
Genomic DNA 3, 12, 128, 130 BamHI/XhoI This study 
pDH077 Kar9 (1-338) pGEX-6P-1 Genomic DNA 26+139 NotI/SalI This study 
pDH078 Kar9 (1-355) pGEX-6P-1 Genomic DNA 26+146 NotI/SalI This study 
pDH079 Kar9 (1-398) pGEX-6P-1 Genomic DNA 26+140 NotI/SalI This study 
pDH080 Kar9 (1-451) pGEX-6P-1 Genomic DNA 26+141 NotI/SalI This study 
pDH081 Kar9 (1-373) pGEX-6P-1 Genomic DNA 26+147 NotI/SalI This study 
pDH082 Kar9 (1-429) pGEX-6P-1 Genomic DNA 26+148 NotI/SalI This study 
pDH083 Kar9 (1-429) pET28a-TEV Genomic DNA 1+149 NheI/SacI This study 
pDH084 Kar9 (1-395) pET28a-TEV Genomic DNA 11+165 
 
NheI/SacI This study 
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pDH085 Kar9 (1-401) pET28a-TEV Genomic DNA 11+166 NheI/SacI This study 
pDH086 Kar9 (1-404) pET28a-TEV Genomic DNA 11+167 NheI/SacI This study 
pDH087 Kar9 (1-408) pET28a-TEV Genomic DNA 11+168 NheI/SacI This study 
pDH089 Kar9 (10-395) pET28a-TEV Genomic DNA 33+165 NheI/SacI This study 
pDH090 Kar9 (12-395) pET28a-TEV Genomic DNA 30+165 NheI/SacI This study 
pDH091 Kar9 (10-398) pET28a-TEV Genomic DNA 33+29 NheI/SacI This study 
pDH092 Kar9 (12-398) pET28a-TEV Genomic DNA 30+29 NheI/SacI This study 
pDH093 Kar9 (10-401) pET28a-TEV Genomic DNA 33+166 NheI/SacI This study 
pDH094 Kar9 (12-401) pET28a-TEV Genomic DNA 30+166 NheI/SacI This study 
pDH095 
Kar9 (FL) + 
Bim1(FL) 
pET-Duet Genomic DNA 174+175 (Kar9) 
40+41 (Bim1) 
SalI/NotI 
KpnI/XhoI 
This study 
pDH096 
Kar9 (FL)-6xHis 
Bim1 (FL) 
pFastBacDual Genomic DNA 155+175 (Kar9) 
79+172 (Bim1) 
SalI/NotI 
KpnI/NheI 
This study 
pDH097 
Kar9 (FL)       
Bim1 (FL)-6xHis 
pFastBacDual Genomic DNA 174+175 (Kar9) 
171+173 (Bim1) 
SalI/NotI 
KpnI/NheI 
This study 
pDH098 
Kar9 (FL)-6xHis 
Bim1 (C-term) 
pFastBacDual Genomic DNA 155+175 (Kar9) 
79+172 (Bim1) 
SalI/NotI 
KpnI/NheI 
This study 
pDH099 
Kar9 (FL)        
Bim1 (C-term)-
6xHis 
pFastBacDual Genomic DNA 174+175 (Kar9) 
170+172 (Bim1) 
SalI/NotI 
KpnI/NheI 
This study 
pDH123 
Bim1 (FL) E214A pETM40 with 
modified linker 
Genomic DNA 3, 12, 198, 199 BamHI/XhoI This study 
pDH124 
Bim1(FL) I215A pETM40 with 
modified linker 
Genomic DNA 3, 12, 200, 201 BamHI/XhoI This study 
pDH125 
Bim1(FL) E216A pETM40 with 
modified linker 
Genomic DNA 3, 12, 202, 203 BamHI/XhoI This study 
pDH126 
Bim1(FL) R217A pETM40 with 
modified linker 
Genomic DNA 3, 12, 204, 205 BamHI/XhoI This study 
pDH127 
Bim1(FL) E218A pETM40 with 
modified linker 
Genomic DNA 3, 12, 206, 207 BamHI/XhoI This study 
pDH128 
Bim1(FL) F219A pETM40 with 
modified linker 
Genomic DNA 3, 12, 208, 209 BamHI/XhoI This study 
pDH129 
Bim1(FL) Y220A pETM40 with 
modified linker 
Genomic DNA 3, 12, 210, 211 BamHI/XhoI This study 
pDH130 
Bim1(FL) F221A pETM40 with 
modified linker 
Genomic DNA 3, 12, 212, 213 BamHI/XhoI This study 
pDH131 
Bim1(FL) N222A pETM40 with 
modified linker 
Genomic DNA 3, 12, 214, 215 BamHI/XhoI This study 
pDH132 
Bim1(FL) K223A pETM40 with 
modified linker 
Genomic DNA 3, 12, 216, 217 BamHI/XhoI This study 
pDH133 
Bim1(FL) L224A pETM40 with 
modified linker 
Genomic DNA 3, 12, 218, 219 BamHI/XhoI This study 
pDH134 
Bim1(FL) R225A pETM40 with 
modified linker 
Genomic DNA 3, 12, 220, 221 BamHI/XhoI This study 
pDH135 
Bim1(FL) D226A pETM40 with 
modified linker 
Genomic DNA 3, 12, 222, 223 BamHI/XhoI This study 
pDH136 
Bim1(FL) I227A pETM40 with 
modified linker 
Genomic DNA 3, 12, 224, 225 BamHI/XhoI This study 
pDH137 
Bim1(FL) E228A pETM40 with 
modified linker 
Genomic DNA 3, 12, 226, 227 BamHI/XhoI This study 
pDH138 
Bim1(FL) I229A pETM40 with 
modified linker 
Genomic DNA 3, 12, 228, 229 BamHI/XhoI This study 
pDH139 
Bim1(FL) H232A pETM40 with 
modified linker 
Genomic DNA 3, 12, 230, 231 BamHI/XhoI This study 
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pDH141 
Bim1(FL) T275A pETM40 with 
modified linker 
Genomic DNA 3, 12, 250, 251 BamHI/XhoI This study 
pDH142 
Bim1(FL) E277A pETM40 with 
modified linker 
Genomic DNA 3, 12, 252, 253 BamHI/XhoI This study 
pDH143 
Bim1(FL) F279A pETM40 with 
modified linker 
Genomic DNA 3, 12, 253, 254 BamHI/XhoI This study 
pDH151 
Bim1 (C-term) 
E214A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 198, 199 BamHI/XhoI This study 
pDH152 
Bim1 (C-term) 
E218A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 206, 207 BamHI/XhoI This study 
pDH153 
Bim1 (C-term) 
F219A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 208, 209 BamHI/XhoI This study 
pDH154 
Bim1 (C-term) 
Y220A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 210, 211 BamHI/XhoI This study 
pDH155 
Bim1 (C-term) 
F221A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 212, 213 BamHI/XhoI This study 
pDH156 
Bim1 (C-term) 
K223A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 216, 217 BamHI/XhoI This study 
pDH157 
Bim1 (C-term) 
R225A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 220, 221 BamHI/XhoI This study 
pDH158 
Bim1 (C-term) 
I227A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 224, 225 BamHI/XhoI This study 
pDH159 
Bim1 (C-term) 
E228A 
pETM40 with 
modified linker 
Genomic DNA 19, 21, 226, 227 BamHI/XhoI This study 
pDH160 
Bim1 (1-187) pETM40 with 
modified linker 
Genomic DNA 3, 263 BamHI/XhoI This study 
pDH161 
Bim1 (1-154) pETM40 with 
modified linker 
Genomic DNA 3, 264 BamHI/XhoI This study 
pDH162 
Bim1 (1-124) pETM40 with 
modified linker 
Genomic DNA 3, 265 BamHI/XhoI This study 
pDH163 
Bim1 (1-187) 
GCN4 
pETM40 with 
modified linker 
Genomic DNA 3, 270 (Bim1)  268, 
269 (GCN4) 
BamHI/XhoI/
HindIII 
This study 
pDH164 
Bim1 (1-154) 
GCN4 
pETM40 with 
modified linker 
Genomic DNA 3, 271 (Bim1) 268, 
269 (GCN4) 
BamHI/XhoI/
HindIII 
This study 
pDH165 
Bim1 (1-124) 
GCN4 
pETM40 with 
modified linker 
Genomic DNA 3, 272 (Bim1) 268, 
269 (GCN4) 
BamHI/XhoI/
HindIII 
This study 
pDH178 
Bim1(FL) S133D pETM40 with 
modified linker 
Genomic DNA 3, 12, 314, 315 BamHI/XhoI This study 
pDH179 
Bim1 (FL) S143D 
S144D 
pETM40 with 
modified linker 
Genomic DNA 3, 12, 316, 317 BamHI/XhoI This study 
pDH180 
Bim1 (FL) S160D 
S161D 
pETM40 with 
modified linker 
Genomic DNA 3, 12, 318, 319 BamHI/XhoI This study 
pDH181 
Bim1 (FL) S171D pETM40 with 
modified linker 
Genomic DNA 3, 12, 320, 321 BamHI/XhoI This study 
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4.3.2 Plasmids for protein expression in S. cerevisiae 
 Insert Vector Template Primer Enzyme Reference 
pDH112-
Gal1 
GAL1 Kar9 (S197A)-
9xmyc pRS403 
Genomic 
DNA 91, 92, 178, 181 XbaI, SalI This study 
pDH113-
Gal1 
GAL1 Kar9 (S496A)-
9xmyc pRS403 
Genomic 
DNA 93, 94, 178, 181 XbaI, SalI This study 
pDH114-
Gal1 
GAL1 Kar9 
(S197A;S296A)-9xmyc pRS403 
pDH113-
Gal1 91, 92, 178, 181 XbaI, SalI This study 
pDH115-
Gal1 
GAL1 Kar9 (K301R)-
9xmyc pRS403 
Genomic 
DNA 95, 96, 178, 181 XbaI, SalI This study 
pDH119-
Gal1 
GAL1 Kar9 
(K301R;K381R)-9xmyc pRS403 
pDH115-
Gal1 101, 102, 178, 181 XbaI, SalI This study 
pDH120-
Gal1 
GAL1 Kar9 
(K301R;K381R;K529R)-
9xmyc 
pRS403 pDH119-Gal1 103, 104, 178, 181 XbaI, SalI This study 
pDH121-
Gal1 
GAL1 Kar9 
(K301R;K381R;K529R;K
3333R)-9xmyc 
pRS403 pDH121-Gal1 97, 98, 178, 181 XbaI, SalI This study 
pDH122-
Gal1 GAL1 Kar9 (WT)-9xmyc pRS403 
Genomic 
DNA 
176, 177 (Promotor); 
178, 181 (Kar9); 
184, 185 
(Terminator)       
186, 187 (Myc-Tag) 
ApaI, XbaI 
(Promotor)  
XbaI, SalI (Kar9) 
NotI, SacI 
(Terminator) 
SalI, NotI    
(Myc-Tag) 
This study 
pDH172 Gal1-Kar9 (K333R) pRS403 Genomic DNA 97, 98, 178, 181 XbaI, SalI This study 
pDH173 Gal1-Kar9 (K333E) pRS403 Genomic DNA 99, 100, 178, 181 XbaI, SalI This study 
pDH174 Gal1-Kar9 (K381R) pRS403 Genomic DNA 101, 102, 178, 181 XbaI, SalI This study 
pDH175 Gal1-Kar9 (K529R) pRS403 Genomic DNA 103, 104, 178, 181 XbaI, SalI This study 
pDH185 Bim1 (1-187 GCN4)-HA pRS405 Genomic DNA 
237, 305, 306, 307, 
308, 309 
HindIII, XbaI 
(Bim1) NheI, 
XbaI (GCN4), 
XbaI (HA-Tag) 
This study 
pDH188 Bim1 (FL) pRS405 Genomic DNA 
237, 238, 239, 240, 
241, 242 
HindIII, EcoRI 
(Bim1) XbaI 
(HA-Tag) 
This study 
pDH189 Bim1 (FL) E214A pRS405 pDH189 198, 199 Quickchange (Stratagene) This study 
pDH190 Bim1 (FL) R217A pRS405 pDH189 204, 205 Quickchange (Stratagene) This study 
pDH191 Bim1 (FL) F219A pRS405 pDH189 208, 209 Quickchange (Stratagene) This study 
pDH192 Bim1 (FL) F221A pRS405 pDH189 212, 213 Quickchange (Stratagene) This study 
pDH193 Bim1 (FL) E228A pRS405 pDH189 226, 227 Quickchange (Stratagene) This study 
pDH194 Bim1 (FL) I229A pRS405 pDH189 228, 229 Quickchange (Stratagene) This study 
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4.4 E. coli strains 
Strain Essential genotype Source 
XL-1 blue recA endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ proAB lacIq ZΔM15 Tn10 (Tetr)] Stratagene (La Jolla, USA) 
BL21 Star (DE3) F- ompT hsdSB (rB-mB-) gal dcm rne131 (DE3) Invitrogen (Karlsruhe, Germany) 
B834 (DE3) F− ompT gal met rBmB Novagen; Schwalbach, Germany 
Rosetta (DE3) pLysS F− ompT hsdSB (rB
- mB-) gal dcm (DE3) 
pLysSRARE (CamR) 
Novagen; Schwalbach, 
Germany 
 
4.5 S. cerevisiae strains 
Strain Essential Genotype Reference 
YDH001 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Kar9-9xmyc::HIS3 this study 
YDH002 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0; Δkar9::ClonNat this study 
YDH003 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Δkar9::ClonNat; pDH112-Gal1::HIS3 this study 
YDH004 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0; Δkar9::ClonNat; pDH113-Gal1::HIS3 this study 
YDH005 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Δkar9::ClonNat; pDH114-Gal1::HIS3 this study 
YDH006 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0; Δkar9::ClonNat; pDH115-Gal1::HIS3 this study 
YDH007 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Δkar9::ClonNat; pDH119-Gal1::HIS3 this study 
YDH008 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0; Δkar9::ClonNat; pDH120-Gal1::HIS3 this study 
YDH009 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Δkar9::ClonNat; pDH121-Gal1::HIS3 this study 
YDH010 MATa; his3Δ 1; leu2Δ 0; met15Δ 0; ura3Δ 0; Δkar9::ClonNat; pDH122-Gal1::HIS3 this study 
YDH011 MATa; ura3-52; trp1Δ2; leu2-3; his3-11; ade2-1; can1-100; Δbim1::ClonNat this study 
YDH012 MATa; ura3-52; trp1Δ2; leu2-3,112; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH189::LEU2 this study 
YDH013 MATa; ura3-52; trp1Δ2; leu2-3; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH190::LEU2 this study 
YDH014 MATa; ura3-52; trp1Δ2; leu2-3,112; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH191::LEU2 this study 
YDH015 MATa; ura3-52; trp1Δ2; leu2-3; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH192::LEU2 this study 
YDH016 MATa; ura3-52; trp1Δ2; leu2-3,112; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH193::LEU2 this study 
YDH017 MATa; ura3-52; trp1Δ2; leu2-3; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH194::LEU2 this study 
YDH018 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Δkar9::ClonNat; pDH172-Gal1::HIS3 this study 
YDH019 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; kar9::ClonNat; pDH173-Gal1::HIS3 this study 
YDH020 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; Δkar9::ClonNat; pDH174-Gal1::HIS3 this study 
YDH021 MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0; kar9::ClonNat; pDH175-Gal1::HIS3 this study 
YDH028 MATa; ura3-52; trp1Δ2; leu2-3,112; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH185::LEU2 this study 
YDH030 MATa; ura3-52; trp1Δ2; leu2-3; his3-11; ade2-1; can1-100; Δbim1::ClonNat; pDH188::LEU2 this study 
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4.6 Media for E. coli and S. cerevisiae 
Medium Composition Purpose 
LB medium 
1 % (w/v) bacto tryptone, 0.5 % (w/v) bacto 
yeast extract, 0.5 % (w/v) NaCl (+1.5 % (w/v) 
agar and /or for plates) 
Growth medium for E. coli 
DH10Bac 
1 % (w/v) bacto tryptone, 0.5 % (w/v) bacto 
yeast extract, 0.5 % (w/v) NaCl, 7 mg/mL 
gentamycin, 10 mg/mL tetracycline, 50 mg/mL 
kanamycin 
for plates + 1.5 % (w/v) agar, 1 M IPTG, 
100 µg/mL bromo-chloro-galactopyranoside 
(X-Gal), 
Medium gowth of DH10Bac 
SOC 
 
2 % (w/v) bacto tryptone, 0.5 % (w/v) bacto 
yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 
mM MgCl2, 10 mM MgSO4, pH 7.0 
Medium for regeneration of 
DH10Bac after transformation 
Minimal Medium 
7,5 mM (NH4)2SO4, 8,5 mM NaCl, 55 mM 
KH2PO4, 100 mM K2HPO4, 1 mM MgSO4, 20 
mM glucose, 1 mg/l CaCl2, 1 mg/l FeCl2, 1 µg/l 
of the following trace element: Cu2+; Mn2+; 
Zn2+; MoO4 2+, 1 mg/l Thiamine, 1 mg/l Biotin, 
100 mg/l of the following amino acids (L-
alanine, L-arginine, L-aspartic acid, L-cysteine, 
L-glutamate, L-glycine, L-histidine, L- 
isoleucine, Lleucine, L-lysine, L-phenylalanine, 
L-proline, L-serine, L-threonine, L-tyrosine, L-
valine, SeMet) 
Medium for expression of L-
selenomethionine labeled 
proteins 
YPD medium 
1 % (w/v) yeast extract, 2 % (w/v) bacto 
peptone, 2 % (w/v) glucose (+2 % (w/v) agar 
for plates) 
Growth medium for 
S. cerevisiae 
Synthetic Complete (SC) 
medium 
0.67 % (w/v) yeast nitrogen base (w/o amino 
acids), 2 % (w/v) glucose, 0.06 % (w/v) drop-
out mix (includes all essential amino acids and 
nucleobases except the amino acids or 
nucleobases used as auxotrophy markers, i.e. 
histidine, leucine, uracil, tryptophane) 
Selective growth medium for 
S. cerevisiae 
 
4.7 Antibodies  
Primary antibody (AB) Source Dilution / Application Supplier 
anti-HA (3F10) rat 1:1000 / Western Blot Roche Applied Science (Mannheim, Germany) 
anti-myc (9E10) mouse 1:1000 / Western Blot Roche Applied Science (Mannheim, Germany) 
anti-myc (9E11) mouse 100 µg AB coupled to 250 µl protein-G beads / Co-IP 
Acris Antibodies (Herford, 
Germany) 
    
Secondary antibody Source Dilution / Application Supplier 
anti-mouse-IgG-HRPO goat 1:3000 / Western BioRad (Munich, Germany) 
anti-rat-IgG-HRPO rabbit 1:10000 / Western Abcam (Cambridge, USA) 
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4.8 General buffers and solutions 
 Application Composition 
4x stacking gel buffer SDS-PAGE 0.5M Tris, 0.4% (w/v) SDS, pH 6.8 
4x resolving gel buffer SDS-PAGE 3 M Tris, 0.4% (w/v) SDS, pH 8.5 
running buffer SDS-PAGE 0.5 M Tris, 1 % (w/v) SDS, 1.9 M glycine 
4x loading dye SDS-PAGE 
110 mM Tris/HCl pH 6.8, 40 % (v/v) 
glycerol, 0.5 % (w/v) bromophenol blue, 4 
% (w/v) SDS, 40 mM DTT 
Coomassie staining solution SDS-PAGE 50 % (v/v) ethanol, 7 % (v/v) acetic acid, 0.2 % Coomassie Brilliant blue R-250 
4x stacking gel buffer Native PAGE 0.5M Tris pH 6.8 
4x resolving gel buffer Native PAGE 1.5M Tris pH 8.9 
running buffer Native PAGE 0.1 M Tris, 0.35 M Glycine, pH 8.9 
5x loading dye Native PAGE 50 % (v/v) glycerol, 0.5 M Tris pH 6.8, 0.5 % (w/v) Bromphenolblue 
1x TBE Agarose gel electrophoresis 8.9 mM Tris, 8.9 mM boric acid, 2 mM EDTA (pH 8.0) 
1x TE DNA 10 mM Tris pH 7.5, 1 mM EDTA 
1x TBS Agarose gel electrophoresis 500 mM Tris pH 7.5, 1.5 M NaCl 
6x loading dye Agarose gel electrophoresis 1.5 g/l bromophenol blue, 1.5 g/l xylene cyanol, 50% (v/v) glycerol 
HU-buffer Western blotting 
8 M urea, 5% SDS, 200 mM Tris pH 8.8, 1 
mM EDTA, 1.5% DTT, 0.01 % 
bromophenol blue 
10x transfer buffer Western blotting 10 mM NaHCO3, 3 mM NaCO3 
1x TBS-T Western blotting 10 mM Tris pH 8.0, 150 mM NaCl, 0.05 % Tween 20 
1x PBS Western blotting 2 mM KH2PO4, 4 mM Na2HPO4, 140 mM NaCl, 3 mM KCl, pH 7.4 
 
4.9 Molecular Biology 
4.9.1 Cloning 
Genes of interest were cloned according to the standard methods for molecular biology 
(Sambrook and Russell 2001). This includes amplification of DNA fragments by polymerase 
chain reaction, restriction digest of DNA, separation of DNA-fragments by agarose gel 
electrophoresis and ligation of DNA fragments. DNA-fragments were purified using the 
Nucleospin Extract II Kit (Macherey & Nagel, Düren, Germany). Restriction enzymes and 
buffers were used according to the manufacturer’s instructions. Digested Plasmid-DNA was 
additionally treated with alkaline phosphatase (FastAP, Fermentas, St. Leon-Roth, 
Germany). Point mutations were introduced using either the QuickChange II Site-Directed 
Mutatgenesis Kit (Agilent Technologies, Waldbronn, Germany) or by PCR-based site-
directed mutagenesis (Ho, Hunt et al. 1989). Cloning strategies for all plasmids used in this 
study and the sequences of the corresponding oligonucleotides are described in chapter 4.3 
and in chapter 4.2, respectively.  
 
4.9.2 Transformation of E. coli and isolation of plasmid DNA 
Transformation-competent Escherichia coli (E. coli) cells were prepared and transformed 
according to the standard chemical methods (Hanahan 1983). Isolation of plasmid DNA from 
E. coli cells was performed using the NucleoSpin-Plasmid from Macherey-Nagel (Düren, 
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Germany). Plasmid-DNA was sequenced by GATC-Biotech (Konstanz, Germany) or by 
Eurofins-MWG (Ebersberg, Germany).  
 
4.9.3 Transformation of S. cerevisiae 
Genes of interest were deleted or tagged using a PCR-based method (Janke, Magiera 
et al. 2004). Plasmids harbouring mutations in BIM1 or KAR9 were linearised with 
NheI (pRS403) or AflII (pRS405) prior transformation to allow for homologous recombination 
in the HIS3 or LEU2 locus. Yeast cells were transformed using the lithiumacetate-method 
(Knop et al., 1999). After transformation, the cells were either resuspended in sterile PBS 
and plated directly on SC-plates lacking the respective amino acids or for antibiotic selection, 
the cells were resuspended in 2 ml of YPD-medium and incubated at 30°C on a shaker for at 
least 5-6 h before plating. Transformants were incubated on plates for 2 days, and then 
streaked as single colonies on fresh selection plates. Positive clones were identified by 
western-blot analysis using TCA-extracts (chapter 4.14.1) or by colony-PCR (chapter 4.9.5).  
 
4.9.4 Isolation of genomic DNA from S. cerevisiae 
Cells from a stationary 5ml culture were sedimented, washed once with 0.5ml ddH2O and 
resuspended in 200 µl breaking buffer (2 % (v/v) Triton X-100, 1 % (v/v) SDS, 100 mM NaCl, 
10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0). After addition of 200 µl phenol/chloroform/ 
isoamyl alcohol (24:24:1) and 200 µl of glass beads (Ø ~ 0.5 mm), the mixture was vortexed 
vigorously for 3 - 4 min. Subsequently, 400 µl of TE buffer were added and the mixture was 
gently vortexed. After centrifugation for 5 min at 14000 rpm at room temperature, the 
aqueous phase was transferred to a new reaction tube and the DNA was precipitated by the 
addition of 1 ml of 96 % ethanol, following centrifugation for 3 min at 14000 rpm at room 
temperature. The pellet was resuspended in 200 µl 10 mM Tris pH 8.5 and RNA was 
digested by the addition of 7 µl RNAse A and incubation at 37°C for 15 min. To precipitate 
again the DNA 20 µl of 4 M ammonium acetate and 500 µl of 96 % ethanol were added, 
gently mixed and centrifuged for 3 min at 14000 rpm at room temperature. The pellet was air 
dried and resuspended in 50 µl 10 mM Tris pH 8.5. A 5 µl sample was taken and analysed 
on an agarose gel.   
 
4.9.5 Colony PCR for S. cerevisiae 
Colony PCR to verify the correct insertion of a PCR cassette was either performed with the 
respective primers on isolated chromosomal DNA or with whole yeast cells. For the second 
method, yeast cells from a freshly streaked plate were scraped off with a pipette tip (amount 
~ size of a pinhead) and resuspended in 50 µl 0,01 % sarkosyl + 0.2 N NaOH. The mixture 
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was incubated at 95 °C for 10 min to disrupt the cells. 0.5 µl of the yeast-cell suspension was 
taken to perform a colony PCR with the standard protocol (chapter 4.9.1).  
 
4.10 Methods for protein analysis 
4.10.1 Protein separation by SDS-PAGE  
Protein samples were analysed by sodium dodecylsulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) as described (Laemmli, 1970). Electrophoretic separation was achieved on 8 –
 19 % polyacrylamid gels depending on the size of the protein. The gels were either stained 
with coomassie-blue staining solution (see chapter 4.8) or with a silver stain kit (Pierce by 
Thermo Fisher Scientific, Bonn, Germany) or further used for western blot analysis. After 
coomassie-blue staining the gels were destained with water.  
 
4.10.2 Protein separation by native PAGE 
To analyse proteins in their native state, e.g. after incubation with heavy atoms or after 
methylation, a native PAGE was carried out. For the analysis of Bim1p (C-term) after 
incubation with different heavy atoms, a 10% native PAGE resolving gel with a 4% stacking 
gel was prepared. The loading dye was added to the samples and the samples were 
immediately loaded on the gel in the cold-room. Electrophoretic separation was performed 
for ~ 1 h at 230 V in the cold-room. Gels were stained with coomassie-blue staining solution.  
 
4.10.3 Western blotting 
After protein separation by SDS-PAGE, proteins were transferred onto a PVDF membrane 
for 2 h at 60 V (Power Pac 300, Bio Rad, Munich, Germany) and 4°C using the wet-blot 
method. After transfer, the membrane was blocked in TBS-T (chapter 4.8) with 10 % (w/v) 
milk powder. Then the membrane was added to the primary antibody (diluted in 1x PBS 
containing 2 % milk (w/v) powder) and incubated for 2 h or overnight at 4 °C. The membrane 
was washed three times with TBS-T and subsequently incubated with the secondary 
antibody (diluted in 1x TBS-T containing 2 % milk powder) for 1 h at room temperature. Six 
washing steps with TBS-T removed unbound antibody. Visualisation of the immuno-stained 
proteins was achieved using the Pierce ECL substrate (Pierce by Thermo Fisher Scientific, 
Bonn, Germany). The membrane was then exposed to light-sensitive films (GE Healthcare, 
Munich, Germany), which were subsequently developed with a Kodak Xomat M35 
developing machine. For quantification of the signals, ECL-treated (SuperSignal West Dura 
Extended Duration Substrate, Pierce by Thermo Fisher Scientific. Bonn, Germany) 
membranes were directly analyzed with the LAS-3000 mini imaging system (FUJIFILM, 
Düsseldorf, Germany) and quantification of the signals was done using the Multi-Gauge 
software.  
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4.10.4 Dynamic Light Scattering 
Dynamic Light Scattering (DLS) is used to determine the hydrodynamic diameter and the 
size distribution of particles in solution. This technique was used to find appropriate buffer 
conditions for small angle X-ray scattering (SAXS) experiments. After centrifugation for 
20 min at 13200 rpm and 4°C, a sample of 50 µl of the respective sample was transferred 
into a fluorescence ultra-micro cuvette and measured at 20 °C in an 802 DLS spectrometer 
(Viskotek Corp., Houston, USA). This way, purified Bim1p and Kar9p fragments in various 
buffers and different salt concentrations were tested at a concentration range of 1-7.5 mg/ml 
for concentration-dependent oligomerisation or aggregation. Each sample was measured ten 
times for 4 s each and the data were analysed with the OmniSIZE 3.0 software. 
 
4.10.5 Small angle X-ray scattering (SAXS) 
SAXS data were collected at the ID14-3 beamline (ESRF, Grenoble, France). Bim1p (FL), 
Bim1p (C-term) and Kar9p (FL) were measured in different buffers and concentrations (see 
table below). Scattering curves were measured with exposure times of ten times 30 seconds. 
Before and after each measurement, a blank measurement with sample buffer was taken. 
For the determination of molecular masses (Mylonas and Svergun 2007), the reference 
proteins bovine serum albumine (4.5 mg/ml) and lysozyme (9.4 mg/ml and 2.4 mg/ml) were 
measured in buffer containing 50 mM HEPES (pH 7.5) and 2 mM DTT. Data were evaluated 
and processed with different programs from the ATSAS 2.1 software package (Konarev, 
Petoukhov et al. 2006). Primary analysis of the data was done with PRIMUS (Konarev, 
Volkov et al. 2003). To calculate the radius of gyration Rg, the Guinier approximation was 
used with the constraint s*Rg < 1.3 (Guinier 1955). The indirect transform package GNOM 
was used to compute the pair-distribution function p(r) and the maximum dimension of the 
particle Dmax. Ab initio models of Bim1p (C-term) were calculated with the program DAMMIN 
assuming P2-symmetry (Svergun, Barberato et al. 1995; Svergun 1995). Theoretical 
scattering curves of the Bim1p (C-term) crystal structure were calculated with the program 
CRYSOL (Svergun, Petoukhov et al. 2001). 
Buffer Bim1p (C-term) Bim1p (FL) 
10 mM Hepes pH 7.5; 500 mM NaCl; 1 mM EDTA; 1 mM DTT 1.0, 1.9, 4.4 mg/ml  
10 mM Sodiumphosphate pH 7.5; 500 mM NaCl; 1 mM EDTA; 1 mM DTT 2.4 mg/ml  
10 mM Sodiumphosphate pH 7.5; 150 mM NaCl; 1 mM EDTA; 1 mM DTT 2.0, 4.6, 4.9 mg/ml  
10 mM Hepes pH 7.5; 500 mM NaCl; 1 mM EDTA; 1 mM DTT; 
5 % Glycerol  1.3 mg/ml 
   
Buffer Kar9p (FL) 
10 mM Tris pH 7.5; 500 mM NaCl; 1 mM EDTA; 1 mM DTT 2.38; 4.88 mg/ml 
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4.10.6 Limited proteolysis 
Different proteases (endoproteinase Glu-C, endoproteinase Lys-C, trypsin or chymotrypsin) 
were added to protein samples in varying ratios (50:1, 100:1, 20:1 w/w) and incubated at 
room temperature or on ice. Samples of 10 µl were taken at time points 0 s, 30 s, 1 min, 
2 min, 5 min, 10 min, 30 min, 60 min, 90 min and the reaction was immediately stopped by 
the addition of 3 µl 4x loading dye. Protein fragments were separated on a SDS-PAGE and 
clearly visible bands were cut out, blotted on a PVDF membrane via passive adsorption and 
subjected to Edman sequencing (Messer et al., 1997). To determine the mass of the protein 
fragments, a second sample was prepared as described above, but instead of adding loading 
dye, the sample was flash frozen in liquid nitrogen and subjected to mass-spectrometric 
analysis.  
 
4.10.7 Pull-down assays 
Cells from logarithmically growing yeast cultures were lysed by vortexing with glass beads 
(4x3 min) in lysis buffer (50mM Tris-HCl pH 7.5; 300mM NaCl; 5% glycerol; 
0.2% Triton-X-100; 1mM DTT). Cell debris was removed by centrifugation (13200 rpm, 
20 min) and the clear supernatant subsequently used for pull-down experiments. Equimolar 
amounts of each analysed protein were incubated with equal amounts of yeast extract and 
50 µl of amylose resin (NEB) for 20 min in lysis buffer. After incubation, the amylose resin 
was washed five times with 1ml lysis buffer. Bound proteins were eluted with 35 µl of elution 
buffer (lysis buffer + 10mM maltose) and 1/3 of the elution volume was analysed by western 
blotting with myc-antibody. 
 
4.11 Protein expression and Purification 
4.11.1 Recombinant protein expression in E. coli 
Different fragments of Kar9p- and Bim1p-fusion proteins were recombinantly expressed in 
E. coli BL21 Star (DE3) or Rosetta cells. Cells were grown at 37 °C in LB medium with the 
appropriate antibiotics to an OD600 of 0.4-0.6 and then cooled down to 18 °C. Protein 
expression was induced by the addition of 0.25 mM IPTG. After further incubation at 18 °C 
for 12-16 hours, the cells were harvested by centrifugation at 4 °C. Cell pellets were 
resuspended in the appropriate lysis buffer, flash frozen in liquid nitrogen, and stored 
at -80 °C. 
 
4.11.2 Selenomethionine labeling of proteins  
L- selenomethionine (SeMet) labeled protein was expressed with the E. coli strain B834 
(DE3). Cells were grown in minimal medium, containing SeMet identical to the procedure 
described above (see chapter 4.11.1). 
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4.11.3 Recombinant protein expression in S. cerevisiae 
For expression of myc-tagged Kar9p, cells were streaked on SC-His- plates. 50 ml of YPD 
were used to inoculate a culture over night at 30°C. The next morning, the culture was 
diluted in 1.5l of YPD and the cells were grown at 30°C until mid-logarithmic phase. 
For overexpression of Kar9p, cells were grown in YP + raffinose until OD600 of 1 and protein 
expression was induced by addition of 20 % galactose (final concentration 2 %) for 3-4 h at 
30°C. 
 
4.11.4 Recombinant protein expression in insect cells 
To express recombinant proteins in insect cells, the Bac-to-Bac baculovirus expression 
system (Ciccarone et al., 1998) was used according to the manufacturer’s instructions 
(Invitrogen, Karlsruhe, Germany). The genes of interest were cloned into pFastBac1-GST 
(pDH004, this study), pFastBac1, pFastBacDual or pFastBac-28 (kind gift from AG Hopfner, 
Gene Centre Munich). The plasmids were amplified in XL-1 Blue cells and isolated using the 
NucleoSpin Plasmid Kit (Macherey & Nagel, Düren, Germany). To generate recombinant 
bacmid DNA, the plasmids were transformed into DH10Bac E.coli cells (Luckow et al., 1993). 
After the heat-shock at 42°C and incubation on ice for 3 min, the cells were incubated in 1 ml 
of SOC medium for 6 h at 37°C. To select the right transformants, a blue-white selection was 
carried out on agar plates at 37°C for 48 h. Single white colonies were picked from the plate 
and incubated over night at 37°C in 5 ml LB-medium containing 7 mg/mL gentamycin, 
10 mg/mL tetracycline and 50 mg/mL kanamycin. Recombinant bacmid DNA was isolated 
with the buffers from the NucleoSpin Plasmid Kit (Macherey & Nagel, Düren, Germany), but 
the DNA was precipitated with isopropanol instead of purification via the provided columns. 
Sf9 and High Five insect cells were transfected using 2 µg recombinant bacmid DNA and 3 µl 
FuGeneHD reagent (Roche, Basel, Switzerland). 300 µl of medium were incubated for 
45 min at room temperature with the transfection reagent and the bacmid DNA: Cells were 
diluted to 0.4 million/ml and 2 ml of cell suspension were transferred to each well of a 6-well 
plate. After incubation of the cells at 27.5°C for 30 min, the transfection mix was added. 
Transfected cells were incubated at 27.5°C for 3-4 days and inspected regularly for signs of 
infection. When cells showed signs of infection, the medium was recovered and centrifuged 
(10 min, 3000 rpm) and the supernatant (P0 virus) filter sterilised and stored at 4°C. The 
virus was amplified in 10 ml cell culture (1 million cells/ml) by adding 1 ml of the P0 virus and 
incubation for 3-4 days at 27.5°C. Regular inspection and counting of the cells was 
performed until the cells stopped growing. To collect the virus, the culture was centrifuged 
(10 min, 3000rpm) and the supernatant (P1 virus) filter sterilised and stored at 4°C. To 
generate P2 virus, the whole procedure was repeated with 250 ml of cells (0.4 million/ml) and 
0.5 ml of P1 virus. For protein expression 1 l of High Five cell culture (1 million cells/ml) was 
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infected with 20 – 50 ml of P2 virus and incubated at 27.5°C for 3 days. Cells were harvested 
by centrifugation (15 min, 3000 rpm) and frozen in liquid nitrogen. Protein expression was 
verified by SDS-PAGE.  
 
4.11.5 Purification of recombinant His-tagged Kar9p 
His-tagged Kar9p was either expressed in Escherichia coli or in insect cells. Cells were 
harvested by centrifugation and the pellet was resuspended in lysis buffer. E. coli cells were 
lysed by sonication whereas insect cells were lysed by the addition of 1 % NP40 to the lysis 
buffer and stirring in a beaker for 30 min at 4 °C, followed by short sonication. Cell debris 
was removed by centrifugation (15000 rpm, 30 min, 4°C, SS34 rotor). The lysate from insect 
cells was additionally filtered through a 0.2 µm syringe filter unit (Millex-FG, Milipore, 
Schwalbach, Germany). The lysate was loaded onto a pre-equilibrated 5 ml His-Trap FF 
column (GE Healthcare, Munich). Subsequently, the column was washed with 10 column 
volumes of wash buffer, and the protein eluted in a stepwise gradient with elution buffer 
(5 colum volumes 75 mM imidazole, linear gradient from 150 mM to 500 mM imidazole for 
5 column volumes). Peak fractions were analysed by SDS-PAGE, pooled and diluted with 
storage buffer (only for Kar9p (FL)). The solution was subsequently loaded onto a pre-
equilibrated HiTrap-Q column (GE Healthcare, Munich), to remove contaminating DNA; 
Kar9p itself does not bind to the HiTrap-Q column. The flow-through was concentrated with 
centrifugal filter devices (Amicon Ultra, Millipore, Billerica, US) and loaded onto a Superdex 
S200 16/60 size exclusion chromatography column equilibrated with gel filtration buffer. Peak 
fractions were again analysed by SDS-PAGE and concentrated. The purified protein was 
subsequently used for crystallisation experiments. 
lysis buffer 50 mM Sodiumphosphate pH 7.5; 500 mM NaCl; 5 mM imidazole; 1 mM DTT 
wash buffer 50 mM Sodiumphosphate pH 7.5; 1 M NaCl; 50 mM imidazole; 1 mM DTT 
elution buffer 50 mM Sodiumphosphate pH 7.5; 500 mM NaCl; 500 mM imidazole; 1 mM DT 
storage buffer 50 mM Sodiumphosphate pH 7.5; 100 mM NaCl; 50 mM Glutamic acid; 50 mM Arginine; 5 % Glycerol; 1 mM DTT 
gelfiltration buffer 10 mM Tris-HCl pH 7.5; 200 mM NaCl; 1 mM EDTA; 1 mM DTT 
 
4.11.6 Purification of recombinant GST-tagged Kar9p 
GST-tagged Kar9p variants were expressed in Escherichia coli and insect cells as described 
above (chapter 4.11.1 and 4.11.4). The cells were harvested by centrifugation and 
resuspended in lysis buffer. After lysis of the cells by sonication, cell debris was removed by 
centrifugation (15000 rpm, 30 min, 4°C, SS34 rotor). The supernatant was loaded onto a 
5 ml GST-Trap FF column (GE Healthcare, Munich, Germany), pre-equilibrated in lysis 
buffer. After loading of the supernatant, the column was washed for 20 column volumes with 
lysis buffer. Elution of the protein was done in 20 ml of elution buffer. GST-tags were 
removed by protease cleavage with 50 µg PreScission-protease (GE Healthcare, Munich), 
which was added to the eluted protein and dialysed for 12 h at 4°C against dialysis buffer. 
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GST-tags were removed by protease cleavage with 50 µg PreScission-protease 
(GE Healthcare, Munich), which was added to the eluted protein and dialysed for 12 h at 4°C 
against dialysis buffer. The cleaved tag was removed from the mixture by loading the dialysis 
fraction onto a GST-Trap FF column. The flow through fraction, which contains the untagged 
Kar9p, was loaded onto a pre-equilibrated (buffer A) HiTrap-Q column (GE Healthcare, 
Munich). Elution of the protein was performed with a linear gradient over 10 column volumes, 
ranging from buffer A to buffer B. Peak fractions were analysed by SDS-PAGE, pooled and 
concentrated using centrifugal filter devices (Amicon Ultra, Millipore, Billerica, US). The 
concentrated protein solution was loaded onto a Superdex S200 16/60 size exclusion 
chromatography column equilibrated with gel filtration buffer. Peak fractions were again 
analysed by SDS-PAGE and concentrated. The purified protein was subsequently used for 
crystallisation experiments. 
lysis buffer 10 mM Tris-HCl pH 7.5; 500 mM NaCl, 1 mM EDTA, 1 mM DTT 
elution buffer 10 mM Tris-HCl pH 7.5; 500 mM NaCl, 1 mM EDTA, 1 mM DTT; 25 mM Glutathion 
dialysis buffer/buffer A 10 mM Tris-HCl, pH 7.5; 250 mM NaCl, 1 mM EDTA, 1 mM DTT 
buffer B 10 mM Tris-HCl, pH 7.5; 1 M NaCl, 1 mM EDTA, 1 mM DTT 
gel filtration buffer 10 mM Tris-HCl, pH 7.5; 200 mM NaCl, 1 mM EDTA, 1 mM DTT 
 
4.11.7 Purification of recombinant GST-tagged Bim1p 
GST-tagged Bim1p variants were expressed and purified via a 5 ml GST-Trap FF column as 
described for Kar9p (chapter 4.11.6). The protein solution after the anion exchange 
chromatography was loaded onto a Superdex S200 16/60 or Superose 12 10/300 GL size 
exclusion chromatography column equilibrated with gel filtration buffer. Peak fractions were 
analysed by SDS-PAGE and concentrated. Subsequently, the purified protein was either 
used for crystallisation experiments or flash frozen in liquid nitrogen and stored at -80 °C. 
lysis buffer 10 mM Tris-HCl, pH 7.5; 500 mM NaCl, 1 mM EDTA, 1 mM DTT 
buffer A/dialysis buffer 10 mM Tris-HCl, pH 7.5; 100 mM NaCl, 1 mM EDTA, 1 mM DTT 
buffer B 10 mM Tris-HCl, pH 7.5; 100 mM NaCl, 1 mM EDTA, 1 mM DTT 
gel filtration buffer  10 mM Tris-HCl pH 7.5; 100 mM NaCl, 1 mM EDTA, 1 mM DTT 
  
4.11.8 Purification of recombinant MBP-tagged Bim1p  
MBP-tagged Bim1p (C-term) and Bim1p (FL) were expressed in E. coli and the cells treated 
as described above (chapter 4.11.6). After centrifugation, the supernatant was loaded onto a 
3 ml amylose resin (New England Biolabs, Frankfurt, Germany), pre-equilibrated with lysis 
buffer. The column was washed extensively with 60 ml lysis buffer and bound proteins were 
eluted with elution buffer. The maltose was subsequently removed on a Superose-12 
10/300 GL column (GE Healthcare, Munich), pre-equilibrated with gel filtration buffer. Peak 
fractions were analysed by SDS-PAGE, concentrated and flash frozen in liquid nitrogen for 
storage at -80°C.  
lysis buffer 20 mM Tris-HCl pH 7.4; 200 mM NaCl; 1 mM EDTA; 1 mM DTT 
elution buffer 20 mM Tris-HCl pH 7.4; 200 mM NaCl; 1 mM EDTA; 1 mM DTT, 10 mM Maltose 
gel filtration buffer  10 mM Tris-HCl pH 7.5; 100 mM NaCl, 1 mM EDTA, 1 mM DTT 
 
 MATERIALS AND METHODS  
80 
4.12 Crystallisation  
All crystallisation experiments were carried out with freshly prepared protein samples, which 
were centrifuged before set up of crystallisation screens (20 min, 13 200 rpm and 4 °C). 
Initial crystallisation screens were set up with a nanoliter crystallisation robot (Phoenix, Art 
Robbins Instruments, Sunnyvale USA) at the crystallisation facility of the Max-Planck-
Institute for Biochemistry (Martinsried, Germany). A drop size of 0.5 µl and a 1:1 mixture of 
protein and crystallisation solution were used for sitting-drop vapour-diffusion experiments in 
a 96-well plate format. Crystallisation drops were imaged at regular time intervals using an 
Xtalfocus visualisation system (Tecan, Männedorf, Switzerland and Leica, Wetzlar, 
Germany). Refinement was done manually using hanging-drop vapour diffusion technique 
with a drop size of 2 µl and a 1:1 mixture of protein and crystallisation solution and a total 
reservoir volume of 500 µl using the 24-well EasyXtal CrystalSupport (Qiagen, Hilden, 
Germany).  
 
4.12.1 Crystallisation of Kar9p (FL) 
Recombinant full-length Kar9p was concentrated in gel filtration buffer to concentrations up 
to 6 mg/ml. Initial screens were set up with different concentrations of protein solution 
(1-6 mg/ml) at room temperature and 4°C. Crystals of Kar9p (FL) appeared after 1-2 days. 
After refinement, crystals of Kar9p (FL) were grown at 21°C by hanging-drop vapor-diffusion 
using a 1:1 mixture of protein (1-6 mg/ml) and crystallisation solution containing 0.1M Hepes 
pH 8.0, 21 % PEG 2000 MME, 125 mM serine or 0.1 M potassium citrate, 20 % PEG 3350, 
125 mM serine. Needle-like shaped crystals with cracked ends appeared within 1-2 days. 
Cryo-protection was achieved with different cryo-protectants (glycerol, ethylene glycol, 
PEG 400), concentrations and incubation times. To slow down crystal growth, paraffine oil 
and silicone oil were used in different ratios (50:50, 65:35) to cover the reservoir solution. 
Isopropanol and glycerol were added in concentrations of 4-6 % to the precipitant solution. 
Proteases as Trypsin and Endoproteinase Glu-C were added to the protein solution in 
different ratios (w/w, 1:1000, 1:500, and 1:200) prior setting up crystal screens. For 
selenomethionine-derivatised protein, 1 mM TCEP was added to the protein solution prior 
crystal set up.  
 
4.12.2 Crystallisation of Kar9p variants 
Different Kar9p variants were crystallised as described for Kar9p (FL). Initial screens were 
set up with concentrations of 1-6 mg/ml for Kar9p variants lacking some amino acids at the 
very N-terminus (1-12) or C-terminus and with concentrations of 1-2 mg/ml for Kar9p 
fragments lacking large parts of the C-terminus (1-398; 1-401). Different cryoprotectants 
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(MPD; ethylenglycol, PEG 400, glycerol, sucrose, glucose) and incubation times with 
cryoprotectants were used.  
 
4.12.3 Methylation of Kar9p 
Reductive methylation of lysine residues is usually performed to improve the crystallisability 
of proteins. Many solvent exposed residues on the surface of proteins such as lysine, 
arginine, aspartic acid or glutamic acid have long flexible side chains. This flexibility can 
cause intrinsic disorders, which hinder formation of a crystal lattice. Addition of methyl groups 
to the side chains of lysine residues can immobilize these side chains and therefore promote 
crystallisation. It can also change the biophysical properties such as pI, solubility and 
hydropathy and therefore enhance the interaction with other molecules. Reductive 
methylation of Kar9p was performed as described (Kim et al., 2008). 1 ml of protein solution 
(conc. < 10 mg/ml) was mixed with 40 µl 1 M formaldehyde and 20 µl of freshly prepared 
1 M dimethylborane complex (ABC). After incubation at 4 °C for 2 h, the procedure was 
repeated and the mixture incubated again on ice for 2 h. At the end of incubation, 10 µL of 
1 M ABC were added and the reaction was left over night at 4 °C. To quench the reaction, 
0.67 M glycine (final conc. 13.3 mM) and 1 M DTT (final conc. 5 mM) were added followed by 
size-exclusion chromatography on a Superdex S200 16/60 column in buffer containing 
10 mM Tris-HCl pH 7.5, 200 mM NaCl, 1 mM EDTA and 1 mM DTT. The protein was 
concentrated again to 6 mg/ml and directly used for crystallisation screens. Initial screens 
were set up at concentrations of 2, 4 and 6 mg/ml.  
 
4.12.4 Co-crystallisation of Bim1p and Kar9p (FL) 
Kar9p (FL), Bim1p (C-term) and Bim1p (FL) were concentrated separately in gel filtration 
buffer. Prior crystallisation, the proteins were mixed in different molar ratios. Initial screens 
were performed either with Kar9p (FL) + Bim1p (FL) or Kar9p (FL) + Bim1p (C-term). 
Crystals appeared only in the screens with Kar9p (FL) + Bim1p (C-term) after 2-3 days.   
 
4.12.5 Crystallisation of Bim1p 
Different protein fragments were concentrated in gel filtration buffer to concentrations up to 
20 mg/ml (for Bim1p (C-term)) and up to 7 mg/ml (for Bim1p (FL)). Initial screens were 
performed with different concentrations of protein solution (1-15 mg/ml). Crystals of 
Bim1p (C-term) appeared after 2-3 days in various conditions. After refinement, crystals of 
Bim1p (C-term) were grown at 21°C by hanging-drop vapor-diffusion using a 1:1 mixture of 
protein (2 mg/ml) and crystallisation solution containing 0.1M Bis-Tris pH 8.0, 20% PEG 
5000MME, 40% γ-butyrlactone. Plate-like shaped crystals appeared within 2-3 days. For 
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selenomethionine-substituted protein, 1 mM TCEP was added to the protein solution prior 
crystal set up.  
 
4.12.6 Heavy atom derivatisation by soaking 
To screen for suitable heavy atom reagents (Hampton Research, Heavy atom screens Pt, 
Au, Hg, Aliso Viejo, USA) that can be used for derivatisation of Bim1p (C-term) in crystals, a 
binding assay with the protein in solution was performed. 1µl of heavy atom reagent solution 
at different concentrations (10 mM and 100 mM) was incubated with 20 µg of protein in a 
buffer containing 10 mM Tris pH 7.5, 100 mM NaCl for 1h on ice. After addition of native 
loading dye, the proteins were resolved on a native PAGE (see 4.10.2). Heavy atom 
conditions, which showed a band shift of the protein on the native PAGE (Potassium 
tetranitroplatinate(II), Potassium tetrabromoplatinate(II), Platinum potassium iodide) were 
used for soaking of crystals of Bim1p (C-term). Different concentrations of the heavy atom 
reagent solutions (10 mM, 5 mM and 1 mM) were prepared, added to the crystallisation drop 
and incubated for 1 min, 2 min, 5 min, 10 min, 30 min, 1 h and 12 h. For heavy atom 
derivatisation of Kar9p (FL), 5-Amino-2,4,6-triiodoisophtahalic acid (JBS Magic Triangle) and 
Hexatantalum tetradecabromide (JBS Tantalum Cluster) were tested (Beck et al., 2008 
Knablein et al., 1997) (Jena Bioscience, Jena, Germany). The heavy atom reagent solutions 
were added directly to the crystals in the way described for Bim1p (C-term) without previous 
binding assays.  
 
4.12.7 Structure determination of Bim1p (C-term) 
Cryoprotection was achieved by adding 20% ethylene glycol and the crystals were 
subsequently mounted onto nylon loops and flash frozen in liquid nitrogen. Single anomalous 
dispersion (SAD) experiments were recorded at beamline ID-29 (ESRF, Grenoble France) 
and native datasets at beamline ID14-4 (ESRF, Grenoble France). The data was integrated 
and scaled using XDS (Kabsch) . Phases were obtained with SHELX (Sheldrick 2008) using 
SAD. The platin-derivatised dataset was used to build the model manually with COOT 
(Emsley and Cowtan, 2004). The native protein structure was solved by molecular 
replacement using PHASER (McCoy, 2007) and the platin-derivatised protein structure as 
search model. Refinement was performed with BUSTER (Blanc et al., 2004), using non-
crystallographic symmetry. 
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4.13 Bioinformatics  
4.13.1 Protein parameters  
Programs that are available via the ExPASy Proteomics Server 
(http://ca.expasy.org/sitemap.html) were used to calculate protein parameters. ProtParam 
(Wilkins, Gasteiger et al. 1999) (www.expasy.org/tools/protparam.html) was used to calculate 
physical and chemical parameters of proteins such as isoelectric point, molecular mass and 
the molar extinction coefficient. The probability of coiled-coil formation was calculated with 
the program COILS (http://www.ch.embnet.org/software/COILS_form.html) (Lupas, Van 
Dyke et al. 1991).  
 
4.13.2 Sequence aligments and structure predictions  
DNA and protein sequences were either obtained from the Saccharomyces genome 
database (www.yeastgenome.org) or from the NCBI database (www.ncbi.nlm.nih.gov). The 
NCBI Basic Local Alignment Search Tool (BLAST) server (Altschul, Madden et al. 1997) 
(www.ncbi.nlm.nih.gov/BLAST) was used to perform homology searches. Multiple sequence 
alignments were performed with ClustalW (Larkin, Blackshields et al. 2007) 
(www.ebi.ac.uk/Tools/msa/clustalw2) and visualized with Jalview (Waterhouse, Procter et al. 
2009) (www.jalview.org). Secondary structures were predicted using the program JPred  
(http://www.compbio.dundee.ac.uk/www-jpred/) (Cole, Barber et al. 2008). The structure 
prediction of Kar9p (FL) was performed with the program HHPred (Cole, Barber et al. 2008) 
(http://toolkit.tuebingen.mpg.de/hhpred#).  
 
4.13.3 Structure visualisation and analysis 
All figures of protein structures were generated with the program PyMOL (Schrodinger 2010) 
(DeLano, Palo Alto, USA). The UCSF Chimera package (University of California, San 
Francisco) (Pettersen et al., 2004) was used to visualize the sequence conservation on the 
surface of the Bim1p protein structure. Superimposition of the homologous Bim1p and 
human EB1 structures and RMSD calculation was performed with PyMOL and LSQMAN 
(http://xray.bmc.uu.se/usf/). Calculation and representation of the electrostatic surface was 
done with CCP4mg (Collaborative Computational Project, 1994). Buried surface areas were 
calculated using AREAIMOL (Collaborative Computational Project, 1994). 
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4.14 Yeast methods 
4.14.1 Preparation of yeast whole-cell extracts 
To analyse the protein-expression level of individual transformants, whole-cell extracts were 
prepared. Cells were grown overnight until stationary phase in 5 ml of appropriate medium. 
Next morning, the cells were diluted in fresh medium to an OD600 of 0.15 and grown at 30°C 
until an OD600 of 1. Cells were harvested by centrifugation, washed once in PBS and lysed by 
the addition of 1 ml alkaline solution (1ml 1.85 M NaOH + 8.5 ml ddH2O). After incubation on 
ice for 10 min, 150 µl trichloroacetic acid (55 % w/v) was added to precipitate proteins. The 
reaction was incubated on ice for 10 minutes. Following sedimentation (13000 rpm, 
15 minutes, 4 °C), the pellet was resupended in 100 µl HU buffer (chapter 4.8) per 
1 absorption unit at OD600. Samples were stored at -20°c and the proteins were denatured by 
incubation at 65 °C for 10 min and analysed by western blot. 
 
4.14.2 Co-immunoprecipitations 
Myc-tagged Kar9p was immunoprecipitated with α-myc antibody from cell extracts. 100 µg of 
monoclonal α-myc antibody 9E11 (Acris Antibodies) was covalently coupled to 250 µl 
magnetic Protein-G beads (Dynabeads, Invitrogen) using dimethyl pimelimidate (DMP) as a 
cross linker according to the manufacturer’s instructions. The beads were stored in TBS at 
4°C until use. 20 µl of beads were equilibrated with lysis buffer (50 mM Tris-HCl, pH 7.5; 
150 mM NaCl, 5 % Glycerol, 0,2 % Triton-X 100). For precipitation of overexpressed Kar9p 
and Kar9p-mutants, a 50 ml culture with an OD600 of 4 was used. For precipitation of Kar9p 
expressed under the native promoter, a 1.5 l culture with an OD600 of 3 was used. The cells 
were lysed in lysis buffer by vortexing with glass-beads for 3 x 4 min. The lysate was cleared 
by centrifugation at 13200 rpm for 20 min and the supernatant incubated with the beads for 
at least 4 h at 4°C on a rotating wheel. After incubation, the beads were washed with lysis 
buffer 3 x for 5 min on a rotating wheel. To reduce unspecific binding of proteins, an 
additional washing step with 300 mM NaCl was performed. The beads were finally washed 
again with lysis buffer. To elute bound proteins and to avoid contamination with the antibody, 
10 µl of 100 mM Glycine pH 2.8 were added and incubated shortly (1-2 min) with the beads. 
The supernatant was transferred to a new tube and the beads were neutralized with 10 µl of 
1 M Tris-HCl pH 8.5. The whole process was repeated twice and the elution fractions 
collected in one tube. After addition of 4 x loading buffer, the sample was boiled at 98°C and 
the proteins separated on a 4 – 20 % Mini-protean TGX pre-cast gel (Bio-Rad, München, 
Germany). Proteins were visualized using a silver-stain kit (Pierce by Thermo Fisher 
Scientific). Desired proteins bands were cut out with a clean scalpel and analysed by mass-
spectrometry to identify proteins co-immunoprecipitating with Kar9p.  
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4.14.3 Benomyl- and temperature-sensitivity 
To analyse Bim1p and Kar9p mutations in vivo, yeast cells that were deleted for either BIM1 
or KAR9, were transformed with the respective plasmids carrying the mutation. Temperature 
sensitivity of the mutants was assayed in a colony growth test on agar-plates. 5 µl of 
logarithmically growing yeast cells were applied to SC-His (for Kar9p) or SC-Leu (for Bim1p) 
agar plates in serial 1:10 dilutions and incubated at 25 °C, 30°C and 37°C for 2 days. 
Benomyl is a fungicide that binds to microtubules and destabilizes them (Stearns, Hoyt 
et al. 1990). It is routinely used to assay mutations of proteins that affect the cell cycle. The 
assay was carried out as described for the temperature sensitivity on YPD agar plates 
containing 0, 2.5, 5, 7.5, 10, 12.5, 15 or 20 µg/ml of benomyl at 30°C for two days.  
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5 Summary  
Accurate positioning of the mitotic spindle relative to the plane of cytokinesis ensures proper 
distribution of the genetic material and of cell fate determinants. Failure in spindle orientation 
and migration can cause severe defects such as aberrant chromosome numbers, which is 
often correlated with the development of cancer.  
In all eukaryotes, spindle positioning is accomplished through interactions between 
cytoplasmic microtubules, actin filaments and the cell cortex. Many of the relevant proteins 
are conserved from yeast to human and the in vivo functions of the proteins are well 
understood in yeast. Therefore, budding yeast is a powerful model system to investigate the 
molecular details and control mechanisms required for accurate spindle positioning. In yeast, 
the spindle is aligned along the axis of division by a complex consisting of the type-V myosin 
Myo2p, the adapter Kar9p and the microtubule-binding protein Bim1p.  
The goal of this study was to elucidate the molecular principles underlying mitotic spindle 
positioning in budding yeast. In order to reach this goal, different structural techniques such 
as X-ray crystallography and small angle X-ray scattering (SAXS) were combined with 
various in vitro and in vivo assays to study the regulation of the Kar9p-Bim1p interaction.  
In this study, crystals of full-length Kar9p and Kar9p variants were obtained, but the X-ray 
diffraction properties were not sufficient to solve a three-dimensional structure. Yet, the 
crystal structure of the C-terminal cargo-binding domain of Bim1p was determined. The 
crystal structure revealed that the C-terminal domain of Bim1p is formed by a dimer. SAXS 
analysis confirmed that Bim1p is dimeric in solution. Structure-guided mutational analysis of 
Bim1p resulted in the identification of residues that either reduced or increased the 
interaction with Kar9p. Remarkably, the residues involved in cargo-binding in Bim1p are 
within a highly conserved region on the surface of the protein. Other studies have shown that 
this highly conserved region mediates cargo binding in the Bim1p homolog EB1, suggesting 
that both proteins interact with their cargo in a similar manner.  
To gain further insight into the regulation of complex assembly, the role of posttranslational 
modifications of both proteins was analysed. Sumoylation of Kar9p is required for binding to 
Bim1p, whereas phosphorylation of Kar9p is not. Furthermore, a yet unknown binding region 
for Kar9p in Bim1p was identified in the unstructured middle region. The middle region of 
Bim1p was only capable of Kar9p binding when the protein was dimerised and it was shown 
that the interaction via this region is regulated by phosphorylation by Aurora B.  
These results in combination with findings from other studies lead to a model that explains 
the cell-cycle dependent regulation of the assembly and disassembly of the Myo2p-Kar9p-
Bim1p complex. Complex assembly during metaphase is regulated by sumoylation of Kar9p, 
whereas the complex disassembly in late anaphase is regulated by phosphorylation of Bim1p 
by Aurora B.  
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7 Appendix 
7.1 Abbreviations 
%  per cent s seconds 
°C degree celcius SAD single anomalous diffraction 
Å angström SAXS Small angle X-ray scattering 
A260/280/600 absorption at 260/280/600 nm SDS Sodium Dodecyl Sulfate 
µ micro SeMet Selenomethionine 
Conc.  concentration TCA Trichloroacetic acid 
C-term C-terminus TLS Twin Lattice Symmetry 
Da Dalton Tris tris(hydroxymethyl)aminomethane 
DAPI 4',6-diamidino-2-phenylindole WT wild type 
DLS Dynamic light scattering σ sigma 
DNA Deoxyribonucleic acid   
E.coli Escherichia coli   
EDTA ethylenediaminetetraacetic acid   
FL Full-length   
g gram   
GST Glutathion-S-Transferase   
h Hours, human   
His Histidine   
I Intensity   
k kilo   
l litre   
M molar   
MES 2-(N-morpholino)ethanesulfonic 
acid 
  
min minute   
MBP Maltose binding protein   
MW Molecular weight   
n nano   
NaCl Sodium Chloride   
NCS Non Crystallographic Symmetry   
PAGE polyacrylamide gel 
electrophoresis 
  
PEG Polyethylene glycol   
Pt Platine   
PVFD polyvinylidene fluoride   
RMSD root-mean-square deviation   
rpm Rounds per minute   
RT Room temperature   
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7.2 Proteins identified by co-immunoprecipitations of Kar9p 
Mass-spectrometry of co-immunoprecipitations (co-IP) of Kar9p 
Tables show mass spectrometry results after CoIP. Co-IPs were performed with wild-type 
yeast and yeast strains harbouring mutations in the phosphorylation sites of Kar9p.  
left column: name of associated protein, middle column: number of measured peptides,  
right column: sequence coverage of peptide sequence in relation to protein sequence, cut off 
was 20% sequence coverage, bold: proteins known to be associated with Kar9p, italic: 
possible new interaction partners 
	   	   	  
Co-immunoprecipitations from YDH001 (WT) 
Protein Number of peptides Sequence coverage 
Tpm1p 23 86% 
Actin 18 73% 
Nap1p 14 64% 
Myo2p 53 62% 
Bim1p 1 3% 
	   	   	  
Co-immunoprecipitations from YDH003 (S197A) 
Protein Number of peptides Sequence coverage 
Tpm1p 15 72% 
Actin 15 35% 
Myo2p 51 30% 
Nap1p 5 16% 
Bim1p 1 3% 
	   	   	  
Co-immunoprecipitations from YDH004 (S496A) 
Protein Number of peptides Sequence coverage 
Actin 16 45% 
Myo2p 45 37% 
Tpm2p 4 36% 
Nap1p 7 27% 
Bim1p 1 3% 
   
Co-immunoprecipitations from YDH005 (S197A + S496A) 
Protein Number of peptides Sequence coverage 
Tpm1p 17 74% 
Actin 19 55% 
Myo2p 74 52% 
Nap1p 8 27% 
Bim1p 2 7% 
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7.3 Supplemental Figures and Tables 
 
Figure 29 Monomers A and B of Bim1p (C-term) are not related by a noncrystallographic symmetry axis. 
(A) Alignment of the two monomers A and B. The structure of the two monomers is not identical after 
superimposition. The monomers can be either aligned from residue 1-41 or from residue 41-106. Residues 43-46 
contain a highly conserved “FYF”-motif that might influence the difference in the structure. These residues are 
involved in the binding to Kar9p and also in forming intramolecular contacts. (B) Crystal packing in 
Bim1p (C-term) crystals. The protein-protein crystal-packing contacts do not seem to influence the structural 
difference between the two monomers. 
 
 
Crystallographic contacts of Bim1p 
Type of 
interface 
Number of 
interface residues 
Buried surface 
interface (Å2) 
∆iG 
(kcal/mol) 
∆iG 
P value 
coiled-coil 47 1987 -45.8 0.051 
dimer-dimer 10 434 -8.7 0.227 
dimer-dimer 10 350 -6.7 0.407 
dimer-dimer 8 314 -4.8 0.412 
∆iG indicates the calculated solvation free energy gain upon formation of 
the interface. A corresponding P-value above 0.5 indicates a lower-than-
average hydrophobicity and thus an interface likely to occur only in crystal 
packing. A P-value below 0.5 indicates a higher- than-expected 
hydrophobicity, indicating a potential protein-interaction surface in solution. 
Among the four interfaces with the largest buried surface interfaces (>300 
Å2) only the calculated values of the coiled-coil interaction are consistent 
with a physiologic dimer. Calculations have been performed with the EBI-
PISA server (http://www.ebi.ac.uk/msd-srv/prot_int/cgi-bin/piserver). 
 
Table 5 Data obtained from the PDBe PISA server 
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Figure 30 Sequence alignment of EB1-family members from different eukaryotes 
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